Home / About / Leadership Updates / Health Industry Updates

Health Industry Updates
from Leadership Directories

For daily updates, list-building, custom alerts, exporting, and more: 

 

January 12, 2017 

Biotech
 
MorphoSys AG appointed Malte Peters Chief Development Officer, effective March 1, 2017. He succeeds Arndt Schottelius, who is leaving the company to pursue other opportunities.
 
 
Charities
 
The Parkinson's Foundation, Inc. appointed John L. Lehr its first Chief Executive Officer following the recent merger of the National Parkinson Foundation and the Parkinson’s Disease Foundation to form the new organization.
 
 
Companies
 
HealthSouth Corporation appointed Troy DeDecker President of its Central Region.
 
Hologic, Inc. appointed Jan Verstreken Regional President for Europe, Middle East and Africa and Canada.
 
DaVita, Inc. announced that Joel Ackerman will join the company as Senior Vice President of Finance on or about February 21, 2017, and will assume the role of Chief Financial Officer on March 1, 2017. He replaces Jim Hilger, who has filled the role in an interim capacity since March 2015 and will continue in his role as Chief Accounting Officer.
 
VCA Inc. announced that it has entered into a definitive agreement to be acquired by Mars, Incorporated for approximately $9.1 billion. VCA will operate as a distinct and separate business unit within Mars Petcare and continue to be led by Bob Antin. The transaction is expected to close in the third quarter of 2017.
 
WellCare Health Plans, Inc. appointed Timothy Trodden Chief Human Resources Officer.
 
 
Corporate Boards of Directors
 
Hill-Rom Holdings, Inc. announced that Mary Garrett, former IBM Corporation marketing executive, and Nancy M. Schlichting, former President and Chief Executive Officer of Henry Ford Health System, will stand for election as directors at the company’s Annual Meeting of Shareholders on March 14, 2017. The company also announced that Eduardo R. Menascé will retire from the board at the meeting.
 
Valeant Pharmaceuticals International, Inc. announced that Richard U. DeSchutter has been appointed to its Board of Directors.
 
Aflac Incorporated announced that Karole F. Lloyd, Vice Chair and Southeast Regional Managing Partner for Ernst & Young, has been appointed to its Board of Directors.
 
DaVita Inc. announced that Pascal Desroches, Chief Financial Officer for Turner Broadcasting, has been appointed to its Board of Directors.
 
 
Hospitals and Health Systems
 
Lake Huron Medical Center has announced the retirement of Rebekah Smith as Chief Executive Officer in the spring of 2017.
 
Menorah Medical Center has appointed Jeff Taylor the new Chief Operating Officer.
 
Virtua Health has announced the retirement of President and Chief Executive Officer Richard P. Miller by the end of 2017.
 
Sisters of Charity Health System has named Thomas Strauss to serve as the new President and Chief Executive Officer.
 
Children’s National Health System has named Vittorio Gallo the new Chief Research Officer, effective July 1, 2017.
 
Children’s Minnesota has appointed Marc Gorelick the new President and Chief Operating Officer, effective March 20, 2017.
 

Pharmacy Benefit Management

Prime Therapeutics LLC appointed Mike Kolar Senior Vice President and General Counsel.

 

 

 

January 5, 2017 

Biotech
 
Alnylam Pharmaceuticals, Inc. announced that David-Alexandre Gros will resign as Senior Vice President and Chief Business Officer, effective January 6, 2017. The company also announced that it has promoted Pushkal Garg to Chief Medical Officer.
 
 
Companies
 
Illumina, Inc. appointed Garret Hampton Executive Vice President of Clinical Genomics, effective January 9, 2017. He succeeds Tristan B. Orpin, who previously announced his intent to step down from the role.
 
WellCare Health Plans, Inc. completed its previously announced acquisition of Care1st Health Plan Arizona, Inc. from Care1st Health Plan, Inc.
 
Gilead Sciences, Inc. appointed Alessandro Riva Senior Vice President and Hematology and Oncology Therapeutic Area Head.
 
Regeneron Pharmaceuticals, Inc. appointed Jay Markowitz Senior Vice President of Portfolio Management.
 
 
Hospitals
 
Saint Thomas Rutherford Hospital has named Timothy Bode the new Chief Medical Officer.
 
Loyola University Medical Center has named John Hart the new Vice President and Chief Integrity Officer.
 
Beth Israel Deaconess Hospital – Milton has named Richard Fernandez the new President and Chief Executive Officer, effective January 30, 2017. He replaces Peter Healy who is stepping down.
 

Medical Device Manufacturers

Cantel Medical Corp. appointed Dottie Donnelly Brienza Senior Vice President and Chief Human Resources Officer.

 

 

December 29, 2016 

Companies

McKesson Corporation completed its previously announced acquisition of Rexall Health for $2.9 billion CAD. In addition, the company appointed Domenic Pilla Chief Executive Officer of McKesson Canada.

 
 
 

December 22, 2016 

Biotech
 
Celldex Therapeutics, Inc. announced that Gerald McMahon, former President and Chief Executive Officer of Kolltan Pharmaceuticals, has been appointed to its Board of Directors. He replaces Richard van den Broek, who has resigned from the Board.
 
 
Companies
 
Biogen Inc. appointed Michel Vounatsos Chief Executive Officer and a member of the Board of Directors, effective January 6, 2017. He succeeds George A. Scangos, who previously announced his intention to step down once a replacement was named.
 
Endo International plc appointed Blaise Coleman Executive Vice President and Chief Financial Officer. He had been serving as Interim Chief Financial Officer since late November 2016.
 
Allergan plc announced on December 20, 2016, that it has entered into a definitive agreement to acquire LifeCell Corporation from Acelity L.P. Inc. for $2.9 billion. The transaction is expected to close during the first half of 2017.
 
ResMed Corp. appointed Carlos Nunez Chief Medical Officer, effective January 3, 2017. He succeeds Glenn Richards, who will continue with the company as Medical Director for Product Development.
 
Illumina, Inc. appointed Jonathan Seaton Senior Vice President of Corporate and Business Development, effective January 3, 2017.
 
Amedisys, Inc. appointed Gary D. Willis Chief Financial Officer, effective January 3, 2017. He assumes the role from Ronald A. LaBorde, who will continue to serve as Vice Chairman until he retires on April 2, 2017.
 
Endo International plc appointed Patrick Barry Senior Vice President of U.S. Branded Pharmaceuticals, effective immediately, and Matthew Davis Senior Vice President of Research and Development for Branded Pharmaceuticals, effective January 3, 2017. The company also announced that Joseph Ciaffoni has resigned as President of U.S. Branded Pharmaceuticals and in addition Susan Hall will resign as Executive Vice President, Chief Scientific Officer and Global Head of Research and Development, effective March 31, 2017.
 
 
Corporate Boards of Directors
 
Hologic, Inc. announced that Amy Wendell, former Senior Vice President of Strategy and Business Development at Covidien, has been appointed to its Board of Directors.
 
Quest Diagnostics Incorporated announced that its President and Chief Executive Officer Stephen H. Ruskowski will assume the additional role of Chairman of the Board of Directors, effective January 1, 2016. He succeeds Daniel C. Stazione, who will continue to serve as Lead Independent Director.
 
AmerisourceBergen Corporation appointed Keri Mattox Vice President of Corporate and Investor Relations, effective January 3, 2017. She succeeds Barbara A. Brungess, who is leaving the company at the end of 2016.
 
Bristol-Myers Squibb Company appointed its Chief Executive Officer Giovanni Caforio to the additional role of Chairman of the Board of Directors, effective at the company’s Annual Meeting of Shareholders on May 2, 2017. He assumes the role from Lamberto Andreotti, who plans to retire.
 
 
Health IT
 
Mediware Information Systems, Inc. announced on December 20, 2016, that it has entered into a definitive agreement to be acquired from Thoma Bravo by TPG Capital. The transaction is expected to close during the first quarter of 2017.
 
 
Hospitals
 
Adventist Health System Sunbelt Health has named Lars Houmann the new Chief Operating Officer.
 
Adventist Health System Sunbelt Healthcare has appointed Terry Shaw, former Executive Vice President and Chief Operating Officer, as the new President and Chief Executive Officer. He replaces Donald Jernigan who has retired.
 
 
Industry Service Providers
 
TRA Medical Imaging and Medical Imaging Northwest, two medical imaging providers in the South Sound, announced today that the two companies have completed their merger and will operate administratively as TRA-MINW starting January 1, 2017.
 
Capital Senior Living Corporation has announced the passing of Keith Johannessen who had been on medical leave after serving as President and Chief Operating Officer.
 
 
Pharmaceutical Manufacturers
 
Impax Laboratories, Inc. announced that G. Frederick Wilkinson has resigned as President, Chief Executive Officer and a member of the Board of Directors. He is replaced by current board member J. Kevin Buchi, who will fill the role in an interim capacity until a permanent replacement has been named.
 

Pharmacy Benefit Management

Prime Therapeutics LLC appointed John Drakulich Chief Sales Officer.

 

 

December 15, 2016 

Companies
 
Alexion Pharmaceuticals, Inc. appointed David R. Brennan Interim Chief Executive Officer, replacing David Hallan, who has resigned from the company and its board for personal reasons. The company also appointed David J. Anderson Executive Vice President and Chief Financial Officer, replacing Vikas Sinha, who resigned to pursue other opportunities.
 
Asahi Group Holdings, Ltd. announced on December 13, 2016, that it has entered into an agreement to acquire from Anheuser-Busch InBev SA/NV its businesses in the Czech Republic, Slovak Republic, Poland, Hungary and Romania other related assets that were owned by SABMiller plc prior to their merger for approximately $7.8 billion. The transaction is expected to be completed in the first half of 2017.
 
Valeant Pharmaceuticals International, Inc. appointed William D. Humphries Executive Vice President of Dermatology, effective January 2, 2017. The company also announced that Anne Whitaker will leave the company on January 13, 2017, and Rob Rosiello and Ari Kellen will leave at the end of the 2016.
 
 
Corporate Boards of Directors
 
Unum Group announced that Kevin T. Kabat will be appointed Chairman of the Board of Directors at its Annual Meeting of Shareholders in May 2017. He succeeds Thomas R. Watjen, who previously announced his intention to retire from the board.
 
 
Hospitals
 
MemorialCare Health System has named Kristen Pugh as the Vice President of Advocacy and Government Relations.
 
St. Jude Children’s Research Hospital has named Ellis J. Neufeld the new Clinical Director, Physician-in-Chief and Executive Vice President, effective March 2017.
 
Sinai Hospital of Baltimore has announced Amy Perry will step down as President, effective January 20, 2017.
 
O’Connor Hospital has announced that Carlton Rule will step down as Chief Executive Officer and Administrator, effective March 1, 2017.
 
Rush University Medical Center has appointed Shafiq Rab the new Senior Vice President and Chief Information Officer, effective January 9, 2017.
 
Stanford Health Services has appointed David Jones the new Chief Human Resources Officer effective January 3, 2017.
 
Beaufort Memorial Hospital has appointed Ken Miller the new Chief Financial Officer. He replaces Jeff White who has retired.
 
TriHealth has named Andrew DeVoe the new Chief Financial Officer, a post he has served in an interim capacity since July of this year.
 
Good Samaritan Hospital Medical Center has named Justin Jaycon the new Director of Public Affairs and Marketing.
 
Geisinger Health System has named Anthony Aquilina the new Regional President and Ronald Beer the new Chief Administrative Officer for Geisinger Northeast respectively.
 
 
Insurance and Managed Care
 
Health Partners Plans, Inc. appointed Mark Cary Senior Vice President of Medicare Sales and Actuarial Services.
 
Priority Health Managed Benefits, Inc. appointed James D. Forshee Senior Vice President of Medical Affairs and Chief Medical Officer.
 
 
Pharmaceutical Manufacturers
 
Ipsen S.A. announced that Claude Bertrand will resign as Executive Vice President of Research and Development and Chief Scientific Officer, effective January 2, 2017. Alexandre Lebeaut will head the research and development division in the interim until a permanent replacement is named.

 

 

December 8, 2016

Biotech

Compugen Ltd. appointed Kirk A. Christoffersen Senior Vice President of Corporate and Business Development.
 
Exelixis, Inc. appointed Susan Hubbard Executive Vice President of Public Affairs and Investor Relations and appointed Stefan Krauss Vice President of Business Development.
 
 
Companies
 
Eisai Inc. appointed Rebecca Jolley as Senior Vice President of Americas Commercial for its Oncology Business Group.
 
Envision Healthcare Holdings, Inc. and AmSurg Corp. completed their merger on December 1, 2016. The combined company now operates as Envision Healthcare Corporation.
 
Teva Pharmaceutical Industries Ltd. appointed Dipankar Bhattacharjee President and Chief Executive Officer of its Global Generic Medicines Group. He succeeds Sigurdur Olafsson, who has stepped down from the role and will retire from the company in early 2017.
 
The Allstate Corporation appointed John Dugenske Executive Vice President and Chief Investment Officer, effective in early 2017.
 
Abbott Laboratories announced that it has filed a complaint to terminate its previously announced agreement to acquire Alere, Inc., as it believes Alere has lost significant value since the transaction was agreed upon.
 
Illumina, Inc. appointed Sam A. Samad Senior Vice President and Chief Financial Officer, effective January 6, 2017. He assumes the role from Marc Stapley, who will continue to serve as Executive Vice President and Chief Administrative Officer.
 
 
Hospitals
 
Cox Medical Center Branson has appointed James Duff the new Chief Medical Officer.
 
Sentara Northern Virginia Medical Center has appointed Katherine A. Johnson, former Vice President and Chief Operating Officer, the new President. She replaces Stephen D. Porter who has stepped down.
 
Cancer Treatment Centers of America has appointed Nancy G. Hesse the new President and Chief Executive Officer of Eastern Regional Medical Center. She has previously served in the role in an interim capacity since February of this year.
 
Dartmouth-Hitchcock Health has announced that James Weinstein will retire as President and Chief Executive Officer at the end of June 2017.
 
McLaren Health Care has appointed Michael P. Lacusta the new Vice President of Business Development.
 
PriMed Management Consulting Services has announced that Tim Richards will serve as Chief Financial Officer. He succeeds Rick Messman who has stepped down.
 
 
Insurance and Managed Care
 
Health Partners Plans, Inc. appointed Kalyan Narayanan Vice President and Chief Technology Officer.
 
Kaiser Permanente appointed Bechara Choucair Senior Vice President of Community Health and Benefit and Chief Community Health Officer.
 
Blue Cross and Blue Shield of Minnesota appointed Aaron Friedkin Medical Director for Key Accounts and Dan Trajano Senior Medical Director for the STARS and Risk Adjustment Center of Excellence.
 
 
Pharmaceutical Manufacturers
 
Taro Pharmaceutical Industries Ltd. appointed Abhay Gandhi Interim Chief Executive Officer, effective following the departure of Kal Sundaram on January 1, 2017. Mr. Gandhi will fill the roll until Uday Baldota assumes leadership of the company in April 2017.
 

 

 

December 1, 2016

Associations

The Joint Commission on Accreditation of Healthcare Organizations appointed Kin Y. Lee Chief Information and Security Officer.
 
 
Companies
 
McKesson Corporation promoted Paula Keays from Senior Vice President to President of its Canadian subsidiary.
 
Quintiles IMS Holdings, Inc. appointed W. Richard Staub, III, President of its Research and Development Solutions business unit, replacing Thomas H. Pike, who is retiring from the company.
 
  
Corporate Boards of Directors
 
Invacare Corporation announced that Susan H. Alexander, Executive Vice President, Chief Legal Officer and Corporate Secretary of Biogen, has been appointed to its Board of Directors.
 
 
Hospitals
 
TriHealth, Inc. has appointed Jamahal C. Boyd Sr. the new Director of Diversity, Inclusion and Language Services reporting to David Cook Jr.
 
Verity Health has appointed Jordan Herget as the new President and Chief Executive Officer of Saint Louise Regional Hospital and O’Connor Hospital.
 
McLaren Greater Lansing has named Casey Kandow the new Chief Operating Officer. Mr. Kandow most recently served as the Director for Laboratory Operations for McLaren Medical Laboratory.
 
Day Kimball Healthcare has announced the resignation of Robert Smanik as the President and Chief Executive Officer. His post will be filled by Joseph Adiletta on an interim basis.
Piedmont Medical Center has appointed Jim Riley the new Chief Operating Officer.
 
Billings Clinic has announced the resignation of Nicholas Wolter as the Chief Executive Officer, effective January 2017. Randall Gibb, current Chief Medical Officer of Clinics will serve in an interim capacity.
 
Medical College of Wisconsin has appointed C. Greer Jordan the new Chief Diversity and Inclusion Officer.
 
San Joaquin Community Hospital has named Sharlet Briggs the new President and Chief Executive Officer.  She had been serving in an interim capacity since earlier this year.
 
Tampa General Hospital has announced the resignation of James R. Burkhart as President and Chief Executive Officer. His post will be filled on an interim basis by Steve Short, current Executive Vice President and Chief Financial Officer.
 
 
Insurance and Managed Care
 
Hylant Group, Inc. promoted JPaul Dixon to Senior Vice President of its Ann Arbor, Michigan office.
 
Capital BlueCross appointed Jack Jaroh Senior Vice President of Commercial Group Sales.
 
 
Pharmaceutical Manufacturers
 
Impax Laboratories, Inc. announced that J. Kevin Buchi, President and Chief Executive Officer of TetraLogic Pharmaceutical Corporation, has been appointed to its Board of Directors.
 
 
Research Organizations
 
The Salk Institute for Biological Studies announced that Theodore W. Waitt, Chairman of the Waitt Foundation and Co-Founder of Gateway, has been appointed Chairman of the Board of Trustees. He succeeds Irwin M. Jacobs, who will remain on the Board as Chairman Emeritus.
 
Cold Spring Harbor Laboratory appointed David A. Tuveson Director of its NCI-Designated Cancer Center.
 
 
 
 

November 23, 2016

Companies

WellCare Health Plans, Inc. announced on November 17, 2016, that it has entered into a definitive agreement to acquire Universal American Corp. The transaction is expected to close in the second quarter of 2017.
 
Gilead Sciences, Inc. promoted James R. Meyers from Senior Vice President of North American Commercial Operations to Executive Vice President of Worldwide Commercial Operations.
 
Nuance Communications, Inc. announced that Paul Ricci will retire as Chairman and Chief Executive Officer at the end of his employment agreement, which is scheduled to end on March 28, 2016. The company also announced that Bill Robbins has resigned as Executive Vice President of Worldwide Sales to pursue another opportunity outside of the company.
 
WebMD Health Services Group, Inc. appointed Brad Kirkpatrick Chief Client Officer.
 
Pfizer Inc. announced that Anthony J. Maddaluna plans to retire as Executive Vice President and President of Pfizer Global Supply. He will be succeeded by Kirsten Lund-Jurgensen, who will assume the position on December 30, 2016.
 
Smith Drug Company appointed Jeff Schneider Vice President of Long Term Care (LTC) Pharmacy Solutions.
 
Select Medical Holdings Corporation appointed Scott Nordlund Executive Vice President of Partnership Growth and Innovation.
 
 
Group Purchasing Organizations
 
Premier Inc. appointed Andrew Ziskind, MD, Senior Vice President of Academic Strategy.
 
 
Pharmaceutical Manufacturers
 
Taro Pharmaceutical Industries Ltd. appointed Uday Baldota Chief Executive Officer, effective on or about April 1, 2017. He succeeds Kal Sundaram, who previously announced his intent to retire at the end of the year.
 
Enanta Pharmaceuticals, Inc. announced that Lesley Russell, Chief Medical Officer at Innocoll Holdings, has been appointed to its Board of Directors.
 
 
Research Organizations
 
The Buck Institute for Research on Aging appointed Eric M. Verdin, MD, President and Chief Executive Officer. He succeeds Edward Lanphier, who has been filling the role in an interim capacity and will continue to serve on the Board of Trustees and as an advisor to Mr. Verdin.
 
 
 

November 17, 2016

Associations

Health Center Partners of Southern California appointed Frank Whelan Senior Vice President of Finance.
 
 
Biotech
 
Vermillion, Inc. appointed Marra Francis, MD, Chief Medical Officer.
 
 
Charities
 
The Susan G. Komen Breast Cancer Foundation, Inc. announced that Judy Salerno will step down as President and Chief Executive Officer and assume the role of Senior Advisor, effective December 15, 2016. She will be succeeded by the nonprofit’s General Counsel, Ellen Willmott, who will fill the role in an interim capacity.
 
 
Companies
 
Tenet Healthcare Corporation appointed Octavio “Tavi” Diaz Chief Medical Officer, effective December 1, 2016.
 
HCA Holdings, Inc. promoted Samuel N. Hazen from Chief Operating Officer to President and Chief Operating Officer.
 
Kimberly-Clark Corporation promoted Michael D. Hsu from Group President of North American Consumer Products to President and Chief Operating Officer, effective January 1, 2017.
 
Anthem, Inc. appointed Scott Towers President of its Dental Business, effective November 28, 2016. He succeeds Michael Malouf, who has decided to step down from the position.
 
  
Corporate Boards of Directors
 
Perrigo Company plc announced that Geoffrey M. Parker, former Chief Financial Officer of Anacor Pharmaceuticals, and Theodore R. Samuels, President of Capital Guardian Trust Company, have been appointed to its Board of Directors. Mr. Parker’s appointment is effective immediately and that of Mr. Samuels is effective January 1, 2017. The company also announced that Michael Jandernoa and Gary Kunkle will not stand for re-election at the 2017 Annual General Meeting of Shareholders.
 
Allergan plc announced that Adriane M. Brown, President and Chief Operating Officer of Intellectual Ventures LLC, has been appointed to its Board of Directors.
 
Torchmark Corporation announced that Steven P. Johnson, former Deloitte & Touche executive, has been elected to its Board of Directors.
 
 
Hospitals
 
Adventist Health has named Karl Nebel the new Chief Strategy and Information Officer.
 
Howard County General Hospital has appointed Elizabeth Edsall Kromm the new Vice President of Population Health and Advancement, who has served as Senior Director of Population Health and Community Relations.
 
Jellico Community Hospital, Inc. has named Farrell Turner as the new Chief Financial Officer on an interim basis.
 
BayCare Health System has named Teri Sholder the new Senior Vice President and Chief Quality Officer.
 
Christus Mother Frances Hospital has appointed Shelly Johnson the new Chief Executive Officer. She replaces Janet Coates who has stepped down.
 
Aurora Diagostics, LLC has named Catherine Dumur the new Director of Molecular and NGS Development.
 
Saint Francis Medical Center has announced the resignation of Dan McElligott, effective November 23, 2016.

 

 

November 10, 2016

Companies

Endo International plc appointed Terrance J. Coughlin Executive Vice President and Chief Operating Officer and promoted Antonio R. Pera to President of Par Pharmaceutical.

Bioventus, LLC appointed Andrew McCartney Managing Director of International for Europe, Middle East and Africa.

Teva Pharmaceutical Industries Ltd. promoted David Stark from Deputy Chief Legal Officer to Chief Legal Officer, replacing Richard Egosi, who is taking a leave of absence.

Kemper Corporation appointed Naimish P. Patel Executive Vice President of its Kemper Preferred business.

 
Corporate Boards of Directors

Magellan Health, Inc. announced that G. Scott MacKenzie, Chief Executive Officer of M*Modal, has been appointed to its Board of Directors.

Kindred Healthcare, Inc. announced that Lynn Simon, President of Clinical Services and Chief Quality Officer for Community Health Systems, has been appointed to its Board of Directors.

Tenet Healthcare Corporation announced that John P. Byrnes, former Chairman and Chief Executive Officer of Lincare Holdings, and Peter M. Wilver, Executive Vice President and Chief Administrative Officer of Thermo Fisher Scientific, have been appointed to its Board of Directors.

Health Systems

McLaren Health Care has named Robert Flora the new Chief Academic Officer.

Sheppard Pratt Health System has appointed Ray Dziensinski the new Chief Financial Officer.

 
Hospitals

St. David’s Round Rock Medical Center has named Tami Taylor the new Chief Nursing Officer.

Monmouth Medical Center has named Joanna Zimmerman the new Chief Financial Officer.

Mercy Health Network has announced that David Vellinga will retire as President and Chief Executive Officer in 2017.

St. Anthony Hospital has appointed Edward H. Sims the new President and Chief Executive Officer, effective January 3, 2017.  He replaces Patrick Green who has been serving in an interim capacity.

Brattleboro Memorial Hospital has announced the promotion of Steven P. Cummings from Chief Implementation Officer to Vice President, Information and Support Services. Jonathan Farina has also been promoted from Director of Information Services to Chief Compliance and Security Officer.

St. Joseph Mercy Livingston has appointed Sharon Blanche the new Chief Nursing Officer.

OSF Saint Anthony’s Health Center has appointed Dennis Sands the new Vice President and Chief Medical officer.

Fairview Health Services has appointed James Hereford as President and Chief Executive Officer, effective December 12, 2016.

 
 

 

November 3, 2016

Companies
 
Astellas USA Foundation appointed Moya Knight President. She succeeds Jeffrey A. Winton, who will continue in his role as the company’s Senior Vice President of Corporate Affairs.
 
Varian Medical Systems, Inc. announced that Elisha W. Finney plans to retire as Chief Financial Officer once a successor is named, which is expected to occur in 2017.
 
HealthSouth Corporation announced that Jay Grinney will retire as President, Chief Executive Officer and a member of the Board of Directors at the end of 2016. He is succeeded by Mark J. Tarr, who will be promoted from Executive Vice President and Chief Operating Officer. Mr. Tarr’s current position will be assumed by Barabara Jacobsmeyer.
 
Patterson Companies, Inc. promoted Dave Misiak from President of Patterson Dental U.S. to President of Patterson Dental North America and Dave Lardy from Vice President of Enterprise Business Services to Chief Information Officer.
 
Team Health Holdings, Inc. announced that it has entered into a definitive agreement to be acquired by funds affiliated with Blackstone for approximately $6.1 billion. The transaction is expected to close in the first quarter of 2017. Once completed, Team Health will become a privately owned company.
 
Amgen Inc. appointed Lori Johnston Senior Vice President of Human Resources, effective December 9, 2016.
 
 
Corporate Boards of Directors
 
Allergan plc announced that its President and Chief Executive Officer, Brenton L. Saunders, has been elected to the additional position of Chairman of the Board of Directors. He succeeds Paul Bisaro, who is stepping down as Executive Chairman but will remain a member of the Board. The company also announced that Christopher Coughlin has been elected Lead Independent Director.
 
Masimo Corporation announced that Adam Mikkelson, Partner at Camber Capital Management, has been elected to its Board of Directors.
 
Catalent, Inc. announced that Uwe Röhrhoff, Chief Executive Officer of Gerresheimer AG, has been appointed to its Board of Directors. The company also announced that Chinh Chu and E. Bruce McEvoy have resigned from the board, President and Chief Executive Officer John Chiminski has assumed the additional position of Chair, and Jack Stahl has been appointed Lead Director.
 
 
Health Research Organizations
 
The Buck Institute for Research on Aging appointed Edward O. Lanphier, III, President and Chief Executive Officer. He succeeds Brian Kennedy who has resigned from the position.
 
Medical Device Manufacturers
 
Haemonetics Corporation announced that Catherine M. Burzik, former President and Chief Executive Officer of Kinetic Concepts, has been elected to its Board of Directors.
 
 
 

October 27, 2016

Companies
 
Endo International plc announced that Suketu Upadhyay will resign as Executive Vice President and Chief Financial Officer, effective November 22, 2016. Blaise Coleman, the company’s Senior Vice President of Global Finance Operations, will serve as Interim Chief Financial Officer until a permanent replacement has been named.
 
Invacare Corporation promoted Ralf Ledda to Senior Vice President and General Manager of Europe, Middle East and Africa, effective November 1, 2016. He currently serves as Managing Director of Alber GmbH, the company’s German-based subsidiary.
 
Diplomat Pharmacy, Inc. promoted Paul Urick from Senior Vice President to President, effective November 1, 2016. He succeeds Gary Kadlec, who will be retiring from the company at the end of the year but will continue to serve on the Board of Directors. The company also announced that Sean M. Whelan will resign as Chief Financial Officer at the end of the year.
 
Group Purchasing Organizations
 
Vizient, Inc. promoted David Levine from Vice President to Senior Vice President of Advanced Analytics and Informatics.
 
Hospitals
 
Presbyterian Healthcare Services has announced the appointment of Dale Maxwell as the President and Chief Executive Officer on an interim basis, effective January 16, 2017. He will replace James Hinton who has stepped down to serve as the future President and Chief Executive Officer for Baylor Scott and White Health.
 
Ascension Health has appointed Ferry Lewis the new Senior Vice President and Chief Information Officer, as well as Chief Executive Officer for Ascension Information Services.
 
Deaconess Health System has announced that Linda White will retire as President and Chief Executive Officer, effective June 30, 2017.
 
Saint Francis Hospital – Memphis has named Samuel Pieh as the new Chief Operations Officer.
 
Adena Health System has announced that Mark Shuter is stepping down as President and Chief Executive Officer.
 
Olean General Hospital has appointed Vi-Anne Antrum the new Chief Nursing Officer. She replaces Jeff Zewe who now serves as the Chief Operating Officer.
 
Holy Name Medical Center has appointed Kristen Silberstein the new post of Vice President and Chief Experience Officer.
 
ICON plc has announced that Ciaran Murray will transition from Chief Executive Officer to Chairman of the Board, effective March 1, 2017. He will be replaced by Steve Cutler who has served as Chief Operating Officer.
 
Insurance and Managed Care
 
Hylant Group, Inc. appointed Debbie Fischer Vice President and Property and Casualty Service Leader. She most recently served as the company’s Vice President of Client Services. 
 
 
 

October 20, 2016

Biotech
 
SIGA Technologies, Inc. appointed Phil Gomez Chief Executive Officer. He succeeds Eric Rose, who will continue with the company as Executive Chairman.
 
Companies
 
WellCare Health Plans, Inc. appointed Elizabeth Miller State President of Florida. She succeeds Gregg MacDonald, who now overseas Florida, Georgia and South Carolina.
 
Corporate Boards of Directors 
 
Amgen Inc. announced that Ellen J. Kullman, former Chairman and Chief Executive Officer of DuPont, has been appointed to its Board of Directors.
 
Health IT
 
Computer Programs and Systems, Inc. (CPSI) appointed William J. Hayes Medical Director with its Physician Adoption team.
 
Hospitals
 
The University of Arkansas for Medical Sciences in Little Rock has named Dr. Richard Turnage the new Vice Chancellor for Clinical Programs and Chief Executive Officer for its Medical Center.
 
Aroostook Medical Center has appointed Gregory LaFrancois as the new President and Chief Executive Officer, effective November 14, 2016. He replaces Glenda Dwyer who has been serving in an interim capacity.
 
Capital Health System has announced the appointment of Dr. Michael Stiefel as the new Institute for Neurosciences Director, a new post within the organization. 
 
Insurance and Managed Care
 
Hylant Group, Inc. promoted Andria Herr from President of its Orlando Office to Senior Vice President of Employee Benefits Client Strategy and Resource Development. She will continue to be based in the company’s Orlando office.
 
Medical Device Manufacturers
 
Integer Holdings Corporation announced that Donald J. Spence, former Chairman and Chief Executive Officer of Lake Region Medical, has been elected to its Board of Directors.
 
 

October 13, 2016

Biotech
 
Acorda Therapeutics, Inc. announced that Michael Rogers has resigned as Chief Financial Officer. David Lawrence has assumed the additional role of Principal Accounting Officer.
 
Regulus Therapeutics Inc. appointed Timothy M. Wright Chief Research and Development Officer.
 
 
Companies
 
WellCare Health Plans, Inc. announced on October 6, 2016, that it has entered into an agreement to acquire Care1st Health Plan Arizona, Inc., a subsidiary of Care1st Health Plan, Inc., for approximately $157.5 million. The transaction is expected to close by the first quarter of 2017.
 
Ardent Health Services, Inc. announced on October 5, 2016, that it has entered into a definitive agreement to merge with LHP Hospital Group, Inc. Ardent staff will continue to run the combined company and Ardent will assume LHP's management and operational responsibilities within each of its joint venture partnership facilities. The transaction is expected to close in early 2017.
 
Valeant Pharmaceuticals International, Inc. appointed Louis W. Yu Chief Quality Officer, Global Quality.
 
Boston Scientific Corporation appointed Ian Meredith Executive Vice President and Global Chief Executive Officer, effective January 2017. He succeeds Keith Dawkins, who will be retiring from the company.
 
Brookdale Senior Living Inc. appointed Cedric T. Coco Executive Vice President and Chief People Officer.
 
 
Corporate Boards of Directors 
 
HMS Holdings Corp. announced that Alex Michael Azar II, President of Lilly USA, has been appointed to its Board of Directors.
 
 
Health IT
 
Extreme Networks, Inc. appointed Simon Naylor Vice President of Sales for the Asia-Pacific region.
 
 
Hospitals
 
Skiff Medical Center has announced that Brett Altman is stepping down as President and Chief Executive Officer, effective January 2, 2017.
 
St. David’s Georgetown Hospital has appointed Skyler Reed the new Chief Operating Officer. He replaces Ruben Castro who has stepped down.
 
Baylor Scott and White Health has appointed James H. Hinton the new President and Chief Executive Officer, effective January 16, 2017.
 
Baylor Scott and White has appointed Darryl Elmouchi the new Chief Medical Officer of Spectrum Health Hospitals.
 
Providence Health and Services has announced Steve Burdick will be stepping down as Chief Executive of Providence St. Mary Medical Center by the end of the year.
 
Concord Hospital has appointed Amy Guilfoil-Dumont the new Chief Nursing Officer.
 
Sarasota Memorial Health Care System has named Connie Andersen the new Chief Nursing Officer. She replaces Jan Mauck who has stepped down.
 
Eastern Maine Health System has announced that Charlie Therrien will be appointed the new President of Mercy Hospital, effective Mid-November 2016.
 
Ascension Health has announced Mike Schatzlein is stepping down as President and Chief Executive Officer, effective December 31, 2016.
 
 
Insurance and Managed Care
 
Blue Cross and Blue Shield of Massachusetts, Inc. promoted Andreana Santangelo from Chief Actuary to Executive Vice President and Chief Financial Officer, effective immediately. She succeeds Allen Maltz, who is retiring from the company at the end of the year.
 
Arkansas Blue Cross and Blue Shield appointed Herbert H. “Bert” Price, III, as Corporate Medical Director.
 
 
Pharmaceutical Manufacturers
 
Taro Pharmaceutical Industries Ltd. appointed Mariano Balaguer Vice President, Chief Financial Officer and Chief Accounting Officer.
 
 

October 6, 2016

Biotech
 
Prothena Corporation plc promoted Gene G. Kinney from Chief Scientific Officer to President, Chief Executive Officer and a member of the Board of Directors. He succeeds Dale B. Schenk, who recently passed away. 
 
 
Corporate Boards of Directors 
 
WellCare Health Plans, Inc. announced that H. James Dallas, consultant and former Senior Vice President of Quality and Operations for Medtronic, has been appointed to its Board of Directors. 
 
 
Hospitals
 
Parkridge Health System has announced that Darrell Moore is retiring as Chief Executive Officer, by December of this year.
 
RCCH HealthCare Partners has announced that Martin Rash, current Executive Chairman of the organization, will take on the additional role of President and Chief Executive Officer. He replaces Michael Wiechart who has resigned.
 
Kosair Children’s Hospital has announced that effective November 10 of this year, the hospital will be changing its name to North Children’s Hospital.
 
 
Pharmacies
 
National HealthCare Corporation announced that Donald K. Daniel and Charlotte A. Swafford will retire from the company, effective December 31, 2016. Jeffrey R. Smith will succeed Mr. Daniel as Senior Vice President, Controller and Principal Accounting Officer and Brian F. Kidd will succeed Ms. Swafford as Senior Vice President and Treasurer. 
 
 
Pharmaceutical Manufacturers
 
Inotek Pharmaceuticals Corporation announced that Timothy J. Barberich, former Chairman and Chief Executive Officer of Sepracor, has been appointed to its Board of Directors.
 
Noven Pharmaceuticals, Inc. appointed Ralph Lipp Vice President and Chief Scientific Officer.
 
Merrimack Pharmaceuticals, Inc. announced that Robert Mulroy has resigned as President, Chief Executive Officer and a member of the Board of Directors as part of a corporate restructuring initiative. The company’s Chairman of the Board, Gary Crocker, was appointed interim President and Chief Executive Officer. 

 

September 29, 2016

Associations
 
New Jersey Hospital Association announced that Elizabeth “Betsy” A. Ryan will retire as Chief Executive Officer in July 2017.
 
 
Biotech
 
Exelixis, Inc. announced that Julie Anne Smith, President and Chief Executive Officer of Raptor Pharmaceuticals, has been elected to its Board of Directors.
 
 
Companies
 
Endo International plc appointed Paul V. Campanelli President, Chief Executive Officer and a member of the Board of Directors. He had previously been serving as President of its Par Pharmaceutical division. Campanelli succeeds Rajiv De Silva, who has stepped down from his position.
 
WellCare Health Plans, Inc. appointed Anat Hakim Senior Vice President, General Counsel and Secretary.
 
WebMD Health Corp. promoted Blake DeSimone from Senior Vice President of Finance to Executive Vice President and Chief Financial Officer. He succeeds Peter Anevski, who has left the company.
 
Pfizer Inc. announced that it completed its previously announced acquisition of Medivation, Inc.
 
 
 
Health Systems
 
Geisinger Health System has announced it will acquire The Commonwealth Medical College to form the new Geisinger Commonwealth College of Medicine, pending regulatory approval from local, state and accrediting agencies.
 
 
 
Hospitals
 
Pardee Hospital has announced the appointment of Andrew Wampler as the new Chief Financial Officer, effective October 3, 2016.
 
Emory Healthcare has appointed Sharon Pappas as the new Chief Nursing Executive, effective November 14, 2016. She comes from Centura Health where she has been serving as Chief Nursing Officer since 1998. She replaces June Connor who has been serving in an interim capacity since earlier this year.
 
BJC HealthCare has named Chris Watts as the new President of Barnes-Jewish St. Peters Hospital and Progress West Hospital, effective in early November 2016. He currently services as Vice President of Planning and Construction, since 2015. He replaces Larry Tracy who has been serving since 2013.
 
BJC HealthCare has named David Aplington as the new Senior Vice President and General Counsel, effective January 1, 2017. He replaces Michael DeHaven who is retiring.
 
Florida Hospital Carrollwood has named Chris Sauder as the new Vice President and Chief Financial Officer. He comes from Frank R. Howard Memorial Hospital where he served in a similar capacity.
 
Largo Medical Center has appointed Stephanie McNulty as the new Chief Operating Officer. She comes from St. Petersburg General Hospital where she most recently held a similar post.
 
Roper St. Francis has appointed Lorraine Lutton the new President and Chief Executive Officer, effective November 14, 2016. She will serve as the first female CEO of the institution and comes from St. Joseph’s Hospital where she most recently served as President.  She succeeds David Dunlap who will be retiring after 13 years of service.
 
Mercy Medical Center – Sioux City has named Jacob Trierweller the new Manager of Medical/Oncology.
 
Miami Valley Hospital has named Marc Belcastro the new Chief Medical Officer.
 
Saint Mary’s Regional Medical Center has named Shibu Skaria as the new Chief Medical Officer, replacing Jose Aguirre who has stepped down.
 
 
 
Industry Service Providers
 
PriMed Management, the management services organization for Hill Physicians Medical Group, has named Umang Jain to the role of Chief Information Officer. He replaces Craig Lanway who is stepping down.
 
 
 
Research Organizations

 

The Patient-Centered Outcomes Research Institute announced that Russell Howerton, Vice President of Clinical Operations and Chief Medical Officer at Wake Forest Baptist Medical Center, and Kathleen Troeger, Director of Outcomes Research at Hologic, have been appointed to its Board of Directors.
 

 

September 22, 2016

Charities

LUNGevity Foundation announced that Lynne Doughtie, Chairman and Chief Executive Officer of KPMG, and Peitao (Patrick) Chen, Chief Executive Officer of JD Capital USA, have been appointed to its Board of Directors.

 

Companies

Kimberly-Clark Corporation announced that Lizanne C. Gottung will retire as Senior Vice President and Chief Human Resources Officer at the end of 2016. She will be succeeded by Scott Boston, who will be promoted to the position from Vice President of Human Resources.

Johnson & Johnson announced that it has entered into a definitive agreement to acquire Abbott Medical Optics from Abbott Laboratories for $4.325 billion. The transaction is expected to close in the first quarter of 2017.

Kemper Corporation appointed Christine “Chris” Theros Mullins Senior Vice President and Chief Human Resources Officer, effective October 2016. She succeeds Lisa M. King, who is retiring from the company. In a separate announcement the company also appointed James J. McKinney Senior Vice President and Chief Financial Officer, effective November 2016. He succeeds Frank J. Sodaro, who will serve as a Senior Advisor through the end of the year. Richard Roeske, the company’s Vice President and Chief Accounting Officer, will serve as interim Chief Financial Officer until McKinney joins the company.

WebMD Health Corp. promoted Steven L. Zatz from President to Chief Executive Officer. He succeeds David J. Schlanger, who is leaving the company by mutual agreement.

PAREXEL International Corporation appointed Christian Dreger Senior Vice President of PAREXEL Access and PAREXEL Consulting.

Molina Healthcare, Inc. appointed Britt Travis Vice President of Medicare Sales.

GlaxoSmithKline plc appointed Emma Walmsley Chief Executive Officer, effective after the retirement of current Chief Executive Officer Andrew Witty on March 31, 2017. She will join the company’s Board of Directors on January 1, 2017.

Allergan plc announced on September 20, 2016, that it has entered into a definitive agreement to acquire Tobira Therapeutics, Inc. for $1.695 billion. The transaction is expected to close by the end of 2016.

Laboratory Corporation of America Holdings appointed John D. Ratliff Chief Executive Officer of Covance Drug Development, effective October 1, 2016. He succeeds Deborah L. Keller, who is leaving the company.

 

Hospitals

Sibley Memorial Hospital has named Dr. Matthew Ladra the new Head of the Pediatric Radiation Oncology Program. 

The Children’s Hospital of Philadelphia has named Dr. Eric Eichenwald the new Chief of Neonatology in the Department of Pediatrics. 

Saint Anne’s Hospital has named Michael Bushell the new President, effective October 3, 2016.

OSF Healthcare has announced that Kevin Schoeplein will be retiring as Chief Executive Officer by the end of 2017.

SSM Health has named Alexander Garza the new Chief Medical Officer.

 
 

September 15, 2016

Companies
 
Acelity L.P., Inc. announced that Tom Casey will resign as Executive Vice President and Chief Financial Officer, effective September 16, 2016. Todd Wyatt, Vice President of Global Corporate Finance, will serve as interim Chief Financial Officer until a replacement has been named.
 
Eli Lilly and Company appointed Levi Garraway Senior Vice President of Global Development and Medical Affairs for Lilly Oncology, effective January 1, 2017.
 
Bayer AG announced on September 14, 2016, that it has entered into a definitive agreement to acquire Monsanto Company. The combined business will have its global Seeds & Traits and North American commercial headquarters in St. Louis, MO, and its global Crop Protection and overall Crop Science headquarters in Monheim, Germany. The transaction is expected to close by the end of 2017.
 
Corporate Boards of Directors
 
Regeneron Pharmaceuticals, Inc. announced that scientists Bonnie L. Bassler and Huda Y. Zoghbi have been appointed to its Board of Directors.
 
Health IT
 
The SSI Group, Inc. appointed David Watson Executive Vice President.
 
Health Research Organizations
 
The Gary and Mary West Health Institute promoted Zia Agha to Chief Medical officer. She will continue to serve as Executive Vice President of Clinical Research and Informatics.
 
Hospitals 
 
San Joaquin Community Hospital has announced the departure of Doug Duffield who will be stepping down as Chief Executive Officer, effective September 30, 2016. Sharlet Briggs, the current Chief Operating Officer, will be assuming his responsibilities on an interim basis.
 
New York Methodist Hospital hasannounced the retirement of Mark Mundy from his post as President and Chief Executive Officer upon the selection of a replacement.
 
Hartford HealthCare has appointed Mark J. Alberts the new Physician-in-Chief for the Neuroscience Institute, effective in early 2017.
 
Rogers Memorial Hospital has appointed Hemalatha Rajanna the new Medical Director of Adult Outpatient Services for West Allis. Jennifer King has also been appointed Medical Director of Child and Adolescent Services for Brown Deer. Finally, Jody Langford has been named the Medical Director for Child and Adolescent Inpatient Eating Disorder at Oconomowoc. 
 
Medical Device Manufacturers 
 
NuVasive, Inc. promoted Jason M. Hannon from Executive Vice President of International to President and Chief Operating Officer. He succeeds Patrick S. Miles, who has been appointed Vice Chairman.
 
 
 

September 8, 2016

Biotech
 
Halozyme Therapeutics, Inc. appointed Mark J. Gergen Senior Vice President and Chief Operating Officer.
 
Companies
 
Novo Nordisk A/S promoted Lars Fruergaard Jørgensen from Executive Vice President to President and Chief Executive Officer, effective January 1, 2016. He succeeds Lars Rebien Sørensen, who is retiring from the company at the end of the year.
 
LifePoint Health, Inc. appointed Michael S. Coggin Chief Financial Officer, effective September 30, 2016. He succeeds Leif Murphy, who will be leaving the company to join TeamHealth as President and Chief Executive Officer.
 
Daiichi Sankyo, Inc. appointed Marielle Cohard-Radice Executive Vice President and Global Head of Development. She succeeds Mahmoud Ghazzi, who is leaving the company.
 
Team Health Holdings, Inc. (TeamHealth) appointed Leif Murphy President, Chief Executive Officer and a member of the Board of Directors, effective by October 1, 2016. He succeeds Michael D. Snow, who is retiring from the company.
 
Pfizer Inc. appointed Ole Isacson Senior Vice President and Chief Scientific Officer of its Neuroscience Research Unit, effective September 16, 2016.
 
Corporate Boards of Directors
 
Stryker Corporation announced that William U. Parfet has resigned from its Board of Directors.
 
Hospitals 
 
The University Hospitals Parma Medical Center has announced the resignation of Nancy Tinsley as President of the organization, effective September 16, 2016.
 
Cleveland Clinic has announced the appointment of Brian Hart as the new President of Cleveland Clinic Akron General, effective September 26, 2016. He replaces Janice Murphy who has been serving in an acting capacity since May of this year, since the resignation of Dr. Thomas Stover.
 
Baptist Easley Hospital has named Todd Walker as the new Chief Executive Officer, effective October 31, 2016. He replaces Michael Batchelor who has stepped down.
 
University of Rochester Medical Center has named Thomas Barnett the new Chief Information Officer, effective October 10, 2016. He replaces Jerry Powell who stepped down earlier this year.
 
Methodist Health System has named Karla Ramberger the new Senior Vice President and Chief Nursing Executive.
 
University of Pennsylvania Health System has named Regina Cunningham the new Senior Vice President and Chief Nursing Executive.
 
Baylor St. Luke’s Medical Center has named Gay Nord the new President, effective October 3, 2016. She is stepping down as Chief Executive Officer of the Methodist Hospital.
 
Medical Device Manufacturers 
 
Cantel Medical Corp. promoted Seth M. Yellin from Senior Vice President of Corporate Development to Executive Vice President of Strategy and Corporate Development.
 
Pharmaceutical Manufacturers 
 
Amneal Pharmaceuticals LLC appointed Sheldon Hirt Senior Vice President and General Counsel, effective September 13, 2016. He succeeds Robert Loewenstein, who will be retiring.
 
Research Organizations
 
Howard Hughes Medical Institute appointed Erin O’Shea President. She succeeds Robert Tijan, who has stepped down from the position.
 
 
 

September 1, 2016

Charities
 
LUNGevity Foundation announced that Scott J. Antonia, Suzanne E. Dahlberg, Jessica S. Donington, Paul K. Paik and Anil Vachani have been appointed to its Scientific Advisory Board.
 
Companies
 
WellCare Health Plans, Inc. appointed William “Bill” Jones State President of Kentucky.
 
Eli Lilly and Company announced that Jamere Jackson, Chief Financial Officer of Nielsen Holdings, has been elected to its Board of Directors, effective October 1, 2016.
 
Hospitals 
 
Rush University Medical Center has appointed Angelique L. Richard the new Vice President for Clinical Nursing and Chief Nursing Officer.
 
The Children’s Hospital of Philadelphia has appointed Monica Taylor Lotty the new Executive Vice President and Chief Development Officer. She comes from the University of Delaware where she previously served as Vice President of Development and Alumni Relations.
 
MaineHealth has appointed Marcy Dunn the new Chief Information Officer. She replaces Andrew Crowder who left in January to take a role with a healthcare system in California. Ms. Dunn comes to MaineHealth from Catholic Health Services where she served in a similar role.
 
Roper St. Francis Healthcare has appointed Mary Flowers the new Vice President and Chief Diversity Officer, effective September 6. 2016. She comes from ETHOS Worldwide where she serviced as President and Chief Executive Officer.
 
St. Jude Children’s Research Hospital has appointed James Morgan the new Scientific Director and Executive Vice President of the hospital. He formerly held a similar post in an interim capacity since 2015.
 
Hospital Sisters Health System has appointed John A. Ludwig as the new President and Chief Executive Officer for HSHS St. Joseph’s Hospital in Highland, Illinois, effective September 19, 2016.
 
Industry Service Providers
 
MedQuest Associates has named Bruce Elder the new Chief Executive Officer. He formerly held the role of Chief Development and Strategy Officer. He replaces Dan Schaefer who served in an interim capacity and who will resume his role as Chief Operating Officer of the company.
 
Insurance and Managed Care
 
Blue Cross and Blue Shield of Minnesota promoted Dana Erickson from Senior Director to Vice President of Case Management and appointed Erin Satterwhite Vice President of Innovation.

 

August 25, 2016

Biotech
 
Telesta Therapeutics Inc. announced on August 24, 2016, that it has entered into a definitive agreement to be acquired by ProMetic Life Sciences Inc. The transaction is expected to close in early November 2016.
 
Companies
 
Valeant Pharmaceuticals International, Inc. appointed Paul S. Herendeen Executive Vice President of Finance and Chief Financial Officer, succeeding Robert L. Rosiello, who will continue as Executive Vice President of Corporate Development and Strategy.
 
Zoetis Inc. promoted Glenn David from Senior Vice President of Finance Operations to Executive Vice President and Chief Financial Officer. He succeeds Paul S. Herendeen, who as resigned from the company to join Valeant Pharmaceuticals International.
 
WellCare Health Plans, Inc. appointed Rhonda Mims Senior Vice President and Chief Public Affairs Officer. In a separate announcement, the company also announced that Larry Anderson has resigned as Senior Vice President and Chief Human Resources Officer.
 
Daiichi Sankyo, Inc. appointed Leigh Ann Errico Vice President of Human Resources.
 
Pfizer Inc. announced on August 22, 2016, that it has entered into a definitive agreement to acquire Medivation, Inc. for approximately $14 billion. The transaction is expected to be completed in the third or fourth quarter of 2016.
 
Corporate Boards of Directors 
 
Varian Medical Systems, Inc. announced that Judy Bruner, retired Executive Vice President and Chief Financial Officer of SanDisk Corporation, has been appointed to its Board of Directors. She replaces Venkatraman “Thyagi" Thyagarajan, who has retired from the board.
 
Universal American Corporation announced that healthcare investor Mohit Kaushal has been appointed to its Board of Directors.
 
Gilead Sciences, Inc. appointed Kelly A. Kramer, Executive Vice President and Chief Financial Officer of Cisco Systems, has been appointed to its Board of Directors.
 
Insurance and Managed Care
 
Hyland Group, Inc. promoted Doug Miller to Vice President and Executive Risk Practice Leader and appointed Spencer Timmel Vice President and Cyber and Technology Risk Practice Leader.
 
Pharmaceutical Manufacturers

Inotek Pharmaceuticals Corporation announced that Patrick Machado, former Chief Financial Officer and Chief Business Officer of Medivation, has been appointed to its Board of Directors.

Impax Laboratories, Inc. announced that Richard A. Bierly, former Chief Financial Officer of Medivation, has been appointed to its Board of Directors. 

 

August 11, 2016

Biotech
 
ImmunoGen, Inc. announced that Charles Morris will resign as Executive Vice President and Chief Development Officer, effective September 2, 2016.
 
Cerus Corporation appointed Vivek Jayaraman Chief Commercial Officer, effective August 29, 2016.
 
Companies
 
Rite Aid Corporation appointed Jeff Fields Chief Financial Officer of its Health Dialog and RediClinicsubsidiaries.
 
Astellas Pharma Inc. announced on August 4, 2016, that it has sold its US subsidiary Astellas Pharma Technologies, Inc. to Avara Norman Pharmaceutical Services, Inc.
 
Amedisys, Inc. announced that Ronald LaBorde intends to retire as Vice Chairman, Chief Financial Officer and a member of the Board of Directors, effective January 2, 2017.
 
Endo International plc appointed Joseph J. Ciaffoni President of U.S Branded Pharmaceuticals, effective August 15, 2016. He replaces Brian Lortie, who previously announced his intent to step down from the position.
 
Valeant Pharmaceuticals International, Inc. appointed Christina Ackermann Executive Vice President and General Counsel succeeding Robert Chai-Onn, who will be resigning. The company also appointed Scott Hirsch Senior Vice President of Business Strategy and Communications.
 
PharMerica Corporation announced that David W. Froesel Jr. intends to retire as Executive Vice President, Chief Financial Officer and Treasurer at the end of September 2016.
 
Community Health Systems, Inc. promoted Tim L. Hingtgen to President and Chief Operating Officer, effective September 1, 2016. He succeeds David L. Miller, who will continue to serve as a special advisor to the Chairman and Chief Executive Officer until he retires at the end of 2016.
 
Eli Lilly and Company appointed Joshua Smiley Senior Vice President, Finance and Treasurer, effective October 1, 2016. He replaces Thomas Grein, who is retiring from the company. 
 
Hospitals 
 
Kaleida Health has appointed Jessica Mabie, the former Manager of Hospital Operations, as the new Director of Strategic Planning and Integration.
 
Saint Thomas Health Services, a member of Ascension Health, has named Paul Cleckner as the new Chief Operating Officer. Cleckner comes from LifePoint Health where he served as Vice President of Business Transformation. He replaces Fahad Tahir who has stepped down.
 
St. Mary Medical Center, a member of Dignity Health, has named Pamela Lindemoen as the new President, effective September 12, 2016. 
 
Insurance and Managed Care
 
Lumeris, Inc. appointed Ray Wolf Senior Vice President of Architecture and Innovation. He will be based out of the company’s Austin, TX office.
 
Pharmacies
 
National HealthCare Corporation promoted Stephen F. Flatt to Chief Executive Officer and R. Michael Ussery to President and Chief Operating Officer, effective once Robert G. Adams retires as Chief Executive Officer at the end of 2016. 
 
Pharmaceutical Manufacturers

Sigma-Tau Pharmaceuticals, Inc. appointed Michael Minarich permanent Chief Executive Officer. He has been filling the role in an interim capacity since July 2015.

 

 

August 5, 2016

Associations
 
California Life Sciences Association announced that Alex Kelly, Chief Communications Officer of Allergan, and Jens H. Vogel, President and Chief Executive Officer of Boehringer Ingelheim Fremont, have been appointed to its Board of Directors.
 
Biotech
 
Array Biopharma Inc. appointed Jason Haddock Chief Financial Officer. He replaces David Horin, who has been filling the role in an interim capacity since November 2015.
 
Companies
 
Welltower Inc. promoted Mercedes Kerr to Executive Vice President of Business Development and Matthew McQueen to Senior Vice President, General Counsel and Corporate Secretary.
 
inVentiv Group Holdings, Inc. announced on April 5, 2016, that it had filed a registration statement with the SEC for a proposed initial public offering. On August 1, 2016, it announced that Advent International intends to become an equal investor in the company alongside Thomas H. Lee Partners in a transaction that is expected to close in the fourth quarter of 2016. As a result, the company will no longer be pursing an initial public offering.
 
Welltower Inc. announced on August 2, 2016, that it has entered into a definitive agreement to acquire a portfolio of properties operated by Vintage Senior Living for $1.15 billion. The transaction is expected to close in parts starting September 2016
 
Teva Pharmaceutical Industries Ltd. announced on August 3, 2016, that it has entered into a definitive agreement to acquire Anda Inc. from Allergan plc for $500 million. The transaction is expected to close in the second half of 2016.
 
Corporate Boards of Directors
 
Illumina, Inc. announced that Philip W. Schiller, Senior Vice President of Worldwide Marketing at Apple, has been appointed to its Board of Directors.
 
Invacare Corporation announced that James L. Jones will step down from its Board of Directors on August 26, 2016, and that Michael F. Delaney will not seek re-election at the 2017 Annual Meeting of Shareholders.
 
Valeant Pharmaceuticals International, Inc. announced that Sarah B. Kavanagh, who most recently served as a Commissioner at the Ontario Securities Commission, has been appointed to its Board of Directors.
 
Becton, Dickinson and Company announced that R. Andrew Eckert, Chief Executive Officer of Valence Health, has been appointed to its Board of Directors.
 
Hospitals 
 
Lee’s Summit Medical Center hasnamedPaige Baker as the new Chief Nursing Officer.
 
Ascension Health hasannouncedthat Sean Mills has been named the new Chief Financial Officer for Our Lady of Lourdes Memorial Hospital, effective August 15, 2016. He replaces David Clements who has been serving in an interim capacity since August 2015. Mills comes from the Samaritan Medical Center where he previously served as the Assistant Vice President and Chief Financial Officer for the last three years.
 
El Camino Hospital has named Dr. William K. Faber the new Chief Medical Officer. He replaces Eric A. Pifer who has stepped down. “He brings decades of experience in improving patient quality and integrating care across communities,” said Tomi Ryba, the President and Chief Executive Officer for the hospital. Faber comes from General Electric Healthcare where he previously served as a Senior Vice President.
 
UP Health System has named Brian Sinotte the new Chief Executive Officer, effective August 15, 2016. He replaces Trent Crable who announced he would be stepping down earlier in July. Sinotte come from MetroSouth Medical Center where he previously served as their Chief Executive Officer.
 
Northwestern Memorial Healthcare has named Mark Modesto their new Vice President and Chief Marketing Executive, effective August 15, 2016. He comes from Epsilon Data Management, LLC where he has been serving as the Managing Director in charge of Client Services. 
 
Insurance and Managed Care
 
BlueCross BlueShield of Tennessee, Inc. promoted Roy Vaughn to Senior Vice President and Chief Communications Officer.
 
Health Alliance Plan of Michigan appointed Michael Genord Chief Executive Officer of its HAP Midwest subsidiary.
 
Lumeris, Inc. appointed Joseph Gifford Senior Vice President of Provider Markets.
 
Medical Device Manufacturers
 
Haemonetics Corporation appointed William P. Burke Chief Financial Officer, effective August 8, 2016.

 

 

July 28, 2016

Biotech
 
Acceleron Pharma, Inc. announced that Thomas McCourt, Chief Commercial Officer of Ironwood Pharmaceuticals, has been elected to its Board of Directors.
 
Companies
 
Biogen Inc. announced that George Scangos will resign as Chief Executive Officer within the next few months once a successor has been named.
 
Laboratory Corporation of America Holdings and Sequenom, Inc. have announced that they have entered into a definitive agreement and plan of merger under which LabCorp will acquire all of the outstanding shares of Sequenom. The closing of the acquisition is expected by the end of 2016.
 
Perrigo Company plc announced that Douglas Boothe has resigned as Executive Vice President and General Manager of Rx Pharmaceuticals. John Wesolowski, the company’s Senior Vice President of Rx Commercial Operations, will serve as acting General Manager of the division until a successor has been determined.
 
Bristol-Myers Squibb Company appointed Fouad Namouni Head of Oncology Development.
 
HCA Holdings, Inc. appointed Heather Rohan President of its TriStar Division, effective December 1, 2016. She succeeds Steve Corbeil, who is retiring from the company.
 
Health IT
 
athenahealth, Inc. announced that Ed Park will step down as Executive Vice President and Chief Operating Officer at the end of 2016, at which point he is expected to join the company’s Board of Directors.
 
Computer Task Group, Inc. promoted Arthur "Bud" Crumlish from Senior Vice President of Strategic Staffing Services to President and Chief Executive Officer. He replaces Cliff Bleustein, who has resigned by mutual agreement with the Board of Directors.
 
Hospitals 
 
Beaufort Memorial Hospital has named Edmond Russell Baxley III the new President and Chief Executive Officer, effective September 12, 2016.
 
UNC REX Healthcare has named Andrew Zukowski the new Chief Financial Officer, effective August 22, 2016.
 
Florida Hospital Zephyrhills Inc. has named Ryan Willis the new Chief Financial Officer, replacing Bill Heinrich who remains as Chief Operating Officer of the hospital.
 
Gundersen Health System has named Rose Ann Laureto the new Chief Information Officer.
 
Einstein Healthcare Network has promoted Ruth Lefton the new Chief Operating Officer. She replaces Susan Bernini who has retired. 
 
Insurance and Managed Care
 
Health New England, Inc. appointed Michael Marrone Chief Financial Officer.
 
Pharmaceutical Manufacturers
 
Impax Laboratories, Inc. appointed Douglas S. Boothe President of its Generics Division, effective August 1, 2016.
 
Lannett Company, Inc. promoted Kristie Stephens from Director of Regulatory Affairs to Vice President or Regulatory Affairs and Chief Compliance Officer and promoted John Kozlowski from Corporate Controller to Vice President of Financial Operations and Corporate Controller.
 
Research Organizations
 
INC Research has announced that Alistair Macdonald has been named the new Chief Executive Officer, effective October 1, 2016. He replaces Jamie Macdonald is stepping down.

 

 

July 22, 2016

Companies
 
HCA Holdings, Inc. promoted Kathryn Torres from Vice President to Senior Vice President of Employer and Payer Engagement.
 
Hospitals 
 
Detroit Medical Center has named Joel Keiper the new Regional Chief Business Development Officer.
 
The University of Michigan Health System has named Mark Prince as the new Chair for the Department of Otolaryngology on an interim basis.
 
St. David’s North Austin Medical Center has named Cindy Nicholas the new Chief Nursing Officer. She replaces Jane McCurley who has stepped down.
 
Johns Hopkins All Children’s Hospital has named John McLendon the new Vice President and Chief Information Officer.
 
NewYork Presbyterian Hospital has named Joe Ienuso the new Senior Vice President of Facilities and Real Estate.
 
Menorah Medical Center has named James Cheray as the new Chief Medical Officer.
 
City of Hope has named Kety Duron the new Chief Human Resources and Diversity Officer. He replaces Alma Apodaca who has stepped down.
 
Mark Twain Medical Center has named Robert Diehl as the new President of the hospital. He replaces Larry Phillips who has been serving in an interim capacity.
 
Geisinger Health System has named David Tilton as the new Executive Vice President and Chief Integration Officer.
 
Medical Supply Distributors
 
Medical Specialties Distributors, LLC (“MDS”) appointed Tom Burke Chief Executive Officer, succeeding James Beck, who will continue with the company as Chairman of the Board of Directors.
 
Pharmacies
 
Modern HC Pharmacy, Inc. (“ModernHEALTH”) announced on July 20, 2016, that it has entered into an agreement with Kroger Co. to be acquired by and merged into Axium Pharmacy Holdings, Inc. to create a combined specialty pharmacy that will operate as a wholly-owned subsidiary of The Kroger Co. The transaction is subject to certain regulatory approvals, including from the FTC.
 
Research Organizations
 
The Lupus Research Institute announced on July 14, 2016, that it is merging with the Alliance for Lupus Researchand the S.L.E. Lupus Foundation to form a new organization named the Lupus Research Alliance. The integration is expected to be completed by August 15, 2016.

 

 

July 14, 2016

Associations
 
The Vermont Association of Hospitals and Health Systems appointed Jeffrey E. Tieman President and Chief Executive Officer, effective late August 2016.
 
Biotech
 
Acorda Therapeutics, Inc. appointed Burkhard Blank permanent Chief Medical Officer. He has been serving as interim Chief Medical Officer since January 2016.
 
BIND Therapeutics, Inc. announced on July 1, 2016, that it has filed a motion for court approval to sell the majority of its assets to Pfizer Inc. The transaction is expected to be completed in the third quarter of 2016. The company voluntarily filed for Chapter 11 Bankruptcy in May of this year.
 
Cleveland BioLabs, Inc. announced that Richard McGowan and James Antal have resigned from its Board of Directors.
 
Companies
 
Cardinal Health, Inc. appointed Pamela O. Kimmet Chief Human Resources Officer.
 
Kemper Corporation appointed George “Chip” D. Dufala, Jr. President of its Property and Casualty Division, effective July 18, 2016. He replaces Joseph W. Metz, who has been leading the division in an interim capacity since February 2016.
 
Astellas Pharma Inc. appointed Joseph Devaney Vice President of Government Affairs for the Americas.
 
Smith & Nephew plc announced that Julie Brown will step down as Chief Financial Officer in January 2017.
 
Boston Scientific Corporation announced that Yoshiaki Fujimori, former President and Chief Executive Officer of LIXIL Group Corporation, has been elected to its Board of Directors.
 
The Allstate Corporation promoted Patrick Macellaro from Vice President of Investor Relations to President of Encompass insurance companies.
 
Corporate Boards of Directors
 
The Allstate Corporation announced that Perry M. Traquina, former Chairman and Chief Executive Officer of Wellington Management Company, has been elected to its Board of Directors.
 
Edwards Lifesciences Corporation announced that Leslie S. Heisz has been appointed to its Board of Directors.
 
DaVita HealthCare Partners Inc. announced that Phyllis R. Yale, an advisory partner at Bain & Company, has been appointed to its Board of Directors.
 
Health IT
 
Spok Holdings, Inc. appointed Nat’e Guyton Chief Nursing Officer.
 
Ciox Health, LLC appointed Jeremy Delinsky, Chief Technology Officer of Wayfair, and Jeff Hammerbacher, Founder and Chief Scientist of Cloudera, to its Board of Directors.
 
Hospitals 
 
Florida Hospital Memorial Medical Center has named Kris Gray the new Chief Medical Officer. He replaces Ronald Jimenez who left to become the Chief Executive Officer for Florida Hospital Flagler.
 
Indiana University Health has announced the retirement of Mark Moore as President of the Bloomington Hospital, effective August 1, 2016.
 
Dartmouth-Hitchcock Medical Center has named Daniel P. Jantzen, Executive Vice President and Chief Operating Officer, the new Chief Financial Officer. He replaces Robin Kilfeather-Mackey who has stepped down.
 
Beaumont Health System has named Jane Jordan the new Senior Vice President and General Counsel, effective August 17, 2016.
 
Howard County General Hospital has named Mohammed Shafeeq Ahmed the new Vice President, Medical Affairs and Chief Medical Officer.
 
Detroit Medical Center has selected Reginald J. Eadie as the new Regional Chief Operating Officer, effective August 1, 2016. Dr. Sidhartha Tan was also named the Director of Neonatal and Perinatal Medicine at the DMC’s Children’s Hospital of Michigan and Hutzel Women’s Hospital.
 
Monmouth Medical Center has named Eric Carney the new Chief Operating Officer.
 
University Hospitals Case Medical Center has appointed Christopher Miller and Goutham Rao as the Chair of Emergency Medicine and Family Medicine, respectively.
 
Florida Hospital North Pinellas has named Patricia Williams the new President and Chief Executive Officer, effective August 1, 2016. She comes from St. Helena Hospital.
 
Medical City Dallas Hospital has appointed Chris Mowan the new Chief Executive Officer, effective July 25, 2016.
 
Albany Medical Center has named Frances Spreer-Albert the new Executive Vice President and Chief Financial Officer.
 
Industry Service Providers
 
Aurora Diagnostics has named Michael Grattendick the new Chief Financial Officer. He previously held the post of Vice President of Finance, Controller and Treasurer.
 
Insurance and Managed Care
 
American Specialty Health Inc. appointed Lori Lorenz Vice President of Marketing.
 
Pharmacies
 
Wellpartner, Inc. appointed Harish Thiagaraj Senior Vice President of Pharmacy and Specialty Pharmacy.
 
Pharmaceutical Manufacturers
 
Ipsen S.A. appointed David D. Meek Chief Executive Officer, effective July 18, 2016. He succeeds Marc de Garidel, whose resignation was announced earlier this year. Mr. de Garidel will continue to serve as the company’s Chairman.

 

 

July 1, 2016

Companies
 
Bioventus, LLC announced that Michael Minogue, Chairman, President and Chief Executive Officer of Abiomed, has been appointed to its Board of Managers. He succeeds Evan Melrose, who is stepping down from the board.
 
Pfizer Inc. announced on June 24, 2016, that it has completed its previously announced acquisition of Anacor Pharmaceuticals, Inc.
 
McKesson Corporation announced on June 28, 2016, that it intends to merge its McKesson Technology Solutionsbusiness with Change Healthcare Holdings, Inc. to create a new company. McKesson will own approximately 70% of the new company, with the remaining equity stake held by Change Healthcare stockholders. John H. Hammergren will serve as Chairman and Neil de Crescenzo will serve as Chief Executive Officer. The transaction is expected to close in the first half of 2017.
 
Hospitals 
 
ICON plc, has agreed to acquire Clinical Research Management, Inc. The transaction is currently pending.
 
The Southeast Permanente Medical Group has named Patrick Austin the new Chief of Vascular Surgery and Plastic Surgery.
 
Advocate Health Care has named Terika Richardson the President of Advocate Trinity Hospital.
 
Children’s Hospital Los Angeles has appointed Nancy Lee the new Senior Vice President and Chief Clinical Officer.
 
Ochsner Health System has announced that Joseph Bisordi will retire as Executive Vice President and Chief Medical Officer, effective September 1, 2016.
 
Geisinger Health System has named Dominic Moffa the new Executive Vice President and Chief Strategy Officer.
 
Our Lady of Lourdes Health Care Services has named Maria Brennan the new Vice President of Patient Care Services and Chief Nursing Officer.
 
Berwick Hospital Center has named Mark McHugh the new Assistant Chief Executive Officer. It was also named Doreen Kolojeechick the new Chief Nursing Officer.
 
Florida Hospital Medical Group has named Howard Drenth the new President and Chief Executive Officer, effective July 25, 2016. He replaces Mike Ferry who has been serving in an interim capacity.
 
St. Luke’s Hospital has named James B. Bross the new President and Chief Executive Officer, effective July 18, 2016. He replaces Kenneth Shull who is stepping down.
 
Pharmaceutical Manufacturers
 
LEO Pharma A/S announced that Jesper Hoiland, Executive Vice President of Novo Nordisk US, has been elected to its Board of Directors.

 

 

June 23, 2016

Biotech
 
BIND Therapeutics, Inc. announced that Amir Nashat and Amy Schulman have resigned from the Board of Directors.
 
Immunomedics, Inc. appointed Michael R. Garone Vice President of Finance and Chief Financial Officer, effective June 27, 2016. He succeeds Peter P. Pfreundschuh, who is resigning to pursue other career opportunities.
 
Companies
 
Amgen Inc. appointed Esteban Santos Executive Vice President of Operations, effective July 25, 2016, replacing Madhavan Balachandran, who is retiring from the company. He will be succeeded as Senior Vice President of Manufacturing by Robert Maroney.
 
Perrigo Company plc announced on June 20, 2016, that it has entered into a definitive agreement to sell its U.S. Vitamins, Minerals & Supplements to International Vitamin Corporation. The transaction is expected to close by early August 2016.
 
NBTY, Inc. appointed Stephen Conboy Senior Vice President and Chief Financial Officer.
               
Bristol-Myers Squibb Company appointed Mundo Gordon Executive Vice President and Chief Commercial Officer.
 
Biogen Inc. appointed Paul McKenzie Executive Vice President of Pharmaceutical Operations and Technology, effective July 1, 2016. He succeeds John Cox, who was named Chief Executive Officer of a new Biogen spin-off company.
 
Johnson & Johnson appointed Joseph Wolk Vice President of Investor Relations, effective August 1, 2016. He succeeds Louise Mehrotra, who will retire from the company. 
 
Corporate Boards of Directors 
 
Kimberly-Clark Corporation announced Christa S. Quarles, Chief Executive Officer of OpenTable, has been appointed to its Board of Directors.
 
Hospitals 
 
Ascension Health has appointed Darcy Burthay the new President and Chief Executive Officer for Providence Hospital, effective July 1, 2016. She replaces Duane Erwin who has been serving in an interim capacity.
 
Novant Health has appointed Kirsten Royster the new President of Medical Park Hospital.
 
ProMedica Health System Inc. has named Michael Browning the new Chief Financial Officer, effective August 6, 2016.
 
University of Virginia Medical Center has appointed Bill Fulkerson the new Chief Operating Officer, effective August 1, 2016.
 
Ann and Robert H. Lurie Children’s Hospital has appointed Grant Stirling the new Executive Vice President and Chief Development Officer in charge of Children’s Memorial Foundation, effective August 1, 2016.
 
Medstar Health has appointed Zeena Dorai the Chief of Neurosurgery for MedStar Good Samaritan Hospital and MedStar Union Memorial Hospital.
 
Orlando Health has named Thomas Kelley the new Chief of Quality and Clinical Transformation.
 
Geisinger Health System has named Jaewon Ryu the new Executive Vice President and Chief Medical Officer, effective September 30, 2016.
 
Saint Mary’s Heath Network has appointed David Fiore the new Director of Medical Education.
 
Mount Sinai Health System has appointed Dr. Joseph Herrera as the new Chief of the Department of Rehabilitation Medicine, effective July 1, 2016.
 
Insurance and Managed Care 
 
Wright Medical Group N.V. announced that Terry M. Rich has resigned as President of Upper Extremities.
 
Medical Supply Distributors
 
Cantel Medical Corp. announced that Ronnie Myers, Senior Associate Dean for Academic and Administrative Affairs at the Touro College of Dental Medicine at New York Medical College, has been elected to its Board of Directors.
 
Pharmaceutical Manufacturers
 
Taro Pharmaceutical Industries Ltd. announced that Michael Kalb will resign as Chief Financial Officer, effective June 29, 2016.
 
Alexza Pharmaceuticals, Inc. announced on June 21, 2016, that Grupo Ferrer Internacional, S.A. has completed its acquisition of the company. Alexza is now a wholly-owned subsidiary of Ferrer.

 

 

June 16, 2016

Biotech
 
Osiris Therapeutics, Inc. announced that Dwayne Montgomery has resigned as President, Chief Executive Officer and a member of the Board of Directors for medical reasons. David A. Dresner, Co-Founder and Chief Financial Officer of the Dresner Group, has been appointed interim President and Chief Executive Officer.
 
Companies
 
Walgreens Boots Alliance, Inc. promoted Alex Gourla and Ornella Barra to Co-Chief Operating Officers and appointed Ken Murphy Chief Commercial Officer, in addition to his current duties as Executive Vice President and President of Global Brands. The company also announced that Simon Roberts will resign as Executive Vice President and President of Boots in July 2016. He is succeeded by Elizabeth Fagan, who will serve as Senior Vice President and Managing Director of Boots.
 
Merck & Co., Inc. announced on June 9, 2016, that it has entered into a definitive agreement to acquire Afferent Pharmaceuticals Inc. for $500 million. The transaction is expected to close in the third quarter of 2016.
 
UnitedHealth Group Incorporated promoted John Rex to Chief Financial Officer. His former role as Chief Financial Officer of the company’s Optum subsidiary has been assumed by Tami Reller.
 
Eli Lilly and Company promoted Aarti Shah to Senior Vice President and Chief Information Officer, effective July 1, 2016.
 
Kimberly-Clark Corporation appointed Scott Usitalo Chief Marketing Officer.
 
Corporate Boards of Directors 
 
State Farm Mutual Automobile Insurance Company announced that Chief Executive Officer Michael Tipsord has been elected to the additional position of Chairman of the Board. He succeeds Edward B. Rust, Jr.
 
Health IT
 
athenahealth, Inc. announced that Thomas J. Szkutak, former Chief Financial Officer of Amazon.com, has been appointed to its Board of Directors.
 
Hospitals 
 
The Cancer Treatment Centers of America has named Rajiv Gupta the new Chief Executive Officer, effective June 20, 2016.
 
Waldo County General Hospital has named Paula Delahanty the Regional Chief Nursing Officer.
 
St. Vincent’s Health System has named Pamela Hess the new Chief Financial Officer, effective July 18, 2016. She replaces Kim Hodgkinson who is stepping down.
 
Advocate Good Samaritan Hospital has named Susan Okuno-Jones the new Vice President of Patient Care Services and Chief Nursing Executive, effective June 27, 2016.
 
Diamond Healthcare Corporation has named Ingram Haley has the new Executive Vice President of Business Development.
 
Children’s Hospital of Illinois has named Kelly Nierstedt the new President, effective June 20, 2016. She replaces Michael Cruz who is stepping down.
 
Insurance and Managed Care 
 
CoreSource, Inc. appointed Bob Wolfkiel President of its Northeast Region.
 
Affinity Health Plan, Inc. announced that Glenn A. MacFarlane will resign as President and Chief Executive Officer later in June 2016. He will be replaced by James A. Hooley, who will fill the role in an interim capacity until a permanent successor is named.

 

June 9, 2016

Biotech
 
Regulus Therapeutics Inc. announced that Hugh Rosen, Professor in the Departments of Chemical Physiology & Immunology at The Scripps Research Institute, has been elected to its Board of Directors.
 
Nektar Therapeutics promoted John Nicholson to Senior Vice President and Chief Operating Officer and Gil M. Labrucherie to Senior Vice President and Chief Financial Officer.
 
Companies
 
New York Life Insurance Company appointed Kirk Lehneis Chief Operating Officer of New York Life Investment Management, the company’s investment management subsidiary.
 
Mutual of Omaha Insurance Company appointed Richard Hrabchak Executive Vice President and Chief Investment Officer.
 
Johnson & Johnson announced on June 2, 2016, that it has entered into a definitive agreement to acquire Vogue International, Inc. for approximately $3.3 billion. The transaction is expected to close during the third quarter of 2016.
 
Shire plc announced on June 3, 2016, that it has completed its previously announced acquisition of Baxalta Incorporated, which is now an indirectly wholly-owned subsidiary of Shire.
 
Assurant, Inc. appointed Emmet Burns Senior Vice President of Brand and Marketing.
 
Zimmer Biomet Holdings, Inc. announced on June 7, 2016, that it has entered into a definitive agreement to acquire LDR Holding Corporation in a transaction worth approximately $1.0 billion. The transaction is expected to close in the third quarter of 2016. 
 
Corporate Boards of Directors 
 
Ventas, Inc. announced that Walter C. Rakowich, former Chief Executive Officer of Prologis, and Roxanne M. Martino, Chief Executive Officer of Aurora Investment Management, have been elected to its Board of Directors.
 
Group Purchasing Organizations
 
Premier Inc. announced on June 7, 2016, that it has agreed to acquire the national specialty pharmacy business of Lincare Holdings Inc. for $75 million. The transaction is expected to close by or before September 30, 2016.
 
Hospitals 
 
HonorHealth has announced Thomas Sadvarywill retire as Chief Executive Officer, effective April 3, 2017. Also Rhonda Forsyth will retire as President on December 31, 2016.
 
SSM Health has announced William Thompson will retire as President and Chief Executive Officer in 2017.
 
Penn State Milton S. Hershey Medical Center has named Thomas Tracy the new Chief Medical Officer, effective August 15, 2016. He replaces Carol Freer who is stepping down.
 
St. Rita’s Medical Center has named Dale Gisi the new President and Chief Executive Officer. He replaces Bob Baxter who is now Chief Executive Officer for the Lima Region of Mercy Health.
 
MemorialCare Medical Foundation has named Laurie Sicaeros the new Chief Operating Officer. 
 
Insurance and Managed Care 
 
Health Care Service Corporation appointed Eric Feldstein Senior Vice President and Chief Financial Officer, effective immediately. He replaces Ken Avner, who is retiring. The company also appointed Blair Todt Senior Vice President and Chief Legal Officer, effective July 1, 2016. Mr. Todt will be leaving his current position at WellCare Health Plans, Inc. effective June 17, 2016.
 
NGOs
 
Medical Teams International appointed Martha Newsome President and Chief Executive Officer, effective January 1, 2016. She replaces Jeff Pinneo, who retired earlier in 2016.
 
Pharmaceutical Manufacturers
 
Grünenthal GmbH appointed Gabriel Baertschi Chairman and Chief Executive Officer effective October 1, 2016. He succeeds Eric-Paul Paques, who is retiring from the company.
 
Research Organizations
 
The Scripps Research Institute appointed Richard A. King Chief Operating Officer. Douglas Bingham, who had been filling the role, will continue as Executive Vice President and General Counsel.
 

 

June 2, 2016

Companies
 
Valeant Pharmaceuticals International, Inc. appointed Sam Eldessouky Senior Vice President and Corporate Controller.
 
Assurant, Inc. appointed Richard S. Dziadzio Executive Vice President, Chief Financial Officer and Treasurer, effective July 18, 2016. He succeeds Christopher J. Pagano, who will continue with the company as Executive Vice President and Chief Risk Officer.
 
Corporate Boards of Directors 
 
Henry Schein, Inc. announced that Joseph L. Herring, former Chairman and Chief Executive Officer of Covance, and Kurt P. Kuehn, former Chief Financial Officer of United Parcel Service, have been elected to its Board of Directors. They succeed directors Norman S. Matthews and Louis W. Sullivan, who have retired from the Board.
 
Hospitals 
 
Ascension Health has named Mike Mullins the new Kansas Ministry Market Executive, effective July 1, 2016.
 
Dallas County Hospital District has named David Lopez the new Executive Vice President and Chief Operating Officer. He formerly held the post on an interim basis.
 
Saint Francis Hospital – Memphis has named Audrey Gregory the new Chief Executive Officer.
 
University of Maryland Medical Center has named Mohan Suntha the new Chief Executive Officer, effective September 1, 2016. He replaces John Ashworth who has served as an interim basis.
 
Aptuit LLC has named Henning Steinhagen the new Executive Vice President of Drug Discovery and Development.
 
The Southeast Permanente Medical Group has named Margaret Kottke the new Chief of Dermatology.
 
Texas Children’s Hospital has named Dr. Howard L. Weiner as the new Chief of Neurosurgery.
 
Adventist Health System Sunbelt Health System has named Lewis Seifert the new Chief Financial Officer for the Multi-State Division, effective September 4, 2016.
 
Cleveland Clinic Akron General has announced that Thomas Stover has announced his retirement.
 
Aurora Diagnostics has named Dr. F. Michael Walsh the new Chief Medical Officer. 
 
Insurance and Managed Care 
 
Blue Cross and Blue Shield of Minnesota appointed Kirstie Foster Vice President of Public Relations and promoted Jason Newman to Vice President and Chief Information Security Officer.
 
eHealth, Inc. appointed Scott Flanders Chief Executive Officer. He succeeds Gary Lauer, whose additional role as Chair has been assumed by Ellen Tauscher.

Medical Device Manufacturers 

Patterson Medical Holdings, Inc., announced on May 31, 2016, that it has entered into a definitive agreement to acquire Performance Health LLC, which will operate as a business segment of Patterson Medical and maintain its existing name and presence in Akron, OH. Marshall Dahneke, Chief Executive Officer of Performance Health, will serve as President of the segment. The transaction is expected to be completed in the summer of 2016.
 
Pharmaceutical Manufacturers
 
Alkermes plc announced that Nancy L. Snyderman, most recently Chief Medical Editor at NBC News, has been elected to its Board of Directors.
 
Jazz Pharmaceuticals plc announced on May 31, 2016, that it has entered into a definitive agreement to acquire Celator Pharmaceuticals, Inc. for approximately $1.5 billion. The transaction is expected to close in the third quarter of 2016.
 

 

May 26, 2016

Biotech
 
Regulus Therapeutics, Inc. appointed Allison Wey Vice President of Investor Relations and Corporate Communications. 

Cytokinetics, Inc. announced that Edward M. Kaye, Interim Chief Executive Officer and Senior Vice President and Chief Medical Officer of Sarepta Therapeutics, has been appointed to its Board of Directors.

Aeterna Zentaris Inc. announced that it has separated the positions of Chairman and Chief Executive Officer. As a result, Carolyn Egbert has been elected Chair of the Board and David A. Dodd will continue to serve as President and Chief Executive Officer.

Transgene S.A. announced that Antoine Béret, Chief Executive Officer of Genoscience Pharma, has been appointed to its Board of Directors. He replaces Arnaud Fayet, who did not seek re-election at the Annual General Meeting.
 
Companies
 
WebMD Health Services Group, Inc. appointed Michael Sokol Chief Medical Officer.
 
Varian Medical Systems, Inc. announced on May 23, 2016, that it intends to spin off its Imaging Components business as a new, stand-alone public company. It will be led by Sunny Sanyal, who will serve as Chief Executive Officer, and Clarence Verhoef, who will serve as Chief Financial Officer. The transaction is transaction expected to be completed by the end of 2016.
 
Gilead Sciences, Inc. appointed Kevin Young Chief Operating Officer and Martin Silverstein Executive Vice President of Strategy.

Corporate Boards of Directors 

Walgreens Boots Alliance, Inc. announced that Barry Rosenstein, managing partner of JANA Partners, has stepped down from its Board of Directors pursuant to a previous agreement under which Mr. Rosenstein’s service was scheduled to end once JANA reduced its investment in the company below a certain threshold, which JANA has now done.
 
Health IT 

Ciox Health, LLC appointed Tammie Miller Vice President of Client Relations for its Payor Solutions division.

Hospitals 
 
Mercy Medical Center – Sioux City has appointed Kristen Ball the new Manager of Post Critical Care.
 
Novant Health has appointed Tanya Blackmon, Denise Mihal and Janet Smith-Hill the new Executive Vice President and Chief Diversity and Inclusion Officer, Executive Vice President and Chief Nursing and Clinical Operations Officer, and Executive Vice President and Chief Human Resources Officer, respectively.
 
Anne Arundel Medical Center has named Maulik Joshi the new Executive Vice President of Integrated Care Delivery and Chief Operating Officer.
 
Mercy Health has named Jeffrey Carr the new Chief Innovation Officer.
 
UP Health System Marquette has named Wael Khouli the new Chief Medical Officer.
 
Intermountain Healthcare has named Marc Harrison the new Chief Executive Officer, effective October 15, 2016. He replaces Charles Sorenson who is retiring.
 
Wake Forest Baptist Medical Center has announced that John McConnell will be stepping down as Chief Executive, effective in 2017.
 
Insurance and Managed Care 
 
AmeriHealth Caritas appointed Mark T. Bullock Senior Vice President and Chief Administrative and Compliance Officer.
 
Health New England, Inc. appointed Ashley Allen Vice President of Sales and Marketing.

Medical Device Manufacturers 

BREG, Inc. appointed Benjamin Hutson Vice President of Operations. 

 

May 19, 2016

Companies
 
Takeda Pharmaceutical Company Limited appointed James Kehoe Chief Financial Officer, effective June 15, 2016. He succeeds Rudolph van Houten, who has been serving as Acting Chief Financial Officer since July 2015.
 
Kimberly-Clark Corporation appointed Suja Chandrasekaran Chief Information Officer.
 
Pfizer Inc. announced on May 16, 2016, that it has entered into a definitive agreement to acquire Anacor Pharmaceuticals, Inc. for approximately $5.2 billion. The transaction is expected to be completed in the third quarter of 2016.
 
Novartis Corporation appointed Paul Hudson Chief Executive Officer of Novartis Pharmaceuticals and Bruno Strigini Chief Executive Officer of Novartis Oncology, both effective July 1, 2016. David Epstein, the current Chief Executive Officer of Novartis Pharmaceutics, will be leaving the company. 
 
Health IT 

Extreme Networks, Inc. appointed Drew Davies Executive Vice President and Chief Financial Officer, effective June 1, 2016. He succeeds Ken Arola, who is stepping down from the position.

Health Systems
 
Northwell Health has named Kevin Beiner the Senior Vice President and Deputy Executive Director of the Eastern Region.
 
Lee Memorial Health System has named Scott Nygaard the new Chief Medical Officer.
 
Johns Hopkins Hospital has named Redonda Miller President, effective July 1, 2016.
 
Hospitals 
 
Christian Hospital has named Rick Stevens the new President, effective June 27, 2016.
 
CHI St. Luke’s Health has named William Brien the new President of Baylor St. Luke’s Medical Center on an interim basis.
 
Walla Walla General Hospital has named Bob Beehler the new President and Chief Executive Officer on an interim basis, effective June 6, 2016. He replaces Monty Knittel who is stepping down.
 
Insurance and Managed Care 

Hylant Group promoted Deborah Bubp to Vice President of Talent Management.

NGOs

Project ORBIS International, Inc. appointed Danny Haddad Chief of Program, effective June 14, 2016.

RHIOs/HIEs

The Indiana Health Information Exchange, Inc. appointed Valita Fredland Vice President, General Counsel and Privacy Officer.

 

 

May 12, 2016

Biotech
 
BIND Therapeutics, Inc. announced on May 2, 2016, that it has voluntarily filed for Chapter 11 Bankruptcy. The company intends to operate normally during the process.
 
NovaBay Pharmaceuticals, Inc. announced that Todd Zavodnick, President of International at ZELTIQ Aesthetics, has been appointed to its Board of Directors, effective May 6, 2016. He replaces Massimo Radaelli, who is resigning from the company.
 
EPIRUS Biopharmaceuticals, Inc. announced that Amit Munshi has stepped down as President, Chief Executive Officer and a member of the Board of Directors. He is succeeded by Scott Rocklage, who will serve as Acting Chief Executive Officer until a permanent replacement has been named. The company also promoted Michael Wyand to President and Chief Operating Officer.
 
Compugen Ltd. appointed Steven Holtzman, former Executive Vice President of Biogen, a Strategic Business Advisor to the company.
 
Lexicon Pharmaceuticals, Inc. appointed Praveen Tyle Executive Vice President of Research and Development, effective May 16, 2016.
 
Alexza Pharmaceuticals, Inc. announced on May 10, 2016, that it has entered into a definitive agreement to be acquired by Ferrer Pharma Inc., a wholly-owned subsidiary of Grupo Ferrer Internacional, S.A. The transaction is expected to close in the second quarter of 2016.
 
Charities
 
Cystic Fibrosis Foundation appointed Marc Ginsky Executive Vice President and Chief Operating Officer.
 
The Brain & Behavior Research Foundation appointed Christina Bishop-Feeny Chief Development Officer.
 
Companies
 
Kemper Corporation appointed Charles T. Brooks Senior Vice President and Chief Information Officer.
 
Abbott Laboratories announced on April 28, 2016, that it has entered into a definitive agreement to acquire St. Jude Medical, Inc. in a transaction worth $25 billion. The acquisition is expected to close in the fourth quarter of 2016.
 
Centene Corporation appointed Christopher Isaak Senior Vice President, Controller and Chief Accounting Officer.
 
Aflac Incorporated promoted J. Todd Daniels to Executive Vice President, Global Chief Risk Officer and Chief Actuary.
 
IMS Health Holdings, Inc. and Quintiles Transnational Holdings Inc. announced that they have entered into a definitive agreement to merge. The combined company will operate as Quintiles IMS Holdings, Inc. and have dual headquarters in Danbury, CT, and Research Triangle Park, NC. Ari Bousbib will serve as Chairman and Chief Executive Officer and Tom Pike will serve as Vice Chairman. The transaction is expected to close in the second half of 2016.
 
Mylan N.V. appointed Kenneth S. Parks Chief Financial Officer, effective June 6, 2016.
 
Anthem, Inc. appointed John E. Gallina Executive Vice President and Chief Financial Officer, effective June 1, 2016. He succeeds Wayne S. DeVeydt, who will be stepping down from the position.
 
Medtronic plc appointed Karen L. Parkhill Executive Vice President and Chief Financial Officer, effective June 20, 2016. She succeeds Gary L. Ellis, who will continue at the company as Executive Vice President of Global Operations and Information Technology.
 
Biogen Inc. announced on May 3, 2016, that it intends to spin off its hemophilia business as an independent, publicly traded company. The new company will be headquartered in the Boston area and John G. Cox will serve as its Chief Executive Officer. The spin-off is expected to be completed by the end of 2016 or early 2017.
 
Endo International plc announced that Brian Lortie will resign as President of U.S. Branded Pharmaceuticals once a successor has been named.
Kemper Corporation appointed Mark A. Green President of its Life and Health Division, effective May 31, 2016.
 
HCA Holdings, Inc. appointed Troy A. Villarreal President of its Gulf Coast Division, effective June 20, 2016. He succeeds Maura Walsh, who is retiring from the company.
 
Allergan plc appointed Bill Meury Chief Commercial Officer and Robert Stewart Chief Operating Officer.
 
Corporate Boards of Directors
 
Valeant Pharmaceuticals International, Inc. announced that Howard B. Schiller, Ronald H. Farmer, Colleen Goggins, Theo Melas-Kyriazi, G. Mason Morfit and Norma A. Provencio will not stand for re-election at the company’s Annual Meeting of Shareholders on June 14, 2016. They are succeeded by Argeris N. Karabelas, Russel C. Robertson and Amy B. Wechsler, who will all stand for election.
 
Endo International plc announced that Douglas S. Ingram, Chief Executive Officer of Chase Pharmaceuticals Corporation, and Todd B. Sisitsky, Managing Partner of TPG Capital, have been appointed to its Board of Directors.
 
Hospitals
 
Grady Memorial Hospital hasnamed Dr. Peter Rhee the new Medical Director for the hospital’s Marcus Trauma Center, effective June 2016.
 
RWJBarnabas Health has named Darrell Terry the new President and Chief Executive Officer for Newark Beth Israel Medical Center, and the Children’s Hospital of New Jersey.
 
Atrium Medical Center has named Michael Uhl the new Chief Operating Officer.
 
George Washington University Hospital has named Kimberly Russo, the current Chief Operating Officer, as the new Chief Executive Officer, effective June 3, 2016. She replaces Barry Wolfman who is resigning.
 
Wesley Medical Center has appointed Suzanne Richards the new Director of Critical Care Services.
 
Insurance and Managed Care
 
MultiPlan, Inc. announced on May 9, 2016, that affiliates of Hellman & Friedman have entered into a definitive agreement to acquire control of the company from Starr Investment Holdings, LLC and Partners Group. Starr and Partners Group will retain minority investments in the company on behalf of their clients.
 
Pharmacies
 
National HealthCare Corporation announced that Robert Adams will retire as Chief Executive Officer on December 31, 2016. He will remain Chairman of the Board of Directors.
 
Dr. Reddy’s Laboratories Ltd. announced that Bharat Doshi, former Group Chief Financial Officer of Mahindra & Mahindra Limited, has been appointed to its Board of Directors.


 

May 5, 2016

Hospitals
 
The University of Maryland Medical System has named Lisa Rowen the new Chief Nurse Executive.
 
McCullough Hyde Memorial Hospital has named Brett Kirkpatrick the new Executive Director of Operations.
 
Prime Healthcare System has named Robert Iannacone as the new President and Chief Executive Officer for Saint Michael’s Medical Center.
 
Desert Springs Hospital has named Jeremy Bradshaw the new Managing Director and Chief Executive Officer.
 
Covenant Health has named Jim VanderSteeg the new President and Chief Executive Officer.
 
Kaiser Foundation Hospitals and Health Plan, Inc. has named Gregory A. Adams the new Executive Vice President and Group President of for all Kaiser Permanente Regions.
 
Industry Service Providers

Medical Properties Trust has completed the acquisition and merger of Capella Healthcare and RegionalCare Hospital Partners, Inc. The resulting company has been named RCCH HealthCare Partners.


 

April 28, 2016

Biotech

ImmunoGen, Inc. appointed Mark J. Enyedy President, Chief Executive Officer and a member of the Board of Directors, effective May 16, 2016. He succeeds Daniel Junius, who will continue to serve on the Board.
 
Charities
 
Juvenile Diabetes Research Foundation International (JDRF) announced that Mark Fischer-Colbrie will assume the role of Chairman of the International Board of Directors on July 1, 2016. He succeeds John Brady, whose two-year term ends at the end of June.
 
Companies
 
Henry Schein, Inc. appointed David McKinley President of Corporate Commercial Development and Chief Commercial Officer, effective immediately, and Karen Prange Executive Vice President and Chief Executive Officer of Global Animal Health and Medical Group, effective May 17, 2016.
 
Assurant, Inc. appointed Ajay Waghray Chief Technology Officer, effective May 9, 2016.
 
Tenet Healthcare Corporation appointed Robert W. K. Webb Senior Vice President and Chief Human Resources Officer, effective May 16, 2016.
 
AmerisourceBergen Corporation announced that David W. Neu, Executive Vice President of Retail Strategy and President of Good Neighbor Pharmacy, will retire from the company in the summer of 2016. His position at Good Neighbor Pharmacy has been assumed by Brian Nightengale, effective immediately.
 
Unum Group promoted Marco Forato to Senior Vice President of Corporate Strategy and Development and Tyler Siira to Vice President and Treasurer. In a separate announcement, the company also announced that it has appointed Josh Nelson Chief Financial Officer of its Colonial Life business.
 
Valeant Pharmaceuticals International, Inc. appointed Joseph C. Papa Chairman and Chief Executive Officer, effective by early May 2016. He succeeds J. Michael Pearson, who previously announced his intention to resign from the company.
 
Perrigo Company plc promoted John T. Hendrickson from President to Chief Executive Officer, succeeding Joseph C. Papa who has resigned from the company to head Valeant Pharmaceuticals. In addition, the Board of Directors elected Laurie Brlas to the role of Chairman of the Board.
 
Community Health Systems, Inc. announced that David L. Miller will retire as President and Chief Operating Officer at the end of 2016.
 
Biogen Inc. appointed Michael Ehlers Executive Vice President of Research and Development, effective in late May 2016.

Health IT

Netsmart Technologies, Inc. completed its previously announced transaction under which it has been acquired by GI Partners in partnership with Allscripts Healthcare Solutions, Inc. Subsequently, Allscripts' homecare software business unit has been merged into Netsmart.
 
Hospitals
 
Brigham and Women’s Hospital has named Adam Landman the new Chief Information Officer, effective May 2, 2016.
 
Beaumont Health has named Mark Bohen the new Senior Vice President and Chief Marketing and Communications Officer.

Texas Children’s Hospital has appointed Tamir Miloh the new Director of Pediatric Hepatology and Liver Transplant Medicine. 

Insurance and Managed Care
 
CareOregon, Inc. appointed Eric C. Hunter Chief Executive Officer, effective June 1, 2016. He succeeds Scott Clement, the company’s Chief Network Officer, who has been serving as interim Chief Executive Officer since November 2015.
 
Affinity Health Plan, Inc. appointed Lisa A. Keehn Vice President and Executive Director of Medicare Operations.
 
Medical Supply Distributors
 
Elekta AB appointed John Lapré Chief Technology Officer, effective May 1, 2016.


 

April 21, 2016

Biotech

Synta Pharmaceuticals Corp. announced on April 14, 2016, that it has entered into a definitive agreement with Madrigal Pharmaceuticals, Inc., under which Synta will acquire Madrigal in an all-stock transaction. Upon closing, the combined company will operate as Madrigal Pharmaceuticals and Paul A. Friedman will serve as Chairman and Chief Executive Officer. The merger is expected to close by the end of the third quarter of 2016.
 
Charities

The Pancreatic Cancer Action Network announced that Jason Kuhn, Chairman and Chief Executive Officer of Kuhn Automotive Group, has been appointed to its Board of Directors. 

Companies
 
WellCare Health Plans, Inc. appointed Darren Ghanayem Senior Vice President and Chief Information Officer. 

Assurant, Inc. appointed Linda Recupero Senior Vice President of Global Communications. 

Corporate Boards of Directors

Shire plc announced that Gail D. Fosler and Albert P.L. Stroucken will be appointed to its Board of Directors effective upon the completion of the company’s merger with Baxalta Incorporated, which is expected to close in mid-2016.

Health IT

Greenway Health, LLC appointed Scott Zimmerman Chief Executive Officer. He succeeds Wyche “Tee” Green, who will continue with the company as Executive Chairman.
 
Health Systems
 
Lifespan Corporation has named Paul Adler the new Senior Vice President and General Counsel, effective June 1, 2016. He replaces Kenneth Arnold who is retiring.
 
Hospitals

Nyack Hospital has named Renee Mauriello and Anthony Matejicka the new Vice President and Chief Nursing officer, and Chief Medical Officer, respectively. 

Children’s Hospitals and Clinics of Minnesota has named Todd Ostendorf Chief Financial officer. 

Community Hospital South has named Anita Capps the new Chief Nursing Executive. 

John Gizdic has been named the new President of New Hanover Regional Medical Center, effective June 30, 2016. He replaces Jack Barto who will remain as Chief Executive Officer for another year.

Owensboro Health has named Greg Strahan the new President and Chief Executive Officer, on an interim basis.

Stanford Health has named David Entwistle the new President and Chief Executive Officer.
 
Medical Device Manufacturers
 
Haemonetics Corporation announced that Christopher Lindop will retire as Executive Vice President and Chief Financial Officer on May 27, 2017.
 
Pharmaceutical Manufacturers
 
Impax Laboratories, Inc. announced that Nigel Ten Fleming and Michael Markbreiter will not stand for re-election at the company’s Annual Meeting of Stockholders on May 17, 2016.

 
 
 

April 14, 2016

Charities
 
The Pancreatic Cancer Action Network promoted Lynn Matrisian to Chief Research Officer and appointed Doug Laidlaw Vice President of Scientific and Medical Affairs.
 
Companies
 
Tenet Healthcare Corporation appointed Howard Hacker Senior Vice President and Chief Compliance Officer, effective May 2, 2016.
 
Eisai Inc. appointed Beyhan Zaim Vice President of Commercial Development and Alzheimer's Disease Global Lead, Neurology Business Group.
 
Laboratory Corporation of America Holdings appointed Jonathan Zung Group President of Clinical Development and Commercialization Services for its Covance division.
 
Health Systems
 
Mercy Health has appointed Anton Decker the new Chief Clinical Officer. Brian Smith has been named Chief Operating Officer. Drew Banks has been appointed Chief Strategy Officer.
 
Presence Health has named Jim Kelly the Chief Financial Officer. He replaces Stephen Walters who has been serving in an interim capacity.
 
Hospitals
 
Children’s Medical Center Foundation has appointed Brent Christopher to replaces Kern Wildenthal as President, effective June 2016.
 
Miller Children’s and Women’s Hospital Long Beach has appointed Eliezer Nussbaum the new Chief of Staff.
 
Industry Service Providers
 
Pharmaceutical Product Development, LLC has appointed Hacene Mekerri the new Vice President of Central Laboratory Organization.
 
Medical Device Manufacturers
 
Tandem Diabetes Care, Inc. announced that Henry Anhalt has resigned from its Board of Directors in order to avoid a potential conflict of interest with his employer.
 
Elekta AB appointed Richard Hausmann President and Chief Executive Officer, effective June 10, 2016. He succeedsTomas Puusepp, who will continue to serve as a member of the Board of Directors.
 
Pharmaceutical Manufacturers
 
Purdue Pharma Canada appointed John Sebben Vice President of Manufacturing Operations.
 
Lannett Company, Inc. announced that Michael J. Bogda will leave the company on June 3, 2016.
 
 
 

April 7, 2016

Biotech

ImmunoGen, Inc. announced that Daniel Junius will retire as President and Chief Executive Officer once a successor has been named. He will continue to serve on the company’s Board of Directors.
 
Anika Therapeutics, Inc. appointed Stephen R. Mascioli Chief Medical Officer and Dana M. Alexander Chief Operations Officer.
 
Compugen Ltd. appointed Elliott Sigal, former Executive Vice President and Chief Scientific Officer of Bristol-Myers Squibb, Strategic Advisor.
 
Companies
 
Omron Healthcare, Inc. appointed Randy Kellogg President and Chief Executive Officer.
 
Anthem, Inc. appointed Swati Mathai Vice President of National Account Management succeeding Perry Pogany, who will be retiring from the company.
 
Aetna Inc. appointed Thomas J. Sabatino, Jr., Executive Vice President and General Counsel effective April 25, 2016. He succeeds William J. Casazza, who will retire from the company once it closes its transaction with Humana.
 
Centene Corporation appointed Mark Brooks Chief Information Officer.
 
Owens & Minor, Inc. appointed Rony C. Kordahi Executive Vice President of North American Operations.
 
Eisai Inc. appointed Paul Hawthorne Senior Vice President of U.S. Commercial, Neurology Business Group.
 
Pfizer Inc. and Allergan plc announced that they have terminated their previously announced merger agreement in response to new tax regulations put forth by the United States Department of Treasury. 
 
Corporate Boards of Directors
 
Unum Group announced that Joseph J. Echevarria, former Chief Executive Officer of Deloitte LLP, has been elected to its Board of Directors.
 
Health IT
 
Wipro Limited announced that Patrick Dupuis, Senior Vice President for Simplicity, Quality and Productivity at PayPal Holdings, has been appointed to its Board of Directors.
 
Health Systems
 
Centura Health has named Peter D. Banko President and Chief Operating Officer, effective May 1, 2016. He takes over for Gary S. Campbell, FACHE who will stay on as Chief Executive Officer.
 
Robert Wood Johnson University Hospital and Saint Barnabas Health System have completed their previously announced merger. The combined organization is called RWJBarnabas Health, and is comprised of the combined staff of the previously two separate organizations.
 
Gundersen Health System has named Dara Bartels the Chief Financial Officer, a position she has been filling on an interim basis since September 2015.
 
Sheppard Pratt Health System has announced that Harsh K. Trivedi will join the health system as President and Chief Executive Officer, effective July 1, 2016.
 
Orlando Health has named Mark Marsh the new Senior Vice President, effective May 1, 2016.
 
Roper St. Francis’s Chief Executive Officer David Dunlap has announced his retirement by the end of 2016.
 
Owensboro Health has announced that Philip Patterson has resigned as President and Chief Executive Officer.
 
Industry Service Providers
 
Assurex Health, Inc. has announced the appointment of Inger Eckert as General Counsel, Mary Sue Findley as Chief People Officer, and Mark Verratti as Chief Sales and Business Development Officer.
 
Insurance and Managed Care
 
On Lok, Inc. promoted Grace Li to Chief Executive Officer. She replaces Robert Edmondson, who is retiring from the company.
 
Kaiser Permanente announced that Ramón Baez, Senior Vice President of Customer Advocacy at Hewlett Packard Enterprise, has been appointed to its Board of Directors.
 
Blue Cross and Blue Shield of North Carolina appointed current Chief Financial Officer Gerald Petkau to the role of Chief Operating Officer, replacing Alan Hughes who has resigned from the company. Mr. Petkau’s role as Chief Financial Officer will be filled by Mitch Perry.
 
Pharmacies
 
Maxor National Pharmacy Services, LLC appointed Michael Ellis Chief Executive Officer. He succeeds John Ward, is retiring as Chief Executive Officer but will remain on the Board of Directors.
 
Pharmaceutical Manufacturers
 
Medivation, Inc. appointed Jennifer Jarrett Chief Financial Officer effective April 23, 2016. She succeeds Richard A. Bierly, who will be retiring from the company in July 2016.
 
Inotek Pharmaceuticals Corporation announced that J. Martin Carroll, former Head of Global Strategy and Development at Boehringer Ingelheim, has been appointed to its Board of Directors replacing Isai Peimer, who has resigned from the Board. Mr. Carroll will be named Chairperson at the company’s Annual Meeting of Stockholders on June 23, 2016. He will succeed Argeris Karabelas in that role, who will be resigning from the board.
 
 
 

March 31, 2016

Associations

The Washington State Hospital Association announced that Scott Bond will retire as President and Chief Executive officer in January 2017.

Biotech

Oncothyreon Inc. appointed Scott D. Myers President, Chief Executive Officer and a member of the Board of Directors effective April 4, 2016. He replaces Christopher S. Henney, the company’s Chairman, who has been serving as interim Chief Executive Officer since January 2016.

Charities

The Michael J. Fox Foundation for Parkinson's Research announced on March 24, 2016, that it has entered into an agreement with Parkinson's Action Network under which PAN will merge with and integrate into MJFF as part of its new public policy department. Two organizations expect the transition to occur over the next several weeks.

Companies

Centene Corporation announced on March 24, 2016, that it has completed its previously announced acquisition of Health Net, Inc.
 
Biogen Inc. appointed Michel Vounatsos Executive Vice President and Chief Commercial Officer effective April 18, 2016.
 
Health IT
 
Hyland Software, Inc. announced that Miguel Zubizarreta will retire as Executive Vice President and Chief Technology Officer on July 29, 2016.
 
Hospitals
 
Hartford HealthCare has named Peter Paul Yu M.D. the new Physician-in-Chief of the Cancer Institute.
 
Rogers Memorial Hospital has appointed Peggy Scallon as the new Medical Director of Adolescent Residential Program.
 
Industry Service Providers
 
ICON plc. announced that the Chairman of the Board, Thomas Lynch, will be retiring at the next re-election of the board.
 
BioClinica, Inc. has named Steven Herne the new Chief Commercial Officer and Francois Audibert the new Vice President for Global Consulting.
 
Insurance and Managed Care
 
Scott & White Health Plan appointed Jeffrey C. Ingrum Chief Executive Officer, effective April 25, 2016.
 
 
 

March 24, 2016

Biotech

Transgene SA appointed Maud Brandely Chief Medical Officer and John Felitti Vice President, General Counsel and Corporate Secretary.

Companies

GlaxoSmithKline plc announced that Andrew Witty will retire as Chief Executive Officer on March 31, 2017. His successor has not yet been named.
 
Aflac Incorporated promoted Bradley Knox from Vice President to Senior Vice President of Federal Relations effective April 1, 2016. He succeeds David Pringle, who is retiring from the company.
 
Valeant Pharmaceuticals International, Inc. announced that J. Michael Pearson will step down as Chief Executive Officer once a successor has been named. The company also announced that William A. Ackman, Chief Executive Officer of Pershing Square Capital Management, has been appointed to its Board of Directors. He replaces Katharine B. Stevenson, who has resigned from the Board.
 
Bayer AG appointed Joyce Lee President of its North American Animal Health business.
 
Tenet Healthcare Corporation promoted Eric Evans from Chief Executive Officer of its Texas Region to President of Hospital Operations. He replaces Britt Reynolds, who has resigned from the company.
 
Corporate Boards of Directors
 
Edwards Lifesciences Corporation announced that Steven R. Loranger, most recently President and Chief Executive Officer of Xylem, has been appointed to its Board of Directors.
 
Team Health Holdings, Inc. announced that it has entered into an agreement with JANA Partners LLC, which owns approximately 8% of TeamHealth stock, under which Scott Ostfeld, Partner of JANA, and Edwin “Mac” Crawford, former Chairman and Chief Executive Officer of CVS Caremark, have been appointed to the company’s Board of Directors. The company also announced that Nancy M. Schlichting, Chief Executive Officer of Henry Ford Health System, will be appointed to the Board in January 2017.
 
Health IT
 
Netsmart Technologies, Inc. announced on March 23, 2016, that it has entered into a definitive agreement to be acquired by GI Partners in partnership with Allscripts Healthcare Solutions, Inc. Once completed, Netsmart will be merged with Allscripts' homecare software business unit. The combined company will continue to be led by Mike Valentine, Netsmart's current Chief Executive Officer. The transaction is expected to close in April 2016.
 
Hospitals
 
Ascension Michigan has appointed Dr. Donald Bignotti the new Chief Clinical Officer, effective May 1, 2016.
 
TriHealth, Inc. has appointed Thomas Tami the new Physician Executive of TriHealth Physician Partners.
 
Indiana University Health has appointed Mark Lantzy the new Chief Information Officer. He replaces Bill McConnell who has is retiring.
 
Saint Francis Hospital-Memphis has announced David Archer is stepping down as Chief Executive Officer, effective May 2016.
 
Capella Healthcare Inc., has entered into a definitive agreement with RegionalCare Hospital Partners, Inc., under which the two will be merged to create a single healthcare company. The combined company's name will be RCCH Health Partners and the transaction is expected to close during second quarter 2016.
 
Rush University Medical Center has named Igor Koralnik the Chair of Department of Neurological Sciences, effective July 1, 2016. He replaces Jacob Fox who is retiring.
 
Medical Device Manufacturers 
 
Cantel Medical Corp. announced that Jorgen B. Hansen has been promoted from President and Chief Operating Officer to President and Chief Executive Officer and a member of the Board of Directors effective August 1, 2016. He succeeds Andrew A. Krakauer, who is stepping down as Chief Executive Officer and a member of the Board but will continue to serve as a Senior Advisor until October 15, 2016.
 
Orthofix International N.V. announced that Michael E. Paolucci, Vice President of Alliances and Human Capital at Halozyme Therapeutics, has been appointed to its Board of Directors.
 
Research Organizations
 
The Patient-Centered Outcomes Research Institute announced that Sharon Arnold, Acting Director of the Agency for Healthcare Research and Quality, has been appointed to its Board of Directors.
 
 
 

March 17, 2016

Biotech

NantKwest, Inc. appointed Fatih M. Uckun Vice President of Research and Clinical Development.

Companies

Allstate Insurance Company announced that Judith P. Greffin will retire as Executive Vice President and Chief Investment Officer on March 31, 2016. Chief Financial Officer Steve Shebik will fill the role in an interim capacity until a replacement has been named. In a separate announcement, the company also announced that Glenn Shapiro has been appointed Executive Vice President of Claims effective April 4, 2016. He succeeds Michael J. Roche, who is retiring from the company.
 
Corizon Health, Inc. appointed Douglas Thompson Executive Vice President and Chief Financial Officer. He replaces Jeff Sholey, who has been serving as interim Chief Financial Officer and Corporate Controller since August 2014 and will continue to serve as Controller.
 
Corporate Boards of Directors
 
LifePoint Health, Inc. announced that Kermit Crawford, former President of Pharmacy, Health and Wellness of Walgreens, and Jana Schreuder, Executive Vice President and Chief Operating Officer of Northern Trust, have been appointed to its Board of Directors.
 
Wipro, Ltd. announced that Patrick J. Ennis, Global Head of Technology at Intellectual Ventures, has been appointed to its Board of Directors effective April 1, 2016.
 
Hospitals
 
Broward Health has appointed Pauline Grant as President and Chief Executive Officer in an acting capacity. She replaces Kevin Fusco, current Acting President and Chief Executive Officer, who will be returning to his role as Chief Operating Officer.
 
DeGraff Memorial Hospital has named Jeffrey Holt the Vice President and Chief Operating Officer.
 
Kaleida Health has named Gary Brice the Vice President of Learning and Engagement.
 
NYU Langone Medical Center has appointed Itai Yanai as the new Director of the Institute for Computational Medicine, effective May 1, 2016.
 
Medical Device Manufacturers 
 
Greatbatch, Inc. completed its previously announced spin-off of its QIG Group subsidiary. The new, independent company now operates as Nuvectra Corporation.
 
 

March 10, 2016

Biotech

Osiris Therapeutics, Inc. appointed Dwayne Montgomery permanent President and Chief Executive Officer and a member of the Board of Directors. He has been serving as interim Chief Executive Officer since February 2016. The company also announced that Thomas M. Brandt has been elected to its Board. 
 
Halozyme Therapeutics, Inc. appointed James M. Daly, most recently Executive Vice President and Chief Commercial Officer of Incyte Corporation, to its Board of Directors.

Companies

McKesson Corporation announced on March 2, 2016, that it has entered into a definitive agreement to acquire Rexall Health from Katz Group for $3 billion CAD.  The operations of Rexall Health will become part of McKesson's Distribution Solutions segment and it will continue to be led by its existing management team. The transaction is expected to close late in 2016.
 
Merck & Co., Inc. appointed Sanat Chattopadhyay Executive Vice President and President of Merck Manufacturing Division effective April 1, 2016. He succeeds Willie A. Deese, who is retiring from the company.
 
Corporate Boards of Directors
 
Bristol-Myers Squibb Company announced that Peter J. Arduini, President and Chief Executive Officer of Integra LifeSciences, has been elected to its Board of Directors effective April 1, 2016.
 
Valeant Pharmaceuticals International, Inc. announced that Fred Eshelman, founder and former Chief Executive Officer and Executive Chairman of Pharmaceutical Product Development, Stephen Fraidin, Vice Chairman of Pershing Square Capital Management, and Mr. Thomas W. Ross, Sr., former President of the University of North Carolina, have been appointed to its Board of Directors.
 
Hospitals
 
Baptist Memorial Hospital for Women has appointed Kevin Hammeran the new Chief Executive Officer and Administrator.
 
HonorHealth, Inc. has appointed Alice Pope the new Chief Financial Officer.
 
Christus Santa Rosa Children’s Hospital has appointed Dr. Ian Thompson the Associate Chief Medical Officer.
 
Capella Health has appointed Rita Croom the Senior Vice President and Chief Experience Officer.
 
Insurance and Managed Care

Blue Cross and Blue Shield of North Carolina promoted Michael Parkerson to Chief Strategy Officer and Brian Caveney to Chief Medical Officer.
 
Health Partners Plans, Inc. appointed Lisa Getzfrid Senior Vice President of Operations and Chief Operating Officer.
 
Medical Device Manufacturers 
 
Mindray Medical International Limited announced that it has completed the necessary transaction to become a privately owned company.
 
Pharmaceutical Manufacturers
 
Noven Pharmaceuticals, Inc. appointed Dolores Calicchio Vice President of Human Resources. She succeeds Lance Williams, who is retiring from the company.
 
ZOLL Medical Corporation promoted Jonathan A. Rennert Chief Executive Officer effective April 1, 2016. He succeeds Richard A. Packer, who will assume a new role at Asahi Kasei, its parent company, and continue to serve ZOLL as Non-Executive Chairman. A. Ernest Whiton will succeed Mr. Rennert as President of its resuscitation business.
 
 

 March 3, 2016

Companies

Hologic, Inc. has appointed Christopher J. Coughlin to the company Board of Directors.
 
Blue Cross and Blue Shield of Minnesota announced that Tina Holmes has been appointed Vice President and Chief of Staff. Also, Eric Hoag has been appointed the Vice President of Provider Relations. Janelle Waldock has been appointed the Vice President of Community Health and Health Equity. Finally, Peter Wickersham has been appointed Vice President of Health Service Operations and the Executive Pharmacy Officer.
 
Valeant Pharmaceuticals International, Inc. has announced that Deb Jorn has resigned as Executive Vice President of the company. Also, Eric Abramson has been appointed General Manager of the U.S. Dermatology business.
 
Hospitals
 
NYU Langone Medical Center has appointed Dr. Douglas J. Levine as Director of the Division of Gynecologic Oncology for the Isaac Perlmutter Cancer Center, and the Department of Obstetrics and Gynecology, effective May 15, 2016.
 
Methodist Le Bonheur Healthcare has announced the retirement of Gary Shorb, effective December 31, 2016.
 
Northwestern Medicine has appointed Dr. Lauren Streicher has the new Medical Director for Sexual Health.
 
The Southeast Permanente Medical Group has appointed Bryan Cook the Senior Director of Acute Care Operations.
 
The Hospital for Special Surgery has appointed Dr. Joel Press the new Chair of the Department of Physiatry, effective September 2016. 
 
Baylor Scott and White Health announced that Joel T. Allison will step down on February 1, 2017.
 
Overlake Medical Center has announced the appointment of Dr. Dennis Rochier as the new Chief Executive Officer.
 
 


 
February 25, 2016
 
Associations
 
The National Hospice and Palliative Care Organization announced that J. Donald Schumacher will retire at the end of 2016 from the organization and its affiliated entities, which include the National Hospice Foundation, Global Partners in Care, and Hospice Action Network.
 
Biotech
 
Aeterna Zentaris Inc. appointed Geneviève Lemaire Vice President of Finance and Chief Accounting Officer. She succeeds Keith Santorelli, who has resigned from the company.
 
Companies
 
Mylan N.V. appointed Anthony Mauro Chief Commercial Officer. Mr. Mauro will continue to serve as President of North America until a successor has been named.
 
Diplomat Pharmacy, Inc. promoted Atheer Kaddis to Executive Vice President of Sales and Strategic Alignment and Lance Neill to Senior Vice President of Corporate Services. 
 
Bayer AG appointed Werner Baumann Chief Executive Officer and Chairman of the Board of Management effective May 1, 2016. He will succeed Marijn Dekkers, whose contract was originally set to expire at the end of 2016.
 
Health IT
 
Quality Systems, Inc. appointed James R. Arnold, Jr. Chief Financial Officer effective March 1, 2016. He will succeed John K. Stumpf, who has been serving as interim Chief Financial Officer since March 2015.
 
Orion Health Ltd. appointed Wayne Oxenham President of North America. He will be based at the company’s North American headquarters in Scottsdale, AZ.
 
Hospitals
 
Wills Eye Hospital has named Dr. Leslie G. Hyman as the new Vice Chair for Research.
 
Dana-Farber Cancer Institute has named Dr. Laurie H. Glimcher the new President and Chief Executive Officer at the end of December 2016.
 
University Hospitals has appointed Robert G. David the President of UH St. John Medical Center, effective April 1, 2016. 
 
Scripps Health has hired Andy Crowder the new Senior Vice President and Chief Information Officer.
 
Pharmaceutical Manufacturers
 
CONMED Corporation announced that Martha Goldberg Aronson, most recently Executive Vice President and President of Global Healthcare at Ecolab, has been appointed to its Board of Directors.

 

February 18, 2016

Affiliated Organizations

Victory Park Capital appointed Upacala Mapatuna Chief Investment Officer.

Companies

Kemper Corporation announced that Denise I. Lynch has resigned as Property & Casualty Group Executive. Her role is assumed on an interim basis by Joseph W. Metz, the company’s Personal and Commercial Lines President, who will lead the segment in partnership with Joseph P. Lacher, Jr., the company’s President and Chief Executive Officer.

Mylan N.V announced on February 10, 2016, a recommended public offer to the shareholders of Meda Aktiebolag to tender their shares to Mylan in a transaction worth approximately $9.9 billion. The acquisition, should it be approved, is expected to close by the end of the third quarter of 2016.

Assurant, Inc. appointed Gene Mergelmeyer Chief Operating Officer effective July 1, 2016. The company also appointed Mike Anderson interim President of Assurant Solutions and Andy Morris President and Chief Executive Officer of Assurant Solutions in Europe, both effective immediately. 

Stryker Corporation announced on February 16, 2016, that it has entered into a definitive agreement to acquire Physio-Control International, Inc. from Bain Capital Private Equity for $1.28 billion. The transaction is expected to close at the beginning of the second quarter of 2016.

Diplomat Pharmacy, Inc. promoted Paul Urick from Vice President of Industry Relations and Pharmaceutical Account Management to Senior Vice President of Industry Relations, Pharmaceutical Account Management and Payor Strategies.

Corporate Boards of Directors

Celgene Corporation announced that Mark Alles, the company’s Chief Executive Officer designate, and Jacqualyn Fouse, its Chief Operating Officer designate, have been appointed to its Board of Directors.

Hospitals

Rush University Medical Center has announced that Peter Butler will retire as President, effective July 1, 2016. He will be succeeded by Michael J Dandorph, currently Executive Vice President and Chief Operating Officer for the Institution.

St. Jude Children’s Research Hospital has announced Pat Keel the new Chief financial Officer.

Carolinas HealthCare System has appointed Eugene Woods as the new President and Chief Executive Officer.

Insurance and Managed Care

Capital BlueCross appointed Chris Davis Vice President of Ancillary Services.

Pharmaceutical Manufacturers

Ipsen S.A. announced that it intends to separate the functions of Chairman and Chief Executive Officer. Marc de Garidel will continue to serve as Chairman and Chief Executive Officer until a replacement Chief Executive Officer has been appointed, at which point he will continue as of Non-Executive Chairman. The company also announced that Christel Bories, Deputy Chief Executive Officer, has left the company.

 

 

February 11, 2016

Biotech

Osiris Therapeutics, Inc. announced that Lode Debrabandere has resigned as President and Chief Executive Officer and a member of the Board of Directors. He is succeeded by Dwayne Montgomery, the company’s Chief Business Officer, who will assume the role in an interim capacity. The company also announced that Frank Czworka has been promoted from Vice President and General Manager of Wound Care to Chief Operating Officer.

Novogen Limited announced that John O’Connor has been appointed Chairman of the Board of Directors and Bryce Carmine has been appointed Deputy Chairman.

Companies

Astellas Pharma Inc. promoted James Robinson to President of Americas Operations for Astellas US LLC, effective April 1, 2016. Mr. Robinson succeeds Masao Yoshida, who is retiring this summer.

Corporate Boards of Directors

Shire plc announced that David Kappler will step down as Deputy Chairman and Senior Independent Director of the Board of Directors at the Annual General Meeting on April 28, 2016. William Burns will be appointed Senior Independent Director effective at that time.

Health IT

Nuance Communications Inc. appointed Robert C. Schassler Executive Vice President and General Manager of its Mobile Division. He succeeds Michael Thompson, who has left the company. In a separate announcement, the company also announced that it appointed Ken Siegel Chief Legal Officer.

Health Systems

Memorial Hermann Health System has announced the hiring of Daniel Styf has the new Senior Vice President and Chief Executive Officer of its Health Plan business.

The Medical College of Wisconsin has appointed Christopher Kops the new Senior Vice President for Finance and Administration, and Chief Operating Officer.

Hospitals

Miller Children’s and Women’s Hospital Long Beach has named Kristin Mascotti the new Quality Medical Officer.

Perry Memorial Hospital has announced the future retirement of Rex Conger as President and Chief Executive Officer, effective January 15, 2017.

Wesley Medical Center has appointed Brian Swallow the new Vice President of Surgical Services.

The Hospital for Special Surgery has appointed Leonard Achan as the new Chief Innovation Officer and Senior Vice President of Innovation and Business Development.

 


February 4, 2016

Associations

The District of Columbia Hospital Association announced that Robert A. Malson will retire as President and Chief Executive Officer effective February 29, 2016. No replacement has been named yet.

Biotech

Aeterna Zentaris Inc. announced that Michael Cardiff, Chief Executive Officer of Accelerents, and Ken Newport, former President of CroMedica, have been appointed to its Board of Directors.

Companies

Gilead Sciences, Inc. promoted John F. Milligan, the company’s President and Chief Operating Officer, to Chief Executive Officer and a member of the Board of Directors effective March 10, 2016. Current Chairman and Chief Executive Officer John C. Martin will assume the role of Executive Chairman.

Abbott Laboratories announced on February 1, 2016, that it has entered into a definitive agreement to acquire Alere Inc. for $5.8 billion.

NBTY, Inc. announced on February 2, 2016, that it has entered into a definitive agreement to sell its Vitamin World business to Centre Lane Partners. The transaction is expected to close by mid-February 2016.

Gilead Sciences, Inc. promoted Katie Watson from Senior Vice President to Executive Vice President of Human Resources.

HealthCare Partners LLC appointed Ilene Moore Chief Legal Officer and General Counsel.

Hospitals

Providence Hospitals has joined LifePoint Health as their newest component hospital.

Seattle Children’s Hospital has appointed Jeff Brown the new Chief Information Officer.

Broward Health has appointed Kevin Fusco, current Chief Operating Officer, the new Chief Executive Officer in an acting capacity.

Hackensack University Health Network has appointed Ihor Sawczuk the new President of the Hackensack University Medical Center, effective April 4, 2016.

Children’s Hospital of Los Angeles has appointed Jaclyn Biegel the new Director of the Center for Personalized Medicine and Chief of New Division Genomic Medicine.

The Southeast Permanente Medical Group has appointed Yudit Krosner the new Senior Director of Clinical Operations and Strategy.

Silverado Senior Living has appointed Shamin Wu the new President and Chief Operating Officer.

Insurance and Managed Care

SelectHealth, Inc. appointed Russel Kuzel, MD, Vice President and Chief Medical Officer effective in March 2016.

Hylant Group promoted William Pridgeon from Executive Vice President to President and Chief Financial Officer.

 

 

January 28, 2016

Biotech

Onxeo S.A. announced that Jean-Pierre Kinet, MD and Jean-Pierre Bizzari, MD have been appointed Observers to the Board of Directors. They will stand for election as full directors at the General Shareholders’ Meeting on April 6, 2016.

Companies

DaVita HealthCare Partners, Inc. appointed Jim Rechtin President of its California-market HealthCare Partners Medical Group, effective February 15, 2016. He succeeds Pratibha Patel, MD, who will continue to serve as President Emeritus throughout 2016.

EMD Serono, Inc. appointed Gary Zieziula permanent President and Managing Director. He has filled the role in an interim capacity since January 1, 2016.

Stryker Corporation announced that William R. Jellison will retire as Vice President and Chief Financial Officer. He is succeeded by Glenn S. Boehnlein, who will assume the role effective April 1, 2016.

Health Systems

St. David’s Healthcare has appointed Roderick Carbonell has the new Vice President of Physician Operations.

Hospitals

Temple University Hospital has named Dr. Verdi J. Disesa as the new President and Chief Executive Officer, effective March 1, 2016.

Orlando Health has named Erick Hawkins as a new Senior Vice President. He comes from UNC Rex Healthcare where he stepped down.

Miami Cancer Institute has named Minesh Mehta the new Deputy Director and Chief of Radiation Oncology.

Inova Dwight and Martha Schar Cancer Institute has named Thomas Conrads the new Associate Director of Scientific Technologies.

The University of Michigan Hospitals and Health Centers has announced Sue Schade has stepped down as Chief Information Officer. 

Insurance and Managed Care

Highmark Health appointed John Paul Special Advisor to the President and Chief Executive Officer, effective February 2016. His position as President and Chief Executive Officer of Allegheny Health Network will be assumed by Cynthia Hundorfean.

 


January 21, 2016

Affiliated Organizations

Affymetrix, Inc. announced on January 8, 2016, that it has entered into an agreement to be acquired by Thermo Fisher Scientific Inc. for approximately $1.3 billion. The transaction is expected to be completed by the end of the second quarter of 2016.

Inotek Pharmaceuticals Corporation announced that Carsten Boess, Chief Business Officer at Kiniksa Pharmaceuticals, has been appointed to its Board of Directors.

Associations

The Hospital Council of Northern and Central California appointed William “T” Abraham Regional Vice President for the North Bay, Northern Sierra and Redwood Coast sections. He replaces Suzanne Ness who is retiring from the organization.

Biotech

Cerus Corporation appointed Gualtiero G. Garlasco interim General Manager of Cerus Europe, replacing Caspar Hogeboom, who is leaving the company on April 1, 2016.

Companies

Mylan N.V. announced that John D. Sheehan will retire as Executive Vice President and Chief Financial Officer effective April 1, 2016.

Triple-S Management Corporation appointed Madeline Hernandez-Urquiza President of Triple-S Salud, succeeding Pablo Almodovar; Juan Jose Roman-Jimenez Executive Vice President and Chief Financial Officer, succeeding Amílcar L. Jordán; and Carlos L. Rodriguez Ramos permanent General Counsel, having served as acting General Counsel since December 2013.

Celgene Corporation announced several executive changes effective March 1, 2016: Robert J. Hugin will step down as Chief Executive Officer and continue to serve as Executive Chairman; Mark J. Alles will be promoted to Chief Executive Officer; and Jacqualyn A. Fouse will be promoted to President and Chief Operating Officer.

Shire plc announced on January 11, 2016, that it has entered into an agreement to combine with Baxalta Incorporated in a transaction worth approximately $32 billion. The transaction is set to close mid-2016.

DaVita HealthCare Partners Inc. appointed Chris Miller Chief Executive Officer of its Paladina Health, LLCsubsidiary.

Corporate Boards of Directors

Laboratory Corporation of America Holdings announced that Richelle Parham, most recently Chief Marketing Officer of eBay, has been appointed to its Board of Directors, effective February 8, 2016.

Health Systems

Capella Healthcare has appointed Vishal Bhatia the new Senior Vice President and Chief Medical Information Officer.

Barnabas Health has appointed Frank Vozos the new Chief Executive Officer for Monmouth Medical Center Southern Campus, effective April 1, 2016. At that time, his post as the Chief Executive Officer for Monmouth Medical Center will be filled by Bill Arnold, the current Chief Operating Officer.

The Medical University of South Carolina has named Raymond N. DuBois M.D., Ph.D., as the next dean of the College of Medicine, effective March 1, 2016.

Adventist University of Health Sciences has announced Alicia Franco Scarcella, PhD as the new Chair of the Nursing Department.

Hospitals

Johns Hopkins Hospital has appointed Dr. Redonda Miller as the new Senior Vice President of Medical Affairs.

The Children’s Hospital of Pittsburgh has appointed Dr. Terence S. Dermody as the new Scientific Director, starting June 1, 2016.

Dayton Children’s Hospital has appointed Chris Bergman the new Chief Financial Officer for Dayton Children’s Hospital. He replaces David Miller who has retired.

Steward Good Samaritan Medical Center has appointed Lani Litchfield Zani the new Chief Nursing Officer. She replaces Jerilyn Thomas who has retired.

Pennsylvania Hospital has announced Jack Ludmir will step down as the Chairman of Obstetrics and Gynecology this spring.

City of Hope has appointed Ravi Salgia as the new Chair of Medical Oncology.

Industry Service Providers

BioDuro, LLC has announced the appointment of Ian R. Wisenberg as the new Chief Financial Officer. 

Diamond Healthcare has appointed Richard R. Feldman the new President and Chief Executive Officer, effective February 1, 2016. He replaces Christopher Carney who is stepping down.

Insurance and Managed Care

Capital BlueCross appointed Scott Frank as Chief Information Officer.

 

 

January 14, 2016

Affiliated Organizations

Affymetrix, Inc. announced on January 8, 2016, that it has entered into an agreement to be acquired by Thermo Fisher Scientific Inc. for approximately $1.3 billion. The transaction is expected to be completed by the end of the second quarter of 2016.

Inotek Pharmaceuticals Corporation announced that Carsten Boess, Chief Business Officer at Kiniksa Pharmaceuticals, has been appointed to its Board of Directors.

Associations

The Hospital Council of Northern and Central California appointed William “T” Abraham Regional Vice President for the North Bay, Northern Sierra and Redwood Coast sections. He replaces Suzanne Ness who is retiring from the organization.

Biotech

Cerus Corporation appointed Gualtiero G. Garlasco interim General Manager of Cerus Europe, replacing Caspar Hogeboom, who is leaving the company on April 1, 2016.

Companies

Mylan N.V. announced that John D. Sheehan will retire as Executive Vice President and Chief Financial Officer effective April 1, 2016.

Triple-S Management Corporation appointed Madeline Hernandez-Urquiza President of Triple-S Salud, succeeding Pablo Almodovar; Juan Jose Roman-Jimenez Executive Vice President and Chief Financial Officer, succeeding Amílcar L. Jordán; and Carlos L. Rodriguez Ramos permanent General Counsel, having served as acting General Counsel since December 2013.

Celgene Corporation announced several executive changes effective March 1, 2016: Robert J. Hugin will step down as Chief Executive Officer and continue to serve as Executive Chairman; Mark J. Alles will be promoted to Chief Executive Officer; and Jacqualyn A. Fouse will be promoted to President and Chief Operating Officer.

Shire plc announced on January 11, 2016, that it has entered into an agreement to combine with Baxalta Incorporated in a transaction worth approximately $32 billion. The transaction is set to close mid-2016.

DaVita HealthCare Partners Inc. appointed Chris Miller Chief Executive Officer of its Paladina Health, LLCsubsidiary.

Corporate Boards of Directors

Laboratory Corporation of America Holdings announced that Richelle Parham, most recently Chief Marketing Officer of eBay, has been appointed to its Board of Directors, effective February 8, 2016.

Health Systems

Capella Healthcare has appointed Vishal Bhatia the new Senior Vice President and Chief Medical Information Officer.

Barnabas Health has appointed Frank Vozos the new Chief Executive Officer for Monmouth Medical Center Southern Campus, effective April 1, 2016. At that time, his post as the Chief Executive Officer for Monmouth Medical Center will be filled by Bill Arnold, the current Chief Operating Officer.

The Medical University of South Carolina has named Raymond N. DuBois M.D., Ph.D., as the next dean of the College of Medicine, effective March 1, 2016.

Adventist University of Health Sciences has announced Alicia Franco Scarcella, PhD as the new Chair of the Nursing Department.

Hospitals

Johns Hopkins Hospital has appointed Dr. Redonda Miller as the new Senior Vice President of Medical Affairs.

The Children’s Hospital of Pittsburgh has appointed Dr. Terence S. Dermody as the new Scientific Director, starting June 1, 2016.

Dayton Children’s Hospital has appointed Chris Bergman the new Chief Financial Officer for Dayton Children’s Hospital. He replaces David Miller who has retired.

Steward Good Samaritan Medical Center has appointed Lani Litchfield Zani the new Chief Nursing Officer. She replaces Jerilyn Thomas who has retired.

Pennsylvania Hospital has announced Jack Ludmir will step down as the Chairman of Obstetrics and Gynecology this spring.

City of Hope has appointed Ravi Salgia as the new Chair of Medical Oncology.

Industry Service Providers

BioDuro, LLC has announced the appointment of Ian R. Wisenberg as the new Chief Financial Officer. 

Diamond Healthcare has appointed Richard R. Feldman the new President and Chief Executive Officer, effective February 1, 2016. He replaces Christopher Carney who is stepping down.

Insurance and Managed Care

Capital BlueCross appointed Scott Frank Chief Information Officer.

 

 

January 7, 2016

Affiliated Organizations

Powell Industries, Inc. announced that Michael A Lucas has resigned as President and Chief Executive Officer and a member of the Board of Directors. He is succeeded by Thomas W. Powell, who will maintain his current role as Chairman and assume the additional roles of President and Chief Executive Officer. The company also announced that it has promoted Brett A. Cope to Senior Vice President and Chief Operating Officer.

Onvoy, LLC announced on January 6, 2015, that it has entered into a definitive agreement to be acquired by private equity firm GTCR, LLC. The transaction is expected to close in the first quarter of 2016.

Companies

Valeant Pharmaceuticals International, Inc. announced that J. Michael Pearson has begun a medical leave of absence in order to recover from a severe case of pneumonia. The company has appointed Howard B. Schiller, its former Chief Financial Officer, to serve as Chief Executive Officer in an interim capacity.

Welltower Inc. appointed Shankh Mitra Senior Vice President of Finance and Investments and Tim McHugh Vice President of Finance and Investments.

Bayer AG announced that it has completed the divesture of its Diabetes Care business to Panasonic Healthcare Holdings, Co., Ltd.

Magellan Health, Inc. appointed Srinivas “Srini” Koushik Chief Technology Officer, effective January 11, 2016.

Health IT

Wipro Ltd. appointed TK Kurien Executive Vice Chairman and promoted Abidali Z. Neemuchwal to Chief Executive Officer, both effective February 1, 2016.

Health Systems

TriHealth, Inc. has named Jim Hauschildt the new President of Good Samaritan College of Nursing and Health Sciences. He replaces Morris Cohen who has retired.

Hospitals

NYU Langone Medical Center has appointed Joel Schuman the new Chairman for the Department of Ophthalmology.

Industry Service Providers

LTC Properties, Inc. has appointed Doug Korey as the new Senior Vice President of Business Development, and Mandi Hogan as their new Director of Marketing, succeeding Mark Hemingway who retires from his role as Vice President of Marketing on February 29, 2016.

Pharmaceutical Manufacturers

BioMarin Pharmaceutical Inc. announced that David E.I. Pyott, former Chairman and Chief Executive Officer of Allergan, has been elected to its Board of Directors.

Noven Pharmaceuticals, Inc. promoted Jeff Mihm to Chief Executive Officer, succeeding Jeffrey Eisenberg. The company also appointed John Choi Vice President, Chief Financial Officer and Treasurer, succeeding Michael Price, and Michael Greene Vice President, General Counsel and Corporate Secretary, assuming the roles previously held by Mr. Mihm.

 

 

December 28, 2015

Associations

The National Quality Forum announced that Christine K. Cassel will step down as President and Chief Executive Officer effective March 1, 2016, to join Kaiser Permanente and help design the new Kaiser Permanente School of Medicine.

Biotech

Isis Pharmaceuticals, Inc. announced that it has changed its name to Ionis Pharmaceuticals, Inc. The company began trading on the NASDAQ Global Select Market under the new ticker symbol "IONS" on December 22, 2015.

Acorda Therapeutics, Inc. announced that Enrique Carrazana will resign as Chief Medical Officer, effective January 4, 2016. Burkhand Blank, MD, will serve as interim Chief Medical Officer until a replacement has been named.

Alnylam Pharmaceuticals, Inc. announced that Michael W. Bonney has been appointed Chairman of the Board, effective January 1, 2016. He succeeds John Clarke, who will remain on the Board as a Director. The company also announced that David E. I. Pyott, former Chairman and Chief Executive Officer of Allergan, has been elected to the Board effective immediately.

Vical Incorporated announced that Thomas E. Shenk, PhD, James A. Elkins Professor in the Life Sciences at Princeton University, has been appointed to its Board of Directors. He replaces Stephen A. Sherwin, MD, who has stepped down.

Companies

AstraZeneca PLC announced on December 17, 2015, that it has entered into a definitive agreement to acquire a 55% majority stake in Acerta Pharma B.V. for $4 billion. Upon completion of the transaction, Acerta will be a majority-owned subsidiary of AstraZeneca. The agreement also included options for AstraZeneca to purchase the remaining 45% of shares resulting in Acerta becoming a wholly-owned subsidiary. The transaction is expected to be completed by the end of the first quarter of 2016.

Centene Corporation promoted Brandy Burkhalter, Cary Hobbs and Holly Benson to Executive Vice President.

Kindred Healthcare Inc. appointed Peter Kalmey President of its Hospital Division, effective January 1, 2016.

Corporate Boards of Directors

New York Life Insurance Company announced that Robert B. Carter, Executive Vice President of FedEx Information Services and Chief Information Officer of FedEx Corporation, has been elected to its Board of Directors, effective January 1, 2016.

Insurance and Managed Care

Independence Blue Cross announced a number of appointments and promotions effective January 1, 2016. Yvette Bright will assume a new position as Executive Vice President and Chief Operating Officer, Brian Lobley as Senior Vice President and President of Commercial and Consumer Markets, Mike Sullivan as Senior Vice President and President of Diversified Businesses, and Richard Neeson as Executive Vice President and Chief Development and Innovation Officer. The company also announced that Chris Cashman will retire as Executive Vice President and President of Commercial Markets on December 31, 2015, and Lisa Taylor will retire as Senior Vice President and Chief Sales Executive in March 2016.

Medical Device Manufacturers

Masimo Corporation announced that former five-term U.S. Senator Tom Harkin has been elected to its Board of Directors.

 


December 17, 2015

Biotech

MEI Pharma, Inc. announced that Christine White, MD, has been appointed Chairman of the Board of Directors. She has been a Director since 2010 and has served as Lead Director since 2013.

Novogen Limited appointed James Garner Chief Executive Officer, effective February 1, 2016. He replaces Iain Ross, who has been serving as acting Chief Executive Officer since July 2015.

BIND Therapeutics, Inc. appointed Jonathan Yingling, PhD, Chief Scientific Officer.

Companies

Aflac Incorporated appointed Gail A. Galuppo Senior Vice President and Chief Marketing Officer, effective January 4, 2016.

Eli Lilly and Company announced that Juan Luciano, President and Chief Executive Officer of Archer Daniels Midland Company, has been elected to its Board of Trustees effective January 1, 2016.

CVS Health Corporation announced that it has completed its previously announced acquisition of Target Corporation’s pharmacy and clinic businesses.

Health IT

Greenway Health, LLC appointed Robert R. Ellis Chief Financial Officer.

Health Systems

Dignity Health has appointed Daniel Morissette as their new Senior Executive Vice President and Chief Financial Officer.

Montefiore Health System has named Yaron Tomer the new Chair of their Department of Medicine.

St. Joseph Health System has appointed Annette Walker as their new Chief Executive Officer.

Hospitals

Beaufort Memorial Hospital has appointed Dr. Norman Bettle as their new Chief of Staff.

Saint Agnes Hospital has named Keith Vander Kolk as the new President and Chief Executive Officer.

Pharmacies

Five Star Quality Care, Inc. appointed Richard A Doyle, Jr. Chief Financial Officer and Treasurer, effective January 1, 2016. He replaces Paul V. Hoagland who will step down at the end of the year.

Pharmaceutical Manufacturers

Enanta Pharmaceuticals, Inc. announced that its Board of Directors has elected Bruce L.A. Carter, PhD, non-executive Chairman of the Board.

Skilled Nursing Facilities

Senior Housing Properties Trust has announced the election of Richard W. Siedel Jr. has their new Chief Financial Officer and Treasurer.

 

 

December 10, 2015

Biotech

Cytos Biotechnology announced on December 3, 2015, that it intends to merge with Kuros Biosurgery Holding AG. The combined company operate under the name Kuros Biosciences AG and be run by the existing Kuros management team.

Regulus Therapeutics Inc. appointed Joseph P. “Jay” Hagan Chief Operating Officer, effective January 4, 2016.

Companies

HealthSouth Corporation appointed Patrick Darby Executive Vice President, General Counsel and Corporate Secretary, effective mid-February 2016. He succeeds John Whittington, who earlier this year announced his plans to retire at the end of December 2015.

Anthem, Inc. announced that Joseph R. Swedish, the company’s President and Chief Executive Officer, has assumed the additional role of Chairman of the Board. He replaces George A. Schaefer, Jr., who will remain on the Board as Lead Director. In a separate announcement, the company also appointed Lawrence Schreiber President of its Empire BlueCross BlueShield division, effective December 28, 2015.

Corporate Boards of Directors

Roche Holding Ltd. announced that Beatrice Weder di Mauro will not stand for re-election at the Annual General Meeting, which is scheduled to take place on March 1, 2016. The Board has appointed Claudia Süssmuth Dyckerhoff, Senior Partner and Sector Leader Asia Health Services and Systems at McKinsey & Company, to replace her and stand for election.

Community Health Systems, Inc. announced that H. James Williams, PhD, former President of Fisk University, has been appointed to its Board of Directors.

Hospitals

St. Jude Children’s Research Hospital has named Dr. Carlos Rodriguez-Galindo as their new Executive Vice President and Program Director of International Outreach.

Anne Arundel Medical Center has appointed Barbara Jacobs the new Chief Nursing Officer. She replaces Sherry Perkins who will remain Chief Operating Officer.

TriHealth has named Mark Clement as the new Chief Executive Officer, effective January 1, 2106. He replaces John Prout who will be retiring.

Mayo Clinic Health System has named Bobbie Gostout the new Chief Executive Officer.  She replaces Rob Nesse who has stepped down.

Wesley Medical Center has named Ellis James as the new Director of Laboratory Services.

University Hospitals Case Medical Center has named Daniel Simon as the new President, effective January 1, 2016.

Insurance and Managed Care

Kaiser Permanente announced on December 4, 2015, that it has entered into a definitive agreement to acquire Group Health Cooperative. Once complete, Group Health will be fully integrated with Kaiser Permanente as the company’s eighth region.

SCAN Health Plan appointed Dennis Tse, MD, Corporate Medical Director for Southern California.

Health Partners Plans, Inc. appointed Veronica Hill-Milbourne Vice President of Clinical Programs.

 

 

December 3, 2015

Companies

Kemper Corporation appointed Joseph P. Lacher, Jr. President and Chief Executive Officer and member of the Board of Directors. He succeeds Donald G. Southwell, who had previously announced his intent to retire and will continue to serve as a Senior Advisor through May 26, 2016. The company also announced that Robert J. Joyce has been named Chairman of the Board of Directors, assuming the role from Mr. Southwell.

Vertex Pharmaceuticals Incorporated appointed Michael J. Parini Executive Vice President and Chief Legal Officer, effective January 4, 2016.

Pfizer Inc. and Allergan plc announced on November 23, 2015, that they have entered into a definitive agreement to merge in a transaction worth approximately $160 billion. The two companies will combine under Allergan, which will subsequently rename itself to Pfizer plc. The combined company will be led by Ian Read, who will serve as Chairman and Chief Executive Officer, and Brent Saunders, who will serve as President and Chief Operating Officer. The company will be legally domiciled in Ireland with its operational headquarters in New York. The transaction is expected to be completed in the second half of 2016.

Corporate Boards of Directors

Invacare Corporation announced that Marc M. Gibeley, Head of Diabetes Care North America for Roche Holding, has been appointed to its Board of Directors.

The Allstate Corporation announced that Jacques P. Perold, former President of Fidelity Management & Research Company, has been elected to its Board of Directors.

Group Purchasing Organizations

VHA-UHC Alliance NewCo, Inc., the new company created earlier this year through the merger of VHA Inc. and UniversityHealthSystem Consortium, announced that it will operate under the name Vizient, Inc. starting in January 2016.

Health Systems

HealthStream has announced that Arthur Newman has retired as their Executive Vice President.

Northwestern Medicine has appointed Jennifer Nam Choi the new Chief of OncoDermatology.

BayCare HomeCare has named James Cote the new Senior Vice President of Ambulatory Services.

US HealthWorks has appointed Sherif Hanna their Senior Vice President of Operations.

ICON plc has appointed Steve Cutler to their Board of Directors.

Sutter Health has named Dr. Elizabeth Vilardo the Chief Executive Officer for Physician Group.

US HealthWorks has appointed Joseph T. Mallas the new President and Chief Executive Officer.

Northwestern Medicine has announced that KishHealth System will become the latest addition to their health system.

Pharmaceutical Manufacturers

Purdue Pharma L.P. appointed Alan W. Dunton, MD Senior Vice President of Research and Development.

Merz Inc. (Merz North America) appointed Philippe Adams Vice President of Managed Markets.

Research Organizations

Cold Spring Harbor Laboratory announced that George D. Yancopoulos, MD, PhD, Chief Scientific Officer of Regeneron Pharmaceuticals, has been elected to its Board of Trustees.

 

 

November 19, 2105

Affiliated Organizations

Symbria, Inc. announced that it has named a new Board of Directors. It’s members include: Lisa Cochrane, James M. Hussey, Jill M. Krueger, Roger Lumpp, Jim Stark, Duane M. Tyler and Albert Weiss.

Companies

Diplomat Pharmacy, Inc. promoted Robert Flecksenstein, former Vice President of Operations, to Senior Vice President of Operations and Gary Rice, former Vice President of Clinical Services, to Senior Vice President of Clinical Services, Education and Human Resources.

Perrigo Company plc announced that on November 13, 2015, its shareholders rejected the hostile takeover bid previously announced by Mylan N.V.

Astellas Pharma Inc. appointed Peter Sandor Vice President and Oncology Therapeutic Area Head for Marketing Strategy. He will be located at the company’s Northbrook, Illinois location.

Corporate Boards of Directors

AmerisourceBergen Corporation announced that Richard C. Gozen will retire as Chairman of the Board at the Annual Meeting of Stockholders, which is scheduled to take place on March 3, 2016. He will be succeeded by Steven H. Collis, the company’s President and Chief Executive Officer, who will assume the additional title of Chairman. The company also announced that Jane E. Henney, MD, will assume the role of Lead Independent Director, effective at the same time.

Health IT

Practice Fusion Inc. appointed Tom Langan permanent Chief Executive Officer of the company. He has been serving as interim Chief Executive Officer since August 2015.

Insurance and Managed Care

Blue Cross and Blue Shield of Louisiana appointed I. Steven Udvarhelyi, MD, President and Chief Executive Officer, effective in the first quarter of 2016. He succeeds Mike Reitz, who announced his intention to retire in February 2015.

Horizon Blue Cross Blue Shield of New Jersey appointed William J. Castner, Jr. Senior Vice President of Corporate and Regulatory Affairs.

Medical Device Manufacturers

AliveCor, Inc. appointed Vivek Gundotra Chief Executive Officer. He replaces Euan Thomson, who has been serving as interim Chief Executive Officer since August 2013.

Tandem Diabetes Care, Inc. announced that Lonnie Smith will retire as Chairman of the Board of Directors on December 31, 2015. His position will be assumed by Dick Allen, effective January 1, 2016. Mr. Allen has been a member of the Board since 2007.

Pharmaceutical Manufacturers

LEO Pharma A/S announced on November 11, 2015, that it has entered into an agreement with Astellas Pharma Inc.to purchase its global dermatology business for euro 675 million. The transaction is expected to close in the first quarter of 2016.

CONMED Corporation announced on November 16, 2015, that it has entered into a definitive agreement to acquire SurgiQuest, Inc. Upon completion of the transaction, Kurt Azarbarzin, SurgiQuest's Chief Executive Officer, will join CONMED as Chief Technology Officer of the Advanced Surgical business. The transaction is expected to close in the first quarter of 2016.

 

 

November 12, 2015

Companies

Community Health Systems, Inc. announced that William S. Hussey, President of Division VI Operations, and J. Gary Seay, Chief Information Officer, will retire from the company at the end of 2015.

Kemper Corporation appointed Joseph W. Metz President of Kemper Person and Commercial Lines business, effective November 16, 2015.

Quest Diagnostics Incorporated announced on November 10, 2015, that it has entered into a definitive agreement to acquire the outreach laboratory service business of Clinical Laboratory Partners, LLC. The transaction is expected to close in early 2016.

Corporate Boards of Directors

Halyard Health, Inc. announced that William A. Hawkins III has been elected to its Board of Directors, effective December 1, 2015.

Health IT

Orion Health Ltd. appointed Susan Anderson Managing Director of its Canada operations.

Health Systems

Nick Desien has announced his retirement as Senior Vice President at Ascension Health, effective December 31, 2015.

Hospitals

Richard Goldberg has announced he is stepping down as President of MedStar Georgetown University Hospital.

Lisa Rediger Hayward has been appointed the Senior Vice President and General Counsel of Seattle Children’s Hospital, effective January 4, 2016.

Susan Huntz has been appointed the Co-Director of the Johnson Center for Pregnancy and Newborn Services at Lucile Packard Children’s Hospital Stanford and Stanford Children’s Health.

Casey Guber has been named the Chief Operating Officer for Wesley Medical Center.

Hazel McCallion, former Mayor of Mississauga, has been appointed the Chief Elder Officer for Revera Inc.

Medical Device Manufacturers

Analogic Corporation appointed Mark Frost Senior Vice President, Chief Financial Officer and Treasurer, effective November 30, 2015.

Pharmaceutical Manufacturers

Lupin Limited appointed Thierry Volle President of Europe, Middle-East & Africa.

 

 

November 5, 2015

Affiliated Organizations

Victory Park Capital appointed Ron Rolighed a Principal of the company with responsibility for business development and client services.

Associations

The New Jersey Hospital Association appointed Karen S. Ali, Esq., General Counsel.

Biotech

Anika Therapeutics, Inc. appointed Richard Hague Chief Commercial Officer.

Companies

Baxter International Inc. appointed José Almeida Chairman and Chief Executive Officer, effective January 1, 2016. He succeeds Robert L. Parkinson, Jr, who remain a member of the Board of Directors and assume the title of Chairman Emeritus.

The Allstate Corporation appointed Mark Green President of its Encompass Insurance Company business.

Mylan N.V. appointed Ranjan Ray Chaudhuri Global Commercial Lead for its Over-the-Counter Business.

WebMD Health Services appointed Donna J. Geringer Chief Client Officer and promoted John Harrison to Senior Vice President of Customer Experience.

Anthem, Inc. appointed Morgan Kendrick President of its National Accounts Business Segment. He succeeds John Martie, who is assuming a new position within the Consumer and Specialty Business Division.

Merck KGaA appointed Laszlo Radvanyi, PhD, Senior Vice President and Head of Global Immuno-Oncology Research. He will be located at the company’s Billerica, MA-based EMD Serono Research & Development Institute.

Shire plc announced on November 2, 2015, that it has entered into an agreement to acquire Dyax Corp. for approximately $5.9 billion. The transaction is expected to close in the first half of 2016.

Brookdale Senior Living Inc. appointed Labeed Diab Chief Operating Officer, effective November 16, 2015, and Lucinda Baier Chief Financial Officer, effective December 1, 2015. Mark Ohlendorf, who currently serves as President and Chief Financial Officer, will step down as CFO but remain President of the company. Brookdale also announced that Mary Sue Patchett has been promoted to Executive Vice President of Community and Field Operations.

Zoetis Inc. announced on November 2, 2015, that it has entered into an agreement to acquire Pharmaq AS for $765 million. The acquisition is expected to close on or about November 10, 2015.

HealthSouth Corporation completed on November 2, 2015, its previously announced acquisition of the home health agency operations of CareSouth Health System, Inc. through its Encompass Home Health operating unit.

Johnson & Johnson announced on November 4, 2015, that it has entered into a definitive agreement to acquire Novira Therapeutics, Inc. The transaction is expected to close during the fourth quarter of 2015.

Corporate Boards of Directors

Kindred Healthcare, Inc. announced that Sharad Mansukan, MD, a Senior Advisor to TPG Capital, has been appointed to its Board of Directors.

Hooper Holmes, Inc. announced that Charles M. Gillman, Executive Managing Director of IDWR Multi-Family Office, has been appointed to its Board of Directors.

New York Life Insurance Company announced that Edward D. Shirley, former President and Chief Executive Officer of Bacardi Limited, has been elected to its Board of Directors.

Catalent, Inc. announced that Dr. Donald E. Morel, former Chairman and Chief Executive Officer of West Pharmaceutical Services, has been appointed to its Board of Directors.

Novartis AG announced that it has nominated Elizabeth Doherty and Ton Buechner for election to the Board of Directors at the Annual General Meeting of Shareholders, which will take place on February 23, 2016.

Health IT

TSI Healthcare, Inc. appointed Martin A. Cody Vice President of Sales, replacing Richard Pedersen who is retiring from the company.

MedAssets, Inc. announced on November 2, 2015, that it has entered into a definitive agreement to be acquired by Pamplona Capital Management for approximately $2.7 billion. Upon completion of the acquisition, Pamplona plans to sell the MedAssets SCM Segment to VHA-UHC Alliance and combine its Precyse business with the MedAssets RCM Segment. The transaction is expected to close in the first quarter of 2016.

Orion Health, Inc. appointed Robert Pepper Vice President of Marketing for North America.

Insurance and Managed Care

BlueCross BlueShield of South Carolina appointed Scott Graves President of its private business division, effective January 1, 2016. He succeeds Jim Deyling, who previously announced his intent to retire at the end of the year.

Health Alliance Plan of Michigan announced on November 2, 2015, that it has entered into a definitive agreement to merge with HealthPlus of Michigan. The merger is expected to close on January 1, 2016.

 

 

October 29, 2015

Companies

Perrigo Company plc promoted John T. Hendrickson to President. Mr. Hendrickson has been serving as Executive Vice President of Global Operations and Supply Chain since March 2007.

Triple-S Management Corporation appointed Ruiz-Jimenez Chief Marketing and Communications Officer.

Astellas Pharma Inc. promoted Doug Geiger to Vice President and Head of New Therapeutic Areas in Marketing Strategy

Hooper Holmes, Inc. appointed Steve Marin Chief Revenue Officer.

Walgreens Boots Alliance, Inc. announced on October 27, 2015, that it has entered into a definitive agreement to acquire Rite Aid Corporation for approximately $17.2 billion. Upon completion of the merger, Rite Aid will survive as a fully owned subsidiary of Walgreens Boots Alliance and retain its existing brand name. The transaction is expected to close in the second half of 2016.

Corporate Boards of Directors

Edwards Lifesciences Corporation announced that Martha H. Marsh, former President and Chief Executive Officer of Stanford Hospital and Clinics, has been appointed to its Board of Directors.

Valeant Pharmaceuticals International, Inc. announced that G. Mason Morfit, President of ValueAct Capital, has been appointed to its Board of Directors. He previously served on the Board from 2007 to 2014.

Hospitals

Jeanny Aragon-Ching, and Thomas Graves have been named the Clinical Program Director of Genitourinary Cancers, and the Associate Director for Administration for the Inova Dwight and Martha Schar Chancer Institute, respectively.

Catherine Bollard and Hemant Sharma have been named the Chief of Allergy and Immunology, and the Clinical Chief of Allergy and Immunology for the Children’s National Health System, respectively.

Dieter Seitz-Tuttler has been named the Vice President of Global Clinical Operations for SynteractHCR

Kevin Erich has announced his retirement as the Chief Executive Officer for Feather River Hospital, effective January 1, 2016.

Medical Device Manufacturers

Endologix, Inc. announced on October 26, 2015, that it has entered into a definitive agreement to acquire with TriVascular Technologies, Inc. for approximately $211 million. The transaction is expected to close in January of 2016.

 

 

October 22, 2015

Affiliated Organizations

The Institute for Healthcare Improvement announced that Maureen Bisognano will retire as President and Chief Executive Officer at the end of 2015. She is succeeded by Derek Feeley, who will assume the role on January 1, 2016.

Associations

The Leapfrog Group announced that John Engler, President of the Business Roundtable and former Governor of Michigan, has been elected to its Board of Directors. 

Joint Commission Resources, Inc. appointed David W. Baker, MD, MPH, Editor-in-Chief of The Joint Commission Journal on Quality and Patient Safety. Dr. Baker will continue serving as Executive Vice President of Health Care Quality Evaluation at The Joint Commission.

Companies

Bristol-Myers Squibb Company appointed Paul Biondi Senior Vice President and Head of Business Development.

Quintiles Transnational Holdings Inc. promoted Kevin Gordon to Executive Vice President and Chief Operating Officer. He is succeeded as Chief Financial Officer by Michael McDonnell, effective December 2015. Mr. Gordon will retain his role as Chief Financial Officer until Mr. McDonnell joins the company.

Community Health Systems, Inc. announced that Martin D. Smith, the company’s current President of Division III Operations, will serve as Executive Vice President of Operations at Quorum Health Corporation following the completion of its previously announced spin-off.

Catalent, Inc. (Catalent Pharma Solutions) appointed Wetteny Joseph President of Clinical Supply Services.

Corporate Boards of Directors

Celgene Corporation announced that Julia A. Haller, MD, Ophthalmologist-in-Chief of the Wills Eye Hospital, has been elected to its Board of Directors.

Baxter International Inc. announced that Michael F. Mahoney, President and Chief Executive Officer of Boston Scientific Corporation, has been appointed to its Board of Directors.

Hospitals

Robert J. Gfeller Jr. has been named the Vice President of Communications, Marketing and Media, and Chief Marketing Officer for the Wake Forest Baptist Medical Center.

Rex Healthcare has been renamed UNC Rex Healthcare to further emphasize the collaboration between Rex Healthcare and UNC Health Care.

Ray Smith has been named the Director of Marketing and Communications at the Southwestern Vermont Health Care.

Christine Kipp has been named the new Vice President of Patient Care Services on an interim basis for Southeast Georgia Health System.

Dan Wolterman, the President and Chief Executive Officer for Memorial Hermann Health System, has announced his intention to retire in the second half of 2016.

Julie Creamer has been named the President of Northwestern Memorial Hospital.

Insurance and Managed Care

Premera Blue Cross appointed Curtis Kopf Vice President of Customer Experience.

Hylant Group appointed Kim Riley President of the company’s Cleveland office and Jim Lash President of its Cincinnati office.

Infinisource, Inc. appointed Russell Hickey Implementation Manager and Jarad Ennis FBA Participant Support Manager.

Medical Device Manufacturers

Accuray Incorporated appointed Kelly Londy Executive Vice President and Chief Operating Officer.

Sorin S.p.A. completed its merger with Cyberonics, Inc. on October 19, 2015. The combined company now operates as LivaNova PLC.

SeaSpine Holdings Corporation appointed Patrick Keran General Counsel.

Pharmacies

Maxor National Pharmacy Services, LLC announced that John Ward will retire as Chief Executive Officer by the end of 2016. He will remain a member of the board of Directors.

 

 

October 15, 2015

Biotech

Telesta Therapeutics Inc. appointed Brian J. Groch Chief Commercial Officer.

BIND Therapeutics, Inc. announced that Arthur Tzianabos, PhD, President and Chief Scientific Officer of OvaScience, has been appointed to its Board of Directors.

Charities

The Breast Cancer Research Foundation appointed Marc Hurlbert Chief Mission Officer, succeeding Margaret Mastrianni who will retire as Deputy Director and Chief Program Officer in January 2016.

Companies

Allscripts Healthcare Solutions, Inc. announced that Rick Poulton has been promoted to President. He will retain his role as Chief Financial Officer until a successor has been named.

St. Jude Medical, Inc. completed its previously announced acquisition of Thoratec Corporation on October 8.

Biogen Inc. announced that Tony Kingsley is resigning as Executive Vice President of Global Commercial Operations.

Corporate Boards of Directors

DaVita HealthCare Partners Inc. announced that Barbara J. Desoer, Chief Executive Officer of Citibank, N.A., has been appointed to its Board of Directors.

Health IT

ZeOmega Inc. appointed Christopher A. Brown Senior Vice President of Sales and Marketing.

Hospitals

Mark Clement has been named the new Chief Executive Officer for TriStar Health on an interim basis until January 2016. He steps in for John Prout who is on medical leave.

Heather Dexter has been named the Chief Executive Officer for Emory St. Joseph’s Hospital, effective October 23, 2015.

James Davidson has been named the new President and Chief Executive Officer for Saint Mary’s Regional Medical Center, effective November 1, 2015.

Divya Joshi has been named the Chief Executive Officer for OSF Saint Francis Medical Center’s Children’s Hospital of Illinois, Children’s Service Line.

Peter Huntsman has been named the Chief Executive Officer for Huntsman Cancer Foundation.

Barry Whyte has been named the Vice President of Communications and Public Relations for St. Jude Children’s Research Hospital.

Insurance and Managed Care

Kaiser Permanente appointed Vanessa Benavides Senior Vice President and Chief Compliance and Privacy Officer, effective November 9. She succeeds Daniel P. Garcia, who is retiring from the company.

Pharmaceutical Manufacturers

Impax Laboratories, Inc. announced that Janet S. Vergis, an executive advisor for private equity firms, has been appointed to its Board of Directors.

 

October 8, 2015

Biotech

Alexza Pharmaceuticals, Inc. promoted Catherine McAuliffe to Vice President of Operations and Stacy Palermini to Vice President of Finance and Corporate Secretary.  Ms. McAuliffe has been serving as Executive Director of Operations since 2014 and Ms. Palermini as Executive Director of Finance since 2011.

Onxeo SA announced that Joseph Zakrzewski has joined the Board of Directors as a Permanent Attendee. He will succeed Patrick Langlois as Director and Non-Executive Chairman after the board’s scheduled meeting in late January 2016.

Charities

The Cystic Fibrosis Foundation appointed Preston W. Campbell, III, MD, President and Chief Executive Officer, effective immediately. He succeeds Robert J. Beall, who had previously announced his intention to step down at the end of the year.

Health Alliance Plan of Michigan announced on October 2, 2015, that it has executed an exclusive, non-binding letter of intent to merge HealthPlus of Michigan into HAP's existing operations.

Companies

Bayer AG appointed Habid Dable President of US-based Bayer HealthCare Pharmaceuticals. He replaces Philip Blake, who has assumed the role of Head of the Americas Region for the global HealthCare Pharmaceuticals business.

Allergan plc completed its previously announced acquisition of Kythera Biopharmaceuticals, Inc. on October 1, 2015.

Cardinal Health, Inc. completed its previously announced acquisition of Cordis Corporation from Johnson & Johnson on October 5, 2015.

AmerisourceBergen Corporation announced on October 6, 2015, that it has entered into a definitive agreement to acquire PharMEDium Healthcare Holdings, Inc. from Clayton, Dubilier & Rice for $2.575 billion. Upon completion, PharMEDium will become a part of AmerisourceBergen Drug Corporation. The transaction is expected to close by the end of 2015.

DaVita HealthCare Partners Inc. appointed Suzanne Hansen Senior Vice President of New Market Integration for its HealthCare Partners division.

Corporate Boards of Directors

Diplomat Pharmacy, Inc. announced that Shawn Cline Tomasello, most recently Chief Commercial Officer of Pharmacyclics, and Benjamin Wolin, co-founder and Chief Executive Officer of Everyday Health, have been appointed to its Board of Directors. The company also announced that Atheer A. Kaddis, the company’s Senior Vice President of Sales and Business Development, has resigned from the Board but will continue in his management position.

Health Systems

James Wade has been named the Deputy Director for Quality and Network Development for Inova.

Hospitals

Edward Schaeffer has been named the Chair of the Department of Urology at Feinberg School of Medicine (Northwestern University), effective December 1, 2015.

Medical Device Manufacturers

BeneChill, Inc. appointed Elmar Landwehr Managing Director for the EMEA region.

Wright Medical Group, Inc. completed its previously announced merger with Tornier N.V. on October 1, 2015. The combined company now operates as Wright Medical Group N.V.

Medical Institutions

Maciej Lesniak has been named the Chair of the Northwestern Medicine Department of Neurological Surgery.

Pharmaceutical Manufacturers

Ipsen S.A. appointed Stéphane Bessette Executive Vice President of Human Resources.

 

 

 

October 1, 2015

Associations

The Joint Commission on Accreditation of Healthcare Organizations appointed Brian H. Enochs Executive Vice President of Business Development and Marketing.

Biotech

Exelixis, Inc. appointed William Berg Senior Vice President of Medical Affairs, Jonathan Berndt Vice President of Sales, and Gregg Bernier Vice President of Marketing.

Charities

The National Kidney Foundation, Inc. appointed Kevin Longino Chief Executive Officer. He has been serving as interim Chief Executive Officer since March 2015.

Companies

Hill-Rom Holdings, Inc. appointed Dr. Dirk Ehlers President of its Trumpf Medical division.

Endo International plc completed its acquisition of Par Pharmaceutical Companies, Inc., which is now a division of the company.

EMD Serono, Inc. appointed Joseph Leveque, MD, Chief Medical Officer.

Ventas, Inc. promoted Gregory R. Liebbe to Senior Vice President, Chief Accounting Officer and Controller. He has been serving as Vice President of Accounting since 2011.

EmblemHealth, Inc. appointed Lorraine Cortés-Vázquez Senior Vice President of Corporate Relations and Government Affairs and Robin Chappelle Golston Vice President of Community and Government Affairs.

Varian Medical Systems, Inc. appointed Rafael Torres Senior Vice President of Business Development and Strategy.

Aetna Inc. appointed Gary Loveman Executive Vice President and President of its Healthagen business. He succeeds Joseph M. Zubretsky, who is leaving the company. The company also appointed Rick Jelinek Executive Vice President responsible for Aetna-Humana integration and enterprise strategy.

Corporate Boards of Directors

Quintiles Transnational Holdings Inc. announced that Annie Hai-yuan Lo, former Chief Financial Officer of Johnson & Johnson’s Worldwide Consumer & Personal Care Group, has been appointed to its Board of Directors.

Brookdale Senior Living Inc. announced that Daniel A. Decker, President and owner of CoastWood Senior Housing Partners, LLC, has been appointed a member and Non-Executive Chairman of the Board of Directors. He succeeds Jeffrey R. Leeds as Chairman, who will remain on the board as an Independent Director.

Health IT

Nightingale Informatix Corporation announced that David Atkins has been appointed Chairman of the Board. He succeeds Brian Schachter, who did not seek re-election at the company’s Annual Special and General Meeting.

Hospitals

Rahul Rastogi has been named the Chief Operations Officer for Northwest Permanente.

Gary Blank and Robert Prichard have been promoted to Executive Vice President and Chief Operating Officer and Chief Clinical Integration Officer for St. Elizabeth Medical Center, respectively.

Lisa Frey and Joseph Bozelli have been promoted to Vice President of Legal Services and General Counsel, and Vice President of Mission and Pastoral Care for St. Elizabeth Medical Center, respectively. 

Lisa Harris Jones has been named to the Senior Housing Properties Trust Board of Trustees.

Gary Terrinoni has been named the new President for the Brooklyn Hospital Center, effective November 2015. He replaces Richard Becker who will step down.

Victoria Seewaldt has been named the Ruth Ziegler Chair in Population Sciences for the City of Hope.

Insurance and Managed Care

Cambia Health Solutions, Inc. promoted Jared Short to Chief Operating Officer. He has been serving as President of Health Insurance Services since 2011.

Medical Device Manufacturers

Haemonetics Corporation announced that Brian Concannon has resigned as President, Chief Executive Officer and a member of the Board of Directors. He is succeeded by the company’s Lead Director, Ronald Gelbman, who will serve as interim Chief Executive Officer.

Pharmaceutical Manufacturers

CONMED Corporation appointed Nathan Folkert Vice President and General Manager of its Orthopedics business. 

Mallinckrodt plc completed its acquisition of Therakos, Inc., from The Gores Group.

 

 

 

September 24, 2015

Biotech

Osiris Therapeutics, Inc. appointed Gregory I. Law Chief Financial Officer and Dwayne Montgomery Chief Business Officer. Mr. Law succeeds Phillip Jacoby, who has stepped down as Chief Financial Officer but will remain involved with the finance department.

Companies

New York Life Insurance Company appointed Jae Yoon Chief Investment Officer of New York Life Investment Management. 

OMRON Corporation announced on September 16, 2015, that it has entered into an agreement to acquire Adept Technology, Inc. for approximately $200 million. The transaction is expected to close on or about October 22, 2015.

WellCare Health Plans, Inc. appointed Lou Gianquinto State President of Missouri.

DaVita HealthCare Partners Inc. appointed Atul Mathur Executive Vice President of Global Operations.

Corizon Health, Inc. appointed Karey Witty Chief Executive Officer, effective November 2, 2015. He succeeds Woodrow A. Myers, Jr., who will assume the role of Vice Chairman of the Board of Directors.

Health Research Organizations

The Scripps Research Institute appointed Peter G. Schultz Chief Executive Officer, effective immediately, and Steve A. Kay President, effective after Mr. Schultz transitions out of his role as Dean of the Dornsife College of Letters, Arts and Sciences at the University of Southern California. They succeed James Paulson, who has been acting President and Chief Executive Officer since August 2014.

The Patient-Centered Outcomes Research Institute appointed Evelyn Whitlock, MD, MPH, Chief Scientific Officer effective January 2016. She succeeds Bryan Luce, who announced his retirement last year.

Hospitals

Kelly J. Johnson has been appointed the Vice President for Patient Care Services and the Chief Nursing Officer for Lucile Packard Children’s Hospital, effective November 2, 2015.

Holly Shill has been named the new Director for the Muhammad Ali Parkinson Center.

Roger Spoelman has been appointed the Chief Executive Officer for Mount Carmel Health System on an interim basis. He temporarily replaces Claus von Zychlin who is going on medical leave.

Michael Fosina has been named the President of Lawrence Hospital. He replaces Edward Dinan who has retired.

Medical Device Manufacturers

Sorin S.p.A. announced that its merger with Cyberonics Inc. has been approved by the High Court of England and Wales is expected to close on October 19, 2015.

 

 

September 17, 2015

Affiliated Organizations

Ontario Teachers’ Pension Plan appointed Nicole Musicco Managing Director for Asia-Pacific and head of its Hong Kong office.

Biotech

Repligen Corporation announced that Glenn P. Muir, former Executive Vice President and Chief Financial Officer of Hologic, has been appointed to its Board of Directors.

Charities

The Susan G. Komen Breast Cancer Foundation, Inc. appointed Charlotte Walsh Senior Vice President of Marketing.

Companies

Regeneron Pharmaceuticals, Inc. appointed Maya Bermingham Executive Director of Public Policy.

Ventas, Inc. appointed James E. Mendelson Executive Vice President of Asset Management for its Lillibridge Healthcare Services subsidiary.

Assurant, Inc. announced on September 9, 2015, that it has entered into an agreement to sell its Employee Benefits business to Sun Life Financial, Inc. for $975 million. The transaction is expected to close by the end of the first quarter of 2016. 

Owens & Minor, Inc. appointed W. Marshall Simpson Executive Vice President and Chief Commercial Officer, effective October 4, 2015.

Express Scripts Holding Company appointed Eric R. Slusser Executive Vice President and Chief Financial Officer. He replaces James M. Havel, who has been serving as interim Chief Financial Officer since January 2015 and will continue with the company as Executive Vice President of Finance for an indeterminate period of time to assist with the transition.

St. Jude Medical, Inc. appointed Phil Ebeling Vice President and Chief Technology Officer and Rachel Ellingson Vice President of Corporate Strategy, both effective January 1, 2016.

Bayer HealthCare appointed Natalie Bartner President of Consumer Care in North America.

Amgen Inc. announced on September 16, 2015, that it has entered into a definitive agreement to acquire Dezima Pharma B.V for $1.55 billion. The transaction is expected to close in the fourth quarter of 2015. 

New York Life Insurance Company appointed Naïm Abou-Jaoudé Chairman and John Grady Vice Chairman of New York Life Investment Management International.

WellCare Health Plans, Inc. appointed Lauralie Rubel State President for Iowa.

Astellas Pharma Inc. appointed Eugene Van Rensburg Chief Financial officer of Astellas Pharma EMEA.

DENTSPLY International Inc. announced on September 15, 2015, that it has entered into a definitive agreement to merge with Sirona Dental Systems Inc. and form a new company named DENTSPLY SIRONA. The combined company will be led by Jeffrey Slovin, who will serve as Chief Executive Officer, and Bret Wise, who will serve as Executive Chairman. The transaction is expected to be completed in the first quarter of calendar 2016.

Health IT

athenahealth, Inc. appointed Tim O’Brien Chief Marketing Officer, effective January 2016. He succeeds Rob Cosinuke, who will assume a new role heading the athenahealth Leadership Institute. The company also announced that Dan Haley has been appointed General Counsel and Kyle Armbrester has been appointed Chief Product Officer, both effective immediately.

Health Research Organizations

Joslin Diabetes Center appointed Peter S. Amenta, MD, PhD, President and Chief Executive Officer, effective October 5, 2015. He succeeds John L. Brooks, III, who resigned earlier this month.

Health Systems

Cling Purvance has been named the new President and Chief Executive Officer for Barton Health.

Kristin Jones has been named the new Vice President of External Affairs for the University of Maryland Medical System, effective October 19, 2015.

Hospitals

Linda Moulton has been named the new Chief Executive Officer of the Executive and International Health Programsfor Lahey Hospital & Medical Center.

Industry Service Providers

Michael Gold has been named the new Vice President of Global Product Development for Pharmaceutical Product Development, LLC.

Insurance and Managed Care

Cambia Health Solutions, Inc. appointed Laurent Rotival Senior Vice President of Strategic Technology Solutions and Corporate Information Officer.

Medical Device Manufacturers

Accuray Incorporated promoted Kevin Waters to Chief Financial Officer succeeding Gregory E. Lichtwardt, who has retired from the company.

Pharmaceutical Manufacturers

PDL BioPharma, Inc. announced that Samuel R. Sakes, MD, most recently Chief Development Officer of Auspex Pharmaceuticals, has been appointed to its Board of Directors.

 

 

September 10, 2015

Affiliated Organizations

Providence St. Peter Foundation announced that Marcia Fromhold has been elected to its Board of Directors. The foundation also announced that Dan Davidson and Jay Rudd are retiring from the board.

Biotech

Array Biopharma Inc. appointed Patricia Henahan Chief Financial Officer.

Synta Pharmaceuticals Corp. appointed Alan C. Rigby, PhD, Senior Vice President and Chief Scientific Officer.

Companies

Endo International plc appointed Craig Paterson, MD, Chief Medical Officer.

St. Jude Medical, Inc. announced that Daniel J. Starks will step down as President and Chief Executive Officer and serve as Executive Chairman, effective January 1, 2015. He is succeeded by Micheal T. Rousseau, who will also serve on the company’s Board of Directors.

EMD Serono, Inc. appointed Scott Filosi Senior Vice President of Managed Markets.

Hill-Rom Holdings, Inc. completed its previously announced acquisition of Welch Allyn, Inc. on September 8, 2015.

Express Scripts Holding Company announced that George Paz will retire as Chief Executive Officer, effective following the company’s Annual Meeting of Stockholders in May 2016. He will continue to serve the company as Chairman of the Board. He is succeeded as Chief Executive Officer by the company’s current President, Timothy C. Wentworth.

Corporate Boards of Directors

AmerisourceBergen Corporation announced that D. Mark Durcan, Chief Executive Officer of Micron Technology, has been elected to its Board of Directors.

Cardinal Health, Inc. announced that Nancy Killefer, a former partner of McKinsey and Co., has been elected to its Board of Directors.

Health IT

MedAssets, Inc. announced that Frederick A. Hessler, former Managing Director of Citigroup, has been appointed to its Board of Directors. The company also announced that Michael P. Nolte and Rand A. Ballard will step down from the Board at the next Annual Meeting of Stockholders.

Health Systems

Michael Free has announced his retirement as the Chief Executive Officer for Priority Health in 2016.

David Bernd has announced his retirement as the Chief Executive Officer for Sentara Healthcare, effective March 3, 2016.

Gary Willis has been named the Executive Vice President and Chief Financial Officer for Capella Healthcare.

Donald Bivacca has been named the Executive Vice President and President of Operations Support for Capella Healthcare.

Pharmaceutical Manufacturers

PDL BioPharma, Inc. announced that Paul R. Edick, Managing Partner of 3G Advisors, has been elected to its Board of Directors.

Lannett Company, Inc. announced on September 2, 2015, that it has signed a definitive agreement to purchase Kremers Urban Pharmaceuticals Inc., the U.S. specialty generic pharmaceuticals subsidiary of UCB S.A. The transaction is expected to close in the fourth quarter of calendar 2015.

 

 

September 3, 2015

Hospitals

Anthony Stahl has been named the Chief Executive Officer for Central Texas Medical Center, effective October 5, 2015.

Dennis Murphy has been appointed the new President of IU Health. He will be appointed the new Chief Executive Officer, effective May 1, 2016. He replaces Daniel Evans Jr. who has announced his retirement.

Michael Scherneck has been appointed the new President and Chief Executive Officer for Southeast Georgia Health System.

Derek Lythgoe, Cheryl Tong, Thomas Matenaer and Darcy Robertson have been appointed the Chief Financial Officers for Banner Baywood Medical Center and Banner Heart Hospital, Banner Desert Medical Center and Cardon Children’s Medical Center, Banner Gateway Medical Center and Banner MD Anderson Cancer Center, and Banner Payson Medical Center, respectively.

Ascension Health has announced that Crittenton Hospital Medical Center will become part of its Michigan branch.

Prime Healthcare Services has completed its purchase of St. Joseph Mercy Port Huron, which will now be rebranded as Lake Huron Medical Center.

 

 

August 27, 2015

Biotech

Regulus Therapeutics Inc. appointed Michael Huang, MD, Vice President of Clinical Development.

Halozyme Therapeutics, Inc. appointed Michael J. LaBarre Vice President and Chief Scientific Officer. He succeeds Michael Shepard, who has assumed the role of Research Fellow.

Charities

The National Parkinson Foundation announced that Guido Goldman, Director of the Program for the Study of Germany at the Minda de Gunzburg Center for European Studies of Harvard University, has been elected to its Board of Directors.

Companies

DaVita HealthCare Partners Inc. appointed Dinesh Kumar Senior Vice President of Clinical Transformation.

Consultants and Service Providers

INC Research Holdings, Inc. promoted Bekki Brown to Executive Vice President of Clinical Development for General Medicine and Tom Zoda, PhD, to Executive Vice President of Clinical Development for Central Nervous System.

Corporate Boards of Directors

Valeant Pharmaceuticals International, Inc. announced that D. Robert Hale, a Partner of ValueAct Capital, has been appointed to its Board of Directors. He replaces Jeffrey W. Ubben, who has resigned from the Board.

PAREXEL International Corporation announced that Maykin Ho, PhD, a former partner of the Goldman Sachs Group, has been elected to its Board of Directors.

Hospitals

Michael Lopez has been named the new Chief Nursing Officer for St. David’s Georgetown Hospital.

Eben Rosenthal has been named the Medical Director of the Stanford Cancer Center.

Patty Maysent has been appointed the Chief Executive Officer of the UC San Diego Health, on an interim basis.

Frank Sacco has announced his retirement as President and Chief Executive Officer of Memorial Healthcare System, effective February 29, 2016.

Insurance and Managed Care

BlueCross BlueShield of Tennessee, Inc. announced that William M. Gracey, the company’s Chief Executive Officer, will retire at the end of August. He is succeeded by J. D. Hickey, the company’s current Chief Operating Officer.

Pharmaceutical Manufacturers

Amneal Pharmaceuticals, LLC appointed Charles Lucarelli, RPh, President of its new Amneal Biosciences subsidiary.

 

 

August 20, 2015

Companies

Hooper Holmes, Inc. appointed Steven Balthazor interim Chief Financial Officer, effective the day after the company files its 10-Q for the second quarter 2015. He replaces Tom Collins who is resigning to join a private company in the Kansas City area.

HealthSouth Corporation promoted Crissy Buchanan Carlisle to Chief Investor Relations Officer. Ms. Carlisle currently serves as Vice President of Financial Reporting and will succeed Mary Ann Arico in the role effective September 1, 2015.

WuXi PharmaTech (Cayman) Inc. announced on August 14, 2015, that it has plans to become a privately held company and will be acquired by New WuXi Life Science Limited, a consortium of various buyers, for approximately US $3.3 billion. The transaction is expected to close during the fourth quarter of 2015.

Cigna Corporation appointed Greg Allen President of its Tennessee Market.

NBTY, Inc. appointed Sonya Soutus Senior Vice President of Public Affairs and Communications.

CVS Health Corporation announced that it has completed its acquisition of Omnicare, Inc.

Corporate Boards of Directors

Unum Group announced that Thomas Kinser will retire from the company’s Board of Directors at the end of the year.

Health IT

Quality Systems, Inc. announced that Steve Puckett has resigned as Executive Vice President and Chief Technology Officer.

Practice Fusion Inc. appointed Tom Langan, currently Chief Commercial Officer, Interim Chief Executive Officer of the company. He replaces Ryan Howard, who has assumed the role of Chairman of the Board of Directors.

Hospitals

Karen Metz has reigned as the Chief Executive Officer for Knoxville’s Physicians Regional Medical Center.

Michael Englehart has been named the President and Chief Executive Officer for Presence Health, effective October 1, 2015. He will replace Sandra Bruce who is retiring.

Keith Perry has been named the new Chief Information Officer for St. Jude’s Children’s Research Hospital.

Donald Sheldon has been named the Regional President of UH Community Hospitals.

 

 

August 13, 2015

Biotech

BioCryst Pharmaceuticals, Inc. announced that Robert Ingram, General Partner of Hatteras Venture Partners, has been elected to its Board of Directors.

Companies

Anthem, Inc. appointed Craig Samitt, MD, Chief Clinical Officer, effective September 21, 2015.

Unum Group promoted Vicki J. Gordan to Senior Vice President and Chief Internal Auditor. She succeeds Matt Royal, who assumed the role of Chief Risk Officer in July.

McKeson Corporation appointed Dave Schulte Managing Director of McKesson Ventures, effective September 8, 2015. 

Humana Inc. appointed Louis M. Fernandez Vice President and Chief Medical Officer of Humana South Florida.

Centene Corporation announced that William N. Scheffel, its Chief Financial Officer, plans to retire in February 2016 after the company files its 10-K form, or when its Health Net transaction is completed, whichever is later. Jeffrey A. Schwanke, the company’s Senior Vice President, Corporate Controller and Chief Accounting Officer, will assume the role of Chief Financial Officer following Mr. Scheffel’s departure.

DaVita HealthCare Partners Inc. appointed Mark Price President of its HealthCare Partners Colorado market.

Former Government Officials Joining Health World

The Alabama Hospital Association appointed Donald Williamson President, effective around November 2015. He currently serves as Alabama’s State Health Officer and will succeed Mike Horsley, who previously announced his retirement.

Health IT

Merge Healthcare, Inc. announced on August 6, 2015, that it has entered into a definitive agreement to be acquired by International Business Machines Corporation (IBM) for $1 billion. The transaction is expected to close later in 2015.

Health Systems

Gary Colberg has been named the President and Chief Executive Officer for Southeast Georgia Health System.

Thomas Beeman has announced he will step down as Chief Executive Officer for Lancaster General Health, effective September 1, 2015.

Ed Rafalski has been named the Chief Strategy and Marketing Officer for BayCare Health System, effective August 24, 2015.

Alexandra Morehouse has been named the Senior Vice President and Chief Marketing Officer for Banner Health, effective August 31, 2015.

Industry Service Providers

Donato J. Tramuto has been named the President and Chief Executive Officer for Healthways, Inc.

Medical Device Manufacturers

Cantel Medical Corporation appointed David Rosen President of Asia Pacific and Emerging Markets.

Pharmacies

BioScrip, Inc. announced on August 10, 2015, that it has entered into an agreement to sell its non-core PBM business to ProCare Pharmacy Benefit Manager Inc. for $25 million. The transaction is expected to close in the third quarter of 2015. The company also announced that it has promoted Chris Luthin to Chief Operating Officer, appointed Kathryn M. Stalmack General Counsel, and contracted Scott J. Davido to serve as Chief Implementation Officer.

Pharmaceutical Manufacturers

Merrimack Pharmaceuticals, Inc. appointed Yasir Al-Wakeel Chief Financial and Officer and Head of Corporate Development. He succeeds William Sullivan, who has assumed the role of Head of Finance and Accounting.

Mallinckrodt plc announced on August 10, 2015, that it has entered into a definitive agreement to acquire Therakos, Inc. from The Gores Group for approximately $1.325 billion. The transaction is to be completed in the third quarter of 2015.

 

 

August 6, 2015

Companies

Envision Healthcare Holdings, Inc. announced on July 30, 2015, that it has entered into a definitive agreement to acquire Rural/Metro Corporation. The transaction is expected to close in the fourth quarter of 2015.

Robert Parkinson announced that he plans to retire as Chairman and Chief Executive Officer or Baxter International Inc. Neither Mr. Parkinson nor the company have announced a timeframe.

Team Health Holdings, Inc. announced on August 4, 2015, that it has entered into a definitive agreement to acquire IPC Healthcare Inc. for approximately $1.6 billion. The transaction is expected to close during the fourth quarter of 2015.

Ortho-Clinical Diagnostics, Inc. appointed Kristie Bouryal Chief Corporate Brand and Communications Officer.

Carestream Health, Inc. appointed Jianqing Bennett President of its Digital Medical Solutions business unit.

Rite Aid Corporation appointed Ken Martindale Chief Executive Officer of Rite Aid Stores. He will continue to serve as President of Rite Aid Corporation.

Community Health Systems, Inc. announced on August 5, 2015, that it plans to spin off 38 hospitals and its Quorum Health Resources business into a new publically traded company called Quorum Health Corporation. The spinoff is expected to be completed in the first quarter of 2016.

Corporate Boards of Directors

LifePoint Health, Inc. announced that Marilyn B. Tavenner has resigned from its Board of Directors to focus more attention on her role as President and Chief Executive Officer of America’s Health Insurance Plans.

Edwards Lifesciences Corporation announced that Robert A. Ingram has retired from its Board of Directors.

Amgen Inc. announced that Fred Hassan, Partner and Managing Director of Warburg Pincus, has been appointed to its Board of Directors.

Molina Healthcare, Inc. announced that Richard M. Schapiro, an industry consultant and Chief Executive Officer of SchapiroCo LLC, has been appointed to its Board of Directors.

St. Jude Medical, Inc. announced that David C. Dvorak, President and Chief Executive Officer of Zimmer Biomet Holdings, Inc., has been appointed to its Board of Directors.

Health IT

Spok Holdings Inc. announced that Stacia Hylton, former Director of the United States Marshal Service, has been elected to its Board of Directors.

Practice Fusion appointed Matt Ackley Chief Marketing Officer, Dorothy Gemmell Senior Vice President of Life Science Practice and Strategic Partnerships, Tim Rauschenbach Vice President of Customer Service and Support, and Dave Caldwell Senior Vice President of Enterprise Solutions. The company also announced that Alan Black, Chief Financial Officer of Zendesk, has been elected to its Board of Directors.

Greenway Health, LLC appointed David Wirta Chief Revenue Officer.

Hospitals

Jinghui Zhang has been named the new Chair of Computational Biology for St. Jude Children’s Research Hospital.

Erik Olson has been named the Chief Executive Officer for Renown Regional Medical Center.

Scott Rathgaber has been named the Chief Executive Officer for Gundersen Health System, effective September 2015.

Shelley Harris has been named the Chief Executive Officer for St. Elizabeth’s Hospital on an interim basis.

Mary Kate FitzPatrick has been named the Chief Nursing Officer for the University of Vermont Medical Center.

Daniel Wolcott has been named the President and Chief Executive Officer of Lodi Memorial Hospital, effective August 3, 2015. He will replace Joe Harrington.

Steven Johnson has been appointed the Vice President, Academic Affairs for TriHealth, Inc., effective August 1, 2015.

Nikki Sikes has been named the Chief Operating Officer for St. David’s Round Rock Medical Center.

Cindy Nicholas has been named the Chief Nursing Officer for St. David’s Round Rock Medical Center.

Insurance and Managed Care

Health Care Service Corporation announced that Pat Hemingway Hall will retire as Chief Executive Officer, effective December 31, 2015. Paula Steiner, the company’s Executive Vice President and Chief Strategy Officer, has assumed the role of President from Ms. Hemingway Hall effective immediately and will be named Chief Executive Officer on January 1, 2015.

Affinity Health Plan appointed Steve Giasi Chief Financial Officer and John A. Selby Senior Vice President of Consumer Markets.

Medical Device Manufacturers

Greatbatch, Inc. announced on July 30, 2015, that it plans to spin off its neuromodulation subsidiary, QiG Group LLC, into an independent company to be called Nuvectra Corporation. Scott Drees will serve as the company's President and Chief Executive Officer and Joseph A. Miller, Jr. as the Chairman of its Board of Directors. The spin-off is expected to be completed by the end of 2015.

 

 

July 30, 2015

Affiliated Organizations

Inotek Pharmaceuticals Corporation appointed Cadmus Collins Rich, MD, Vice President of Medical Affairs and Clinical Development.

Biotech

Novogen Limited announced that Graham Kelly has resigned as Chairman and Chief Executive Officer. He is succeeded by Iain Ross, who has been appointed Acting Chief Executive Officer and member of the Board of Directors. Board member Ian Phillips has assumed the role of Interim Chairman.

CTI BioPharma Corp. appointed Bruce J. Seeley Executive Vice President and Chief Commercial Officer.

Companies

St. Jude Medical, Inc. announced on July 22, 2015, that it has entered into a definitive agreement to acquire Thoratec Corporation for approximately $3.4 billion. The transaction is expected to be completed in the fourth quarter of 2015.

UnitedHealth Group Incorporation completed its acquisition of Catamaran Corporation, which it intends to integrate into its existing OptumRx business.

Anthem, Inc. announced on July 24, 2015, that it has entered into a definitive agreement to acquire Cigna Corporation for $54.2 billion. Following the completion of the acquisition, Joseph Swedish will serve as Chairman and Chief Executive Officer of the combined company and David Cordani will be President and Chief Operating Officer. In addition, five Cigna directors will join Anthem's board. The transaction is expected to close in the second half of 2016. 

Novo Nordisk A/S appointed Brian Hilberdink President of Novo Nordisk Canada, Inc.

Teva Pharmaceutical Industries Ltd. announced on July 27, 2015, that it has entered into a definitive agreement with Allergan plc to acquire Allergan Generics for $40.5 billion. The transaction is expected to close in the first quarter of 2016.

Allergan plc announced on July 26, 2015, that it has entered into a definitive agreement to acquire Naurex Inc. Immediately prior to the closing of the acquisition, Naurex will spin-out its preclinical assets and discovery platform into a new company. The transaction is expected to close by the end of 2015.

WellCare Health Plans, Inc. appointed Kathy Warner State President of South Carolina.

Laboratory Corporation of America Holdings promoted Deborah Keller to Chief Executive Officer of Covance, effective August 1, 2015. She replaces Joseph Herring who is retiring from the company.

Beacon Health Options, Inc. appointed Jorge Petit, MD, Regional Senior Vice President of its New York market.

Corporate Boards of Directors

Alere, Inc. announced that Geoffrey S. Ginsburg, founding Director of the Center for Applied Genomics & Precision Medicine at Duke University, has been appointed to its Board of Directors.

Unum Group announced that Francis J. Shammo, Executive Vice President and Chief Financial Officer of Verizon Communications, Inc., has been elected to its Board of Directors.

Intuitive Surgical, Inc. announced that Michael A. Friedman, Emeritus Cancer Center Director of City of Hope, has been appointed to its Board of Directors.

Catalent, Inc. announced that J. Martin Carroll, former President and Chief Executive Officer of Boehringer Ingelheim Corporation, has been appointed to its Board of Directors.

Merck & Co., Inc. announced that Pamela J. Craig, former Chief Financial Officer of Accenture, and Dr. Paul B. Rothman, Dean of the Medical Faculty of The Johns Hopkins University and Chief Executive Officer of Johns Hopkins Medicine, have been appointed to its Board of Directors, effective September 1, 2015.

Health IT

Nuance Communications Inc. promoted Daniel Tempesta to Executive Vice President and Chief Financial Officer, succeeding Thomas Beaudoin who is resigning to pursue an opportunity at another company.

Hospitals

Emory University Hospital promoted Bryce Gartland, MD, to Chief Executive Officer, effective August 14, 2015. He has been serving as the hospital’s Chief Operating Officer since 2012. Dr. Gartland succeeds Robert Bachman, who will assume the role of Executive Director for Expansion/Renovation.

Insurance and Managed Care

Health Care Service Corporation appointed Manika Turnbull Vice President and Chief Diversity Officer, effective August 3, 2015.

American Specialty Health Incorporation appointed Jerome Bonhomme Chief Technology Officer.

 

 

July 23, 2015

Affiliated Organizations

Inotek Pharmaceuticals Corporation appointed Claudine Prowse, PhD, Vice President of Strategy and Investor Relations Officer. In a separate announcement, the company also announced that Richard N. Spivey has been appointed to its Board of Directors.

Biotech

Exelixis, Inc. appointed Christopher J. Senner Executive Vice President and Chief Financial Officer. He replaces Deborah Burke as Chief Financial Officer, who will continue with the company as Senior Vice President of Finance and Controller.

Companies

Rite Aid Corporation promoted Frank Ho to Vice President of Indirect Procurement. He has been serving as Senior Director of Indirect Procurement since 2013.

Triple-S Management Corporation appointed Dr. Jose E. Novoa-Loyola Chief Medical Officer.

HealthSouth Corporation announced that John Whittington will retire as Executive Vice President, General Counsel and Secretary on December 31, 2015. Following his retirement, he will continue to serve as Of Counsel to the company.

Biogen Inc. announced that Douglas Williams will step down as Executive Vice President of Research and Development at the end of July 2015 to lead a start-up biotechnology company.

Henry Schein, Inc. promoted Peter McCarthy to President of Global Animal Health. He has been serving as President of Henry Schein International.

Hospitals

Brian Kellar has been named the Chief Executive Officer for Page Hospital.

Unhee Kim has been named the new President of Mount Carmel St. Anne’s Hospital.

Robert Adamson has been named the Chief Pharmacy Officer for Barnabas Health.

Edmundo Castaneda has been named the President of Mercy Hospital of Folsom. He replaces Michael Ricks who has stepped down.

Amy Hasty has been named the Vice President of Access Center and Ambulatory Training and Support for OSF Medical Group.

 

 

July 16, 2015

Associations

The Healthcare Supply Chain Association appointed Todd Ebert President and Chief Executive Officer. He succeeds Curtis Rooney, who has accepted a position at SmithBucklin.

Charities

The Cystic Fibrosis Foundation announced that Robert J. Beall will step down as President and Chief Executive Officer on December 31, 2015. He will be succeeded by Preston W. Campbell III, who has been serving as Executive Vice President of Medical Affairs since 1998.

Companies

Walgreens Boots Alliance, Inc. appointed Stefano Pessina Chief Executive Officer. He has been serving as Acting Chief Executive Officer since January 2015.

United Health Services, Inc. appointed John F. Rizzo Vice President of Strategy and Business Development.

Genentech, Inc. announced that Evan L. Morris, the company’s Vice President of Government Affairs, has passed away.

HealthSouth Corporation promoted Lisa Charbonneau to Chief Medical Officer.

Corporate Boards of Directors

Team Health Holdings, Inc. appointed Patrick E. Fry, President and Chief Executive Officer of Sutter Health, and Kenneth H Paulus, former President and Chief Executive Officer of Alina Health, have been appointed to its Board of Directors.

Boston Scientific Corporation announced that Donna A. James, Founder and Managing Director of Lardon & Associates LLC, has been appointed to its Board of Directors.

Group Purchasing Organizations

Amerinet, Inc. appointed Brent Johnson President and Chief Executive Officer. He succeeds Todd Ebert, who has resigned to lead the Healthcare Supply Chain Association.

Health Systems

Robert Wood Johnson Health System and Barnabas Health have signed a definitive agreement to merge. The combined system will be known as RWJ Barnabas Health. The merger is expected to be completed in 2016.

Hospitals

Ted Inman has been hired as the Vice President of Strategic Planning and Special Projects for UC Health.

Tony McLean has been named the President of St. Elizabeth Hospital on an interim basis.

Courtney Burke has been named the Senior Vice President and Chief Strategy Officer for Albany Medical Center. She replaces Kim Fine was is stepping down after two years.

Daniel Wolcott has announced he will be stepping down as President and Chief Executive Officer for Takoma Regional Hospital at the end of the month.

Sheila Daly has announced she will be stepping down as President and Chief Executive Officer for Clinton Hospital at the end of the year.

Madlyn Murrey has been appointed the Senior Vice President and Chief Nursing Officer for Seattle Children’s Hospital.

Medical Device Manufacturers

NuVasive, Inc. announced its new executive team, reporting to Chairman and Chief Executive Officer Gregory T. Lucier: Pat Miles serves as President and Chief Operating Officer; Matt Link as President of U.S. Commercial; Quentin Blackford as Executive Vice President and Chief Financial Officer; Jason Hannon as Executive Vice President of International and General Counsel; Carol Cox as Executive Vice President of Strategy, Corporate Development and External Affairs; and Pete Leffy as Executive Vice President of Human Resources and Corporate Integrity.

Pharmaceutical Manufacturers

Cipla Ltd. announced that Samina Vaziralli has been appointed to its Board of Directors.

 

 

July 9, 2015 

Companies

Centene Corporation announced on June 2, 2015, that it has entered into a definitive agreement to acquire Health Net, Inc. for approximately $6.8 billion. The transaction is expected to close by early 2016. 

Aetna Inc. announced on July 3, 2015, that it has entered into a definitive agreement to acquire Humana Inc. for $37 billion. Upon closing, Mark Bertolini will serve as Chairman and Chief Executive Officer of the combined company and four Humana directors will join Aetna's board. The transaction is expected to close in the second half of 2016.

Rite Aid Corporation appointed Paul Zikmund Group Vice President of Risk and Controls.

Cardinal Health, Inc. completed its acquisition of The Harvard Drug Group from Court Square Capital Partners.

Beacon Health Options, Inc. appointed Matt Wolff Chief Executive of its Texas Operations.

Corporate Boards of Directors

IASIS Healthcare LLC appointed Sharad Mansukani, MD, a member of the Board of Directors since 2005, Lead Independent Director of the board.

Hospitals

Herbert Chen has been named the Surgeon in Chief for the University of Alabama at Birmingham Hospital. 

Jani Johnson, formerly of Saint Luke’s South Hospital, has been appointed the new Chief Executive Officer for Saint Luke’s Hospital, effective July 27, 2105.  She replaces Julie Quirin who has been named Senior Vice President for Hospital Operations at Saint Luke’s Health System.

Paul Viviano has been named the President and Chief Executive Officer for the Children’s Hospital Los Angeles. 

Medical Device Manufacturers

NuVasive, Inc. announced that Daniel J. Wolterman, President and Chief Executive Officer of Memorial Hermann Health System, has been elected to its Board of Directors.

Pharmaceutical Manufacturers

LEO Pharma Inc. appointed Mitchell Johnson Vice President of Sales.

Research Organizations

The Gary and Mary West Health Institute announced that Nick Valeriani will retire as Chief Executive, effective September 4, 2015. He will remain a member of the Institute’s Board of Directors. He is succeeded as Chief Executive by Shelly Lyford, currently the organization’s Chief Operating Officer.

 

 

July 2. 2015

Biotech

AMAG Pharmaceuticals, Inc. announced on June 29, 2015, that it has entered into a definitive agreement to acquire CBR Systems, Inc. (d/b/a Cord Blood Registry) for $700 million. The transaction is expected to close in the third quarter of 2015.

Sarepta Therapeutics, Inc. announced that Henri Termeer, former Chief Executive Officer of Genzyme, will serve as an advisor to the company.

Companies

Aflac Incorporated appointed Frederick J. Crawford Executive Vice President and Chief Financial Officer, effective June 30, 2015. He succeeds Kriss Cloninger, III, who will step down as Chief Financial Officer but remain President of the company.

New York Life Insurance Company appointed Saad Khalil Vice President and Head of Corporate Mergers and Acquisitions. 

Rite Aid Corporation appointed Bryan Everett Executive Vice President of Store Operations, effective August 3, 2015.

Patterson Companies, Inc. announced on July 1, 2015, that it has entered into a definitive agreement to sell its medical business, Patterson Medical, to Madison Dearborn Partners for approximately $715 million. The divested company will continue to operate as Patterson Medical for a transition period before ultimately rebranding. The transaction is expected to close in the second fiscal quarter of 2015.

Corporate Boards of Directors

Pfizer Inc. announced that Joseph J. Echevarria, former Chief Executive Officer of Deloitte LLP, has been elected to its Board of Directors.

United Therapeutics Corporation announced that Judy D. Olian, PhD, Dean of the UCLA Anderson School of Management, has been appointed to its Board of Directors.

Health Systems

Peter Donato, Craig Lewis and Sandra Gunselman have been named the Assurex Health Chief Financial Officer, Chief Marketing and Strategy Officer, and Vice President of Clinical Operations, respectively.

Alex Popowycz has been named the Chief Information Officer for Health First.

Todd Lupton has been named the Chief Financial Officer for Mercy Health in Cincinnati.

Hospitals

Bradley Chambers has been named the new President of MedStar Good Samaritan and MedStar Union Memorial Hospital.

Industry Service Providers

Michael Kedansky has been named the Chief Medical Officer of Transitional Care Services for Sound Physicians Inc.

Joseph Garbely has been named the Medical Director for Caron Treatment Centers.

Insurance and Managed Care

Cambia Health Solutions announced several executive appointments: Mark Stimpson was named Senior Vice President and Chief Human Resources Officer; John Attey was named Senior Vice President, Chief Legal Officer and Corporate Secretary; Gail Baker was named Senior Vice President of Strategic Communications; and Peggy Maguire was named Senior Vice President of Corporate Accountability and Performance

Blue Cross and Blue Shield of Minnesota appointed Mary Ellen Anderson Vice President and President of Comprehensive Care Services, Inc. and Sandy Hill Vice President of Commercial Markets, Sales Operations and Shared Services.

Medical Device Manufacturers

Orthofix International N.V. announced that Lilly Marks, Vice President of Health Affairs at the University of Colorado, was appointed to its Board of Directors.

Cantel Medical Corp. appointed David C. Hemink President of its Medivators division, effective July 6, 2015, and promoted Michael G. Spicer to President of Americas Sales and Global Service, effective immediately.

Pharmaceutical Manufacturers

Lannett Company, Inc. announced that Albert R. Paonessa, III, former President of Anda, Inc., has been appointed to its Board of Directors.

Enanta Pharmaceuticals, Inc. appointed Nathalie Adda, MD, Senior Vice President and Chief Medical Officer.

CONMED Corporation announced that David M. Bronson, former Executive Vice President and Chief Financial Officer of PSS World Medical, and John L. Workman, former Chief Executive Officer of Omnicare, have been appointed to its Board of Directors.

 

 

June 25, 2015

Biotech

 BIND Therapeutics, Inc. appointed Andrew J. Hirsch President and Chief Executive Officer and a member of the Board of Directors. He has been serving as Acting President and Chief Executive Officer since March 2015.

Charities

The Crohn's & Colitis Foundation of America promoted Michael Osso to President and Chief Executive Officer, effective August 1, 2015. He currently serves as Chief Business Development Officer and replaces current Chief Executive Officer Richard J. Geswell.

Companies

Brookdale Senior Living Inc. announced that Mark Ohlendorf will step down as Chief Financial Officer, but remain President, once a successor has been named. The company also announced that Gregory Richard will step down as Executive Vice President and Chief Operating Officer, effective September 30, 2015.

McKesson Corporation appointed Kathy McElligott Executive Vice President and Chief Information and Chief Technology Officer, effective July 20, 2015.

CVS Health Corporation appointed Norman de Greve Chief Marketing Officer, effective July 15, 2015.

Zimmer Holdings, Inc. completed its acquisition of Biomet, Inc., through its parent company LVB Acquisition, Inc., on June 24, 2015. It subsequently changed its corporate name to Zimmer Biomet Holdings, Inc. and will begin trading on the New York Stock Exchange as ZBH on June 29, 2015.

Corporate Boards of Directors

Vertex Pharmaceuticals Incorporated announced that Sangeeta N. Bhatia, a researcher and Professor at the Massachusetts Institute of Technology, has joined been appointed to its Board of Directors.

Kimberly-Clark Corporation announced that Michael D. White, Chairman, President and Chief Executive Officer of DIRECTV, has been appointed to its Board of Directors.

Invacare Corporation announced that A. Malachi “Mal” Mixon, III, the company’s founder, plans to retire from the Board of Directors to deal with health issues, effective June 30, 2015.

Health IT

MedAssets, Inc. announced that Kevin M. Twomey, former President of The St. Joe Company, has been appointed to its Board of Directors.

Kryptiq Corporation appointed Joseph Siemienczuk, MD, Chief Medical Officer.

Hospitals

Sheila Fata has been named the Chief Nursing Officer for St. David’s Medical Center.

Fizan Abdullah has been appointed the new Division Head of Surgery at Ann and Robert H. Lurie Children’s Hospital of Chicago.

Jim Boyle has been named the Chief Executive officer for Central Texas Medical Center.

Industry Service Providers

Jonathan Klein has been appointed the Medical Director of the Molecular Pathology Laboratory Network

Insurance and Managed Care

SCAN Health Plan announced that Jennie Chin Hansen, Senior Strategic Advisor and former Chief Executive Officer of the American Geriatrics Society, has been appointed to its Board of Directors.

Pharmaceutical Manufacturers

Merz North America (Merz Inc.) appointed David Dobrowski Vice President and Head of North American Research and Development.

PDL BioPharma, Inc. appointed Steffen Pietzke Controller and Chief Accounting Officer.

 

 

June 18, 2015

Companies

HealthSouth Corporation announced on June 11, 2015, that it has entered into a definitive agreement to acquire the operations of Reliant Hospital Partners, LLC and affiliated entities for $730 million. The transaction is expected to close in 2015.

Valeant Pharmaceuticals International, Inc. appointed Robert L. Rosiello Executive Vice President, effective immediately. He will assume the role of Chief Financial Officer on July 1, 2015, succeeding Howard B. Schiller, who is retiring from the company.

CVS Health Corporation announced on June 15, 2015, that it has entered into a definitive agreement to acquire Target Corporation's pharmacy and clinic businesses for approximately $1.9 billion. Target's pharmacies will be rebranded as CVS/pharmacy and its clinics as MinuteClinic. The transaction timing is still uncertain, but is expected to close near the end of 2015.

Shire plc appointed Bill Mordan General Counsel and Corporate Secretary and Michele Galen Head of Corporate Communications and Public Affairs.

Allegan plc announced that it has changed its corporate name to Allergan plc.

Tenet Healthcare Corporation and Welsh, Carson, Anderson & Stowe completed their previously announced acquisition of United Surgical Partners International on June 16, 2015. Tenet owns a majority stake in the company and will have full ownership within the next five years.

Cook Group Incorporated announced that Kem Hawkins will retire as President on July 1, 2015. He is succeeded by Pete Yonkman, currently President of Cook Medical.

Magellan Health, Inc. appointed John Little Senior Vice President of Government Affairs and Communications.

Allergan plc announced on June 17, 2015, that it has entered into a definitive agreement to acquire KYTHERA Biopharmaceuticals, Inc. for approximately $2.1 billion. The transaction is expected to close in the third quarter of 2015. 

Hill-Rom Holdings, Inc. announced on June 17, 2015, that it has entered in a definitive agreement to acquire Welch Allyn, Inc. for approximately $2.05 billion. The transaction is expected to close by September 2015.

Corporate Boards of Directors

Shire plc announced that Olivier Bohuon, Chief Executive Officer of Smith & Nephew plc, has been appointed to its Board of Directors, effective July 1, 2015.

Express Scripts Holding Company announced that Tim Wentworth, the company’s President, has been appointed to its Board of Directors.

Hologic, Inc. announced that David R. LaVance, Jr. has resigned as Chairman of the Board of Directors and will not seek re-election at the 2016 Annual Meeting of Stockholders. Stephen P. MacMillan, the company’s President and Chief Executive Officer, has assumed the additional title of Chairman. In addition, the company announced that Elaine S. Ullian has been appointed Lead Independent Director.

Health Systems

Stephanie York, former aide to Akron Mayor Don Plusquellic, has been appointed the Director of Communications and Public Relations for Akron General Health System.

Randy Peak has been appointed the System Vice President and General Counsel for Ochsner Health System.

Tracey Moffatt has been named the Vice President of Quality and the System Chief Nursing Officer for Ochsner Health System.

Dawn Pevey-Mauk has been named the System Vice President of Service Lines for Ochsner Health System.

Hospitals

Brian Livingston has been appointed the Chief Executive Officer for Swedish Medical Center - First Hill.

Craig Schmidt has been named the Chief Operating Officer for the Jewish Hospital in Cincinnati.

Leesa Galatz has been named the Chair for the Mount Sinai Hospital Department of Orthopaedics, effective October 1, 2015.

Mark Creager has been appointed the Director of Dartmouth-Hitchcock Heart and Vascular Center.

Michael Mewhirter has been named the Chief Financial Officer for Fort Hamilton Hospital.

Luis Chanaga has been named the Vice President of Finance for Grandview Medical Center.

Insurance and Managed Care

Health Care Service Corporation appointed Carl McDonald Divisional Senior Vice President of Treasury, Investments and Business Development.

Highmark Inc. appointed F.G. “Chip” Merkel Executive Vice President of Diversified Business. He will continue in his role as President and Chief Operating Officer of the company’s United Concordia Dental business.

Capital BlueCross appointed Debbie Rittenour Senior Vice President of Government Programs.

Pharmaceutical Manufacturers

Merrimack Pharmaceuticals, Inc. announced that John M. Dineen, former Chief Executive Officer of GE Healthcare, has been appointed to its Board of Directors. He replaces Gordon J. Fehr, who has resigned from the Board.

 

 

 


June 11, 2015

Biotech

Halozyme Therapeutics, Inc. announced that David Ramsay will retire as Chief Financial Officer on June 15, 2015. He is succeeded by Laurie Stelzer.

Cerus Corporation appointed Richard J. Benjamin, MD, PHD, Chief Medical Officer, effective July 13, 2015. Current Chief Medical and Scientific Officer, Laurence Corash, will continue to serve as Chief Scientific Officer.

Alnylam Pharmaceuticals, Inc. appointed David-Alexandre “DA” Gros, MD, Senior Vice President and Chief Business Officer.

Companies

Magellan Health, Inc. announced that its National Imaging Associations (NIA Magellan) division will be integrated into Magellan Healthcare on July 1, 2015. In addition Robert Field is retiring from the company and stepping down as Chief Executive Officer of Magellan Rx Management on June 30, 2015. He is replaced by Mostafa Kamal, who will assume leadership of the division on July 1, 2015.

State Farm Mutual Automobile Insurance Company announced that Edward B. Rust, Jr. is retiring as Chief Executive Officer in September 2015, but will remain Chairman of the Board of Directors. He is succeeded by Michael Tipsord, who will assume the role of Chief Executive Officer.

Cardinal Health, Inc. announced that it plans to acquire The Harvard Drug Group from Court Square Capital Partners for $1.115 billion. The transaction is expected to close in the beginning of fiscal year 2016. 

Quality Systems, Inc. announced that Steven T. Plochocki will retire as President and Chief Executive Officer, effective June 30, 2015. He will remain a member of the Board of Directors until the company’s annual meeting of shareholders on August 11, 2015. He is succeeded by John “Rusty” Frantz, who will assume leadership of the company on July 1, 2015.

Baxter International Inc. announced that its Board of Directors has approved its planned spin-off of its biopharmaceuticals division into a separately traded company named Baxalta Incorporated. The transaction is expected to close on July 1, 2015.

Bayer AG announced on June 10, 2015, that it has entered into a definitive agreement to sell its Diabetes Care business to Panasonic Healthcare Holdings Co., Ltd. for EUR 1,022 million. The transaction is expected to close in the first quarter of 2016.

HCC Insurance Holdings announced on June 10, 2015, that it has entered into a definitive agreement to be acquired by Tokio Marine Holdings, Inc. for approximately $7.5 billion. The transaction is expected to close in the fourth quarter of 2015.

Bioventus, LLC promoted Andrew Hosmer to Managing Director of International with responsibility for Europe, Middle East and Africa and the international Headquarters office Amsterdam, and Isabelle Levy-Unger to Managing Director of International with responsibility for Canada, Latin America and Asia Pacific.

Corporate Boards of Directors

LifePoint Health, Inc. announced that Richard H. Evans has been appointed Lead Director of the Board of Directors. He replaces Owen G. Shell, Jr., who has stepped down from the Board.

Johnson & Johnson announced that Mary Beckerle, Chief Executive Officer and Director of Huntsman Cancer Institute at the University of Utah, has been appointed to its Board of Directors.

Hospitals

Louis Ralosky has been appointed the President and Chief Executive Officer of the Upper Valley Medical Center.

Chris Lock has been appointed the new Chief Executive Officer for Saint Francis-Bartlett.

Darren Bass has been named the new President and Chief Executive Officer for Cox Monet Hospital.

Reynold Jennings has been named the Chief Strategy Officer for WellStar Health System, effective July 1, 2015. He steps down as President and Chief Executive Officer.

Michael Tarwater has announced his intention to retire June 2016 as Chief Executive Officer for Carolinas Health Care.

Medical Device Manufacturers

Abiomed, Inc. announced that Robert Bowen will retire as Vice President and Chief Financial Officer, effective July 15, 2015. He is succeeded as Chief Financial Officer by Michael Tomsicek.

 


June 4, 2015

Biotech

ArQule, Inc. promoted Robert J. Weiskopf to Chief Financial Officer.

Regulus Therapeutics Inc. announced that Kleanthis G. Xanthopoulos has stepped down as President, Chief Executive Officer and a member of the Board of Directors. He is succeeded by the company’s former Chief Medical Officer, Paul Grint, who has also been appointed to the Board. In addition, Neil W. Gibson has been appointed President’s Fellow to assist in assembling a new leadership team.

AMAG Pharmaceuticals, Inc. appointed Jule Frop, MD, Senior Vice President of Clinical Development and Regulatory Affairs and Chief Medical Officer and appointed Audrey Wu Vice President of Commercial Strategy at Lumara Health, the company’s maternal health business.

Novogen Limited announced Bryce Carmine, Chairman and Chief Executive Officer of HaemaLogiX, and Ian M. Phillips, President of KUMARA Inc., have been appointed to its Board of Directors.

Companies

EMD Serono, Inc. appointed David Trexler Senior Vice President of Oncology and Zhen Su, MD, MBA Vice President of Medical Oncology.

Walgreens Boots Alliance, Inc. announced that Tim Theriault has stepped down as Executive Vice President and Global Chief Information Officer, but will continue to serve as a consultant and senior advisor to the company. He is succeeded by Anthony Roberts, who has been appointed Senior Vice President and Global Chief Information Officer.

Bayer AG announced that Bayer MaterialScience will be renamed Covestro on September 1, 2015. Bayer intends to spin Covestro off as a separate company by mid-2016.

Eisai Inc. appointed Ivor Macleod Senior Vice President, Chief Financial Officer and Chief Compliance Officer.

Humana, Inc. completed its divesture of Concentra, Inc., to a joint venture between Selected Medical Holdings Corporation and the private equity fund Welsh, Carson, Anderson & Stowe XII, L.P. on June 1, 2015.

Group Purchasing Organizations

The recently merged VHA Inc. and University HealthSystem Consortium, currently operating as VHA-UHC Alliance NewCo, Inc., announced its new leadership team: Jody Hatcher was appointed President of Offering Delivery and Operations; Byron Jobe was appointed President of Strategic Growth, Marketing and Innovation; Colleen Risk was appointed Executive Vice President of Research, Public Affairs and Human Resources; Chris Dunleavy was appointed Area Senior Vice President of Finance, Accounting and Information Technology and Chief Financial Officer; and David Berry was appointed Senior Vice President of Legal and Enterprise Risk Management and General Counsel.

Health Systems

Effective late this summer, Jamal Hakim and Bernadette Spong have been appointed the new Orlando Health Chief Operating Officer and Chief Financial Officer, respectively.

Hospitals

Tiffany Weber has been named the new Chief Financial Officer for Sterling Regional MedCenter.

Industry Service Providers

David Peters has been named the new Chief Financial Officer for BioClinica Inc., effective June 8, 2015.

Michael McKelvey has been named the new Health Executive Vice President of the Inventive Health Clinical Division, and the new President of inVentiv Health Clinical.

Medical Device Manufacturers

Elekta AB announced several executive management appointments, effective July 7, 2015: Ian Alexander has been appointed Chief Commercial Officer; Bill Yaeger has been appointed Executive Vice President of Region North America, replacing Jay Hoey who assumes the role of Head of External Relations; Todd Powell has been appointed Executive Vice President of Comprehensive Oncology Solutions; John Lapre has been appointed Executive Vice President of Research and Innovation; Maurits Wolleswinkel has been appointed Executive Vice President of Marketing and Strategy; and Jonas Bolander has been appointed Executive Vice President of Legal and Compliance. The company also announced that Gilbert Wai will step down as Executive Vice president of Asia Pacific on July 7, 2015, and Valerie Binner will join the company as Executive Vice President of Human Resources on August 1, 2015.

Pharmaceutical Manufacturers

Purdue Pharma L.P. appointed Jean-Jacques “JJ” Charhon Executive Vice President and Chief Financial Officer. Edward Mahoney, the company’s former CFO, has assumed the role of Executive Vice President for Due Diligence and Integration Management.

Research Organizations

The Sarah Cannon Research Institute appointed Dawn Sauro President of Development Innovations, the nonprofit’s contract research organization, effective in June.

 

 

 

May 28, 2015

Companies

New York Life Insurance Corporation appointed John Y. Kim President and Chief Investment Officer. Ted Mathas will remain Chairman and Chief Executive Officer. Chris Blunt has succeeded Mr. Kim as President of the Investments Group. In a separate announcement, the company appointed Yie-Hsin Hung Chief Executive Officer of New York Life Investment Management LLC. She replaces Andrew E. Lawton, who is now a special advisor to Mr. Blunt and will retire at the end of the year.

CVS Health announced on May 21, 2015, that it has entered into a definitive agreement to Omnicare, Inc. for approximately $12.7 billion. The transaction is expected to close near the end of 2015. 

Ownes & Minor, Inc. appointed P. Cody Phipps President and Chief Executive Officer, effective July 1, 2015. He succeeds Craig R. Smith, who will continue to serve as an advisor through the end of 2015.

Ortho-Clinical Diagnostics, Inc. announced that Jeff Capello has stepped down as Chief Financial Officer, effective June 12, 2014. He is succeeded by Charles F. Wagner, Jr, who will assume the role on June 24, 2015.

AbbVie Inc. completed its acquisition of Pharmcyclics, Inc., which now operates as a wholly owned subsidiary of AbbVie and has changed its operating name to Pharmacyclics LLC. Wulff-Erik von Borcke has been appointed president of the subsidiary.

Health Net, Inc. appointed Andy Ortiz Senior Vice President of Organization Effectiveness and Chief People Officer, effective June 29, 2015. He succeeds Karin Mayhew, who is retiring from the company.

Anthem, Inc. announced that Kenneth R. Goulet will retire as Executive Vice President and President of the company’s Commercial and Specialty Business later this summer.

Hospitals

Kary McIlwain has been appointed the new Vice President of Marketing for Ann and Robert H. Lurie Children’s Hospital of Chicago, effective July 2015.

Lynn Wold has been named the President and Chief Executive Officer of UnityPoint Health – Sioux, effective June 1, 2015.

Kenneth Beutke has been named the President and Chief Executive Officer for OSF Saint Elizabeth Medical Center.

Industry Service Providers

Bradley Sorte has been named the Executive Director for Caron Renaissance, effective July 1, 2015.

Insurance and Managed Care

EmblemHealth, Inc. appointed Karen Ignagni President and Chief Executive Officer, effective September 1, 2015. She succeeds Frank Branchini, who will continue to serve as Chairman of the Board of Directors.

Kaiser Permanente announced that former U.S. Surgeon General, Regina Benjamin, MD, has been appointed to the Board of Directors of Kaiser Foundation Hospitals and Health Plan, Inc., effective June 1, 2015.

Medical Supply Distributors

NuVasive, Inc. appointed Gregory T. Lucier Chairman and Chief Executive Officer. Mr. Lucier has been serving as Chairman and interim Chief Executive Officer since March 2015.

 

 

May 21, 2015

Affiliated Organizations

Affymetrix, Inc. announced that Riccardo Pigliucci, Managing Partner of Aldwych Associates, has been appointed to its Board of Directors.

Biotech

Biodel announced that Arlene M. Morris, most recently President and Chief Executive Officer of Syndax, has been appointed to its Board of Directors.

Companies

Endo International plc announced on May 18, 2015, that it has entered into a definitive agreement to acquire Par Pharmaceutical Companies, Inc. from TPG Capital for $8.05 billion. The transaction is expected to close in the second half of 2015.

Triple-S Management Corporation announced that Ramon Ruiz-Comas will step down as President and Chief Executive Officer, effective January 1, 2016. He is succeeded by Roberto Garcia-Rodriguez, the company’s current Chief Operating Officer.

Amgen, Inc. appointed Jonathan P. Graham Senior Vice President, General Counsel and Secretary, effective July 13, 2015. He succeeds David J. Scott, who is retiring from the company.

Corporate Boards of Directors

Pfizer Inc. announced that Marc Tessier-Lavigne has resigned from its Board of Directors.

Invacare announced that Clifford D. Nastas has been appointed to the company’s Board of Directors along with Matthew E. Monaghan, its President and Chief Executive Officer, who will also serve as Chairman. He replaces C. Martin Harris, who has been serving as interim Chairman and will return to his role as Lead Director. The company also announced that Dan T. Moore, III, Charles S. Robb and Ellen O. Tauscher have stepped down from the board.

Health Systems

Geri Towndrow has been named the Chief Nursing Officer for SCL Health.

Alfred Lumsdaine has been named the President and Chief Executive Officer for Healthways.

Robert Kasdin has been appointed the Senior Vice President and Chief Operating Officer for Johns Hopkins Medicine.

Pat Fry has been named Pat Fry has announced his retirement as the Chief Executive Officer for Sutter Health, effective January 4, 2016.

Hospitals

Sandy Melzer has been appointed the Executive Vice President for Networks, Population Health for Seattle Children’s Hospital. 

Ed Banos has announced his resignation as the Chief Executive Officer for UP Health System – Marquette, effective June 11, 2015.

Julie Holt has been named the Chief Nursing Officer for The Christ Hospital Health Network.

London Quicci has been named the Chief Operating Officer for Sinai-Grace Hospital.

Linda Chen has been named the new President for Mary Bridge Children’s Hospital, effective June 15, 2105.

Gary Tucker has been named the Chief Executive Officer for Mount St. Mary’s Hospital.

Walter Ramos has been named the President of Carney Hospital.

Insurance and Managed Care

Blue Cross Blue Shield of Kansas announced that James Klausman, President and Chief Executive Officer of Midwest Health, and Rick C. Jackson, Executive Vice President and Chief Lending Officer of Capital Federal, have been appointed to its Board of Directors. They replace Edward J. Miller and Louis E. Moisiman, who have retired from the Board.

 

 

 

May 14, 2015

Biotech

Dyax Corporation announced that Abbie Celniker, PhD, President and Chief Executive Officer of Eleven Biotherapeutics, has been appointed to its Board of Directors.

Companies

Kemper Corporation promoted C. Thomas Evans, Jr. to General Counsel, Nan Hoff to Deputy General Counsel, and John Boschelli to Senior Vice President and Chief Investment Officer. In a separate announcement the company also announced that Donald G. Southwell plans to retire as Chairman, President and Chief Executive Officer when he turns 65 on May 26, 2016. 

Bayer MaterialScience LLC appointed Glenn Kelly Director of Government Relations.

DaVita HealthCare Partners Inc. appointed George Hong, MD, and Paul Lim, MD, National Medical Directors of HealthCare Partners, LLC.

Lifepoint Hospitals, Inc. announced that it has changed its name to Lifepoint Health, Inc. 

Bioventus, LLC appointed Jeanne Forneris Vice President of Strategy and General Counsel and Thomas Umbel Vice President of Business Development. 

Beacon Health Options, Inc. appointed Jay Curley Executive Vice President of Corporate Affairs and Chief of Staff. 

Health Systems

John Ward has been named the Chief Information Officer for TriHealth Health System.

R. Craig McCoy has been named the new Chief Executive Officer for Bon Secours St. Francis Health System, effective June 8, 2015.

Hospitals

Roger Oxendale has announced his retirement by the end of the year as the President of Nemours Children’s Hospital.

Medical Device Manufacturers

Sysmex America, Inc. appointed Ramon Simon-Lopex, MD, Medical Director.

Elekta AB announced that Niklas Savander has stepped down as President, Chief Executive Officer and a member of the Board of Directors. He is replaced by current Director Tomas Puusepp, who previously served as the company’s Chief Executive Officer from 2005-2014.

 

 

May 7, 2015

Associations

The Accreditation Association for Ambulatory Health Care appointed Stephen A Martin, Jr, PhD, MPH, Chief Executive Officer, effective June 15, 2015. He succeeds John Burke, who is retiring. 

The Alabama Hospital Association announced that J. Michael Horsley will retire as President and Chief Executive Officer at the end of 2015.

Biotech

Alexza Pharmaceuticals, Inc. promoted Edwin S. Kamemoto, PhD, to Executive Vice President of Research and Development and Quality and Lori H. Takahashi to Vice President of Pharmaceutical Research and Development and Quality.

Charities

Autism Speaks Inc. announced that Bob Wright has stepped down as Chairman of the Board of Directors. He will continue to serve as member of the Board. He is succeeded by Brian Kelly, who has been appointed Chairman.

Companies

Shire plc appointed Jeff Poulton Chief Financial Officer and a member of the Board of Directors. He has been serving as interim Chief Financial Officer since December 2014.

Magellan Health, Inc. announced that it has established the Magellan Cares Foundation, which will work to improve the health and well-being of the lives and communities Magellan Health serves.

HMS Holdings Corp. appointed Gary S. Call, MD, Chief Medical Officer.

Thoratec Corporation appointed Marta Antonucci, PhD, President of International.

Patterson Companies, Inc. announced on May 4, 2015, that it has entered into a definitive agreement to acquire Animal Health International. The transaction is expected to close in the company's first fiscal quarter. John Adent will serve as the combined veterinary business' President and George Henriques will serve as its Chief Commercial Officer.

Aetna Inc. appointed Cain Hayes President of its Mid-America Region.

Alexion Pharmaceuticals, Inc. announced on May 6, 2015, that it has entered into a definitive agreement to acquire Synageva BioPharma Corp. for approximately $8.4 billion. The transaction is expected to close mid-2015.

NBTY, Inc. appointed Matthew Roberts, PhD, Chief Scientific Officer and a member of the company’s Scientific Advisory Board.

Bayer AG appointed Steffan Huber President of Bayer MaterialScience Greater China.

Pfizer, Inc. appointed Michael D. Ehlers Group Senior Vice President and Head of BioTherapeutics Research & Development and Site Head for Pfizer’s Cambridge and Boston, Massachusetts locations. The company also appointed John Lin Senior Vice President and Chief Scientific Officer of its Rinat biotechnology unit.

Corporate Boards of Directors

HMS Holdings Corp. announced that Robert M. Holster will step down as Chairman at the company’s Annual Meeting of Stockholders on July 9, 2015, but remain a member of the Board of Directors.  Bill Lucia, the company’s President and Chief Executive Officer, will assume the additional role of Chairman. Effective at the same time, Richard H. Stowe will become Lead Independent Director.

Catalent, Inc. announced that Gregory T. Lucier, Chairman and interim Chief Executive Officer of NuVasive has been appointed to its Board of Directors.

Health IT

Nuance Communications, Inc. announced that Robert Finocchio has been appointed to its Board of Directors.

Health Systems

Bonnie Phipps has been named the Senior Vice President and Group Operating Executive for Ascension Health.

Pete Gilbert has been named the Chief Operating Officer for UC Health.

Hospitals

Frank Schwab has been named the new Chief of Spine Surgery for the Hospital for Special Surgery. He succeeds Frank Cammisa who has stepped down.

Lionel Ivashikiv has been appointed the new Chief Scientific Officer of the Hospital for Special Surgery, effective July 1, 2015. He succeeds Steven Goldberg who has been serving in the role since 2006.

Industry Service Providers

Scott Treiber has been named the new Executive Vice President and General Manager of Biopharmaceutical Development for Theorem Clinical Research.

Pharmaceutical Manufacturers

Impax Laboratories, Inc. appointed Donna M. Hughes Senior Vice President of Human Resources and Deborah M. Penza Senior Vice President and Chief Compliance Officer.

 

 

April 30, 2015

Associations

The Illinois Hospital Association announced on April 22, 2015, that it has signed a letter of intent to merge with the Metropolitan Chicago Healthcare Council. The merger is expected to be completed by the end of 2015.

Biotech

GenVec, Inc. announced that Michael Richman, President and Chief Executive Officer of Amplimmune, Inc., has been appointed to its Board of Directors.

Ligand Pharmaceuticals, Inc. announced that Nishan de Silva is resigning as Chief Financial Officer on May 20, 2015. He is succeeded by the company’s Chief Accounting Officer, who will assume the role on in interim basis.

Synta Pharmaceuticals Corp. announced that Anne Whitaker is resigning as President, Chief Executive Officer and a member of the Board of Directors, effective May 7, 2015. She is succeeded by Chen Schor, the company’s current Executive Vice President and Chief Operating Officer. 

Companies

UnitedHealth Group Incorporated appointed Michael Tuffin Senior Vice President of Public Affairs.

Centene Corporation appointed Ken Yamaguchi, MD, Executive Vice President and Chief Medical Officer. Mary Mason, the company’s previous Chief Medical Officer, has been appointed Chief Medical Officer of Specialty Companies.

Carestream Health, Inc. appointed Lisa Ashby President of its Dental business, effective May 4, 2015.

Endo International plc appointed Matthew J. Maletta Executive Vice President and Chief Legal Officer, effective May 4, 2015. He replaces Caroline B. Manogue, who is retiring from the company.

Valeant Pharmaceuticals International, Inc. announced that Howard B. Schiller will resign as Executive Vice President and Chief Financial Officer once a successor has been named, but will remain on the company’s Board of Directors. The company also announced that Anne C. Whitaker will join the company as Executive Vice President and Company Group Chairman.

Corporate Boards of Directors

Brookdale Senior Living, Inc. announced that Mark J. Parrell, Executive Vice President and Chief Financial Officer of Equity Residential, and Lee S. Wielansky, Chairman and Chief Executive Officer of Midland Development Group, have been appointed to its Board of Directors. They replace Mark J. Schulte and Samuel Waxman, who have retired from the board.  

Health IT

Extreme Networks, Inc. appointed Bob Gault Executive Vice President of Worldwide Sales, Channel and Services, Eileen Brooker Executive Vice President of Global Alliances and Strategic Accounts, and Norman Rice Executive Vice President of Global Marketing and Corporate Development. In a separate statement, the company also announced that it has promoted Eric Broockman to Executive Vice President, Engineering and Chief Technology Officer. 

Hospitals

Larry Schumacher has stepped down as Chief Operating Officer for Hospital Sisters Health System.

Nikki Roux has been appointed the Vice President and Chief Nursing Officer for Memorial Hermann North Hospital.

Mark Clement has been named the Chief Executive Officer for TriHealth. He replaces John Prout who is stepping down.

Mukhtar Ahmed has been named the President of eClinical of BioClinica.  

Jena Hausmann has been named the new Chief Executive Officer for Children’s Hospital Colorado.

Insurance and Managed Care

The Permanente Federation, LLC appointed Jeffrey Grice, MD, Associate Executive Director of Communications, Marketing and Human Resources.

Medical Device Manufacturers

Haemonetics Corporation promoted Kent Davies to Chief Operating Officer and Byron Selman to President of Global Markets.  

Pharmacies

BioScrip, Inc. appointed Jeffrey M. Kreger Senior Vice President, Chief Financial Officer and Treasurer.

 

 

 

April 23, 2015

Companies

Aflac Incorporated appointed Hideto Yamamoto Senior Vice President and Chief Investment Officer of Aflac Japan.

EMD Serono, Inc. appointed Alise Reicin, MD, Senior Vice President and Head of Global Clinical Development, effective May 11, 2015.

NBTY, Inc. announced several executive appointments: Andre Branch was appointed Chief Marketing Officer; Derek Bowen was appointed Senior Vice President and General Manager for Vitamins, Minerals, Herbals and Supplements; Bradley Charron was appointed Senior Vice President and General Manager for Sports and Active Nutrition; and Jill Staib was promoted to Vice President of Strategic Initiatives and Private Label.

Rite Aid Corporation appointed Steve Rempel Senior Vice President and Chief Information Officer.

Actavis plc announced that Charles M. Mayr has stepped down as Chief Communications Officer and will retire from the company on May 15, 2015, due to health issues. He is succeeded by Alex Kelly, who was appointed Chief Communications Officer effective immediately.

Corporate Boards of Directors

LifePoint Hospitals, Inc. announced that Marilyn B. Tavenner, former administrator of the Centers for Medicare and Medicaid Services, has been appointed to its Board of Directors. 

Health IT

Extreme Networks, Inc. appointed Edward Meyercord President and Chief Executive Officer. Mr. Meyercord had been serving as Chairman of the Board of Directors since 2011. He succeeds Chuck Berger who has resigned from the company. 

Insurance and Managed Care

Fallon Community Health Plan, Inc. promoted Emily West to Senior Vice President and Chief Operating Officer. 

BlueCross BlueShield of Tennessee, Inc. promoted Dawn Weber to Director of Community Relations and Foundations. She has been serving as Manager of Community Relations and Foundations since 2013.

Pharmacies

Diplomat Pharmacy, Inc. appointed Shannon Beltrand Chief Information Security Officer. 

Pharmaceutical Manufacturers

Purdue Pharma L.P. appointed Alan Butcher Senior Vice President of Licensing and Business Development.

 

 

 

April 16, 2015

Biotech

Osiris Therapeutics, Inc. promoted Alla Danilkovitch, PhD, to Chief Scientific Officer. She previously served as Vice President of Research and Development since 2014. 

Halozyme Therapeutics, Inc. appointed Harry J. Leophardt, Esq. Senior Vice President, General Counsel and Chief Compliance Officer. 

Kolltan Pharmaceutics, Inc. announced that Frank Karbe, former Chief Financial Officer of Exelixis, has been appointed to its Board of Directors. 

NovaBay Pharmaceuticals, Inc. announced that Mark M. Sieczkarek has been appointed Chairman of the Board of Directors. Ron Najafi will continue to serve as President and Chief Executive Officer and remain on the Board. The company also announced that LI Xinzhou (Paul Li) has been appointed to its Board, and that current directors Charles J. Cashion and Tony Wicks have chosen to not stand for reelection at the company’s Annual Meeting of Stockholders on June 12, 2015.  

Charities

LUNGevity Foundation announced that Dennis Bookshester, an independent investor and consultant, has been appointed to its Board of Directors.  

Companies

Parallon Business Solutions, LLC appointed Curtis Watkins President and Chief Executive Officer of the company’s Technology Solutions business unit. He has been serving as its interim President since October 2014.

Takeda Pharmaceutical Company Limited appointed Ramona Sequeira President of its United States business unit, Takeda Pharmaceuticals U.S.A., effective June 1, 2015. 

Health Net, Inc. appointed Billy Maynard President of Health Net Federal Services, LLC, effective May 1, 2015. He succeeds Thomas Carrato who is retiring from the company. In a separate announcement, the company also announced that it has appointed Kathleen Alyce Waters Senior Vice President, General Counsel and Secretary, effective April 27, 2015. She succeeds Angelee Bouchard, who is retiring but will serve as Special Counsel through May 26, 2015. 

Astellas Pharma, Inc. appointed Jennifer Saputo Associate Director of Employee Communications at its Northbrook, IL office.

Merck KGaA appointed Udit Batra to head its combined life science business once its acquisition of Sigma-Aldrich has been completed, which is expected to occur in mid-2015.

Corporate Boards of Directors

Zoetis Inc. announced that Paul M. Bisaro, Executive Chairman of Actavis plc, has been appointed to the company’s board of Directors, effective after its Annual Meeting of Shareholders on May 1, 2015. 

John H. Short, former President and Chief Executive Officer of RehabCare, passed away on April 10, 2015. He had been serving on the boards of Kindred Healthcare, Inc. and Anthem, Inc. 

Celgene Corporation announced that Michael W. Bonney, former President and Chief Executive Officer of Cubist Pharmaceuticals, has been appointed to its Board of Directors.

Health IT

Beacon Partners announced on April 13, 2015, that it has entered into an agreement to be acquired by KPMG LLP. 

Health Systems

Rhonda Medows has been appointed the new Executive Vice President of Population Health for Providence Health and Services, effective May 4, 2015.

Joe Piemont has stepped down as the President and Chief Operating Officer of Carolinas HealthCare, effective May 31, 2015.

Hospitals

Lisa Billars has been named the new Chief of Neurology for the Southeast Permanente Medical Group.

Andrew Behan has been named the Chief Quality and Patient Safety Officer of Mercy Health Partners – Kentucky. 

Al Swallow has been appointed the new Executive Vice President and Treasurer for MaineHealth. He replaces Frank McGinty who has stepped down. 

Christopher O’Connor has been named the Chief Executive Officer for Inova Heart and Vascular Institute.

Medical Device Manufacturers

Nihon Kohden Corporation promoted Wilson P. Constantine to Chief Executive Officer of its United States subsidiary, Nihon Kohden America, Inc. He has been serving as Chief Operating Officer since September 2014. The company also appointed Michael R. Stone Senior Vice President of Sales, Kathy Hart Vice President of Marketing, Veffa Devers Vice President of Clinical Excellence Programs, Thomas Bento Senior Vice President of Regulatory and Quality Affairs, and Betzy Estrada Director of Human Resources.

Pharmacy Benefit Management

Prime Therapeutics, LLC promoted Jim DuCharme President and Chief Executive Officer, effective April 20, 2015. Mr. Ducharme has been serving as Chief Financial Officer since 2012. He succeeds Eric Elliott, who is resigning from the company to pursue other opportunities.

 

 

 

 

April 9, 2015

Associations

The Joint Commission on Accreditation of Healthcare Organizations promoted Wendi J. Roberts to Executive Director of its Certification Programs.

Biotech

Vermillion, Inc. appointed Fred Ferrara Chief Information Officer. 

Acceleron Pharma, Inc. announced that Francois Nader, MD, MBA, has been appointed Chairman of the Board of Directors. Mr. Nader has served as a Director since December 2014.  

Charities

The Susan G. Komen Breast Cancer Foundation appointed Bob Green Chief Financial Officer.

The National Parkinson Foundation announced that Gregory E. Katz, Vice Chairman of Miami at Newmark Grubb Knight Frank, and Jonathan Levin, Principal at The Williams Capital Group, were appointed to its Board of Directors. 

Companies

Ventas, Inc. announced on April 6, 2015, that it has entered into a definitive agreement to acquire Ardent Medical Services, Inc. and its affiliates Ardent Health Services from private funds managed by Welsh, Carson, Anderson & Stowe for $1.75 billion. Upon closing of the transaction, Ventas plans to sell Ardent's hospital operations to a newly formed operating company that will be majority owned by the current management of Ardent Health Services. The transaction is expected to close mid-year 2015.

Astellas Pharma Inc. appointed Shontelle Dodson, MD, MBA Vice President of Medical Excellence for Medical Affairs. She is based at Astellas’ Northbrook, IL location. 

Health Care REIT, Inc. promoted Steven W. Schroeder to Vice President and Treasurer, succeeding Michael A. Crabtree, who retired at the beginning of the month. 

Amedisys, Inc. announced several executive changes: Ronnie LaBorde has been appointed Chief Financial Officer in addition to his current position as Vice Chairman; Dan McCoy has been appointed Chief Operating Officer; Martin Howard has been appointed Chief Information Officer; Larry Pernosky has been appointed Chief Human Resources Officer, effective April 22, replacing Martha Williams who will assume a new role as Chief Administrative Officer; Stephen Seim has been appointed Chief Strategy Officer; David Kemmerly has been appointed Senior Vice President of Government Affairs; David Bucey will resign as Senior Vice President, General Counsel and Secretary, effective May 11, 2015, with Mr. Kemmerly filling the role in an interim capacity; and Michael Fleming will resign as Chief Medical Officer, effective April 15, 2015. The company also announced that Bruce D. Perkins, former President of Humana’s Healthcare Services Segment, has been elected to its Board of Directors, effective April 22, 2015. 

Beacon Health Options appointed William Fandrich Executive Vice President and Chief Operating Officer.

Bayer MaterialScience, LLC appointed Bill Brengel General Manager of its Spray Polyurethane Foam Materials Business.

Mylan N.V. announced on April 8, 2015, that it has made a proposal to acquire Perrigo Company plc. 

Health Systems

Gary Raju has been named the Chief Financial Officer for West Region for Mercy Health. 

Michael Waldrum has been named the Chief Executive Officer for Vidant Health. 

Jack Cox has been named the Chief Medical Officer for St. Joseph Health.

Dimitri Cruz has been named the Vice President of Information Technology and Chief Information Officer for Englewood Hospital and Medical Center. 

James Dover has been named the President and Chief Executive Officer for Southern Illinois Division of Hospital Sisters Health System.

Hospitals

Tom DeBord has been named the new Chief Operating Officer for Overlake Medical Center.

Kyle Price has been named the new Chief Executive Officer for Memorial Hermann Southeast Hospital. 

Edith Pemberton has been named the Chief Financial Officer for East Morgan County Hospital.

 

 

 

April 2, 2015

Affiliated Organizations

Ontario Teacher’s Pension Plan announced that Neil Petroff will retire as Executive Vice President and Chief Investment Officer, effective June 1, 2015.

Biotech

Sarepta Therapeutics, Inc. announced that Christopher Garabedian has resigned as President, Chief Executive Officer and a member of the Board of Directors. He is succeeded by the company’s Chief Medical Officer, Edward Kaye, who will serve as Chief Executive Officer in an interim capacity. 

Companies

Davita HealthCare Partners Inc. announced that Garry E. Menzel has stepped down as Chief Financial Officer. He is replaced by the company’s Chief Accounting Officer, James K. Hilger, who will fill the role in in interim capacity. 

UnitedHealth Group Incorporated announced that it has entered into an agreement to acquire Catamaran Corporation and combine it with its OptumRx business. Upon completion, Mark Thierer will become Chief Executive Officer of OptumRx and Timothy Wicks will become President. Jeff Park will serve as Chief Operating Officer and Jeffrey Grosklags will remain Chief Financial Officer. The transaction is expected to close in the fourth quarter of 2015.

Valeant Pharmaceuticals International, Inc. completed its acquisition of Salix Pharmaceuticals, Ltd. on April 1, 2015.

Celgene Corporation announced that Lawrence V. Stein will retire as Executive Vice President, General Counsel and Corporate Secretary, effective June 1, 2015. He is succeeded by Gerald F. Masoudi, who will assume the position at that time. 

Centene Corporation appointed Marcela Manjarrez-Williams Senior Vice President and Chief Communications Officer.

EMD Serono, Inc. appointed Frederick E. Munschauer, MD, Vice President of Medical Affairs, Neurology and Immunology. 

Corporate Boards of Directors

IMS Health Holdings announced that Karen Katen, former Vice Chairman of Pfizer and President of Pfizer Human Health, has been appointed to its Board of Directors. 

Group Purchasing Organizations

VHA, Inc. and UniversityHealthSystem Consortium completed their planned merger on April 1, 2015. The combined company will announce its new name in 2016, but until then it operates as VHA-UHC Alliance NewCo, Inc. and VHA and UHC retain their separate brands. Curt Nomomaque, former Chief Executive Officer of VHA has been appointed to serve as the new organization’s President and Chief Executive Officer. 

Health Systems

Emily Holliman has been named the Chief Executive Officer for HackensackUMC.

Stephen Massini has been named the Chief Financial Officer for Penn State Hershey Medical Center, effective April 20, 2015. 

Scottsdale Lincoln Health Network has been rebranded and renamed HonorHealth.

Hospitals

Chad Eckes has been named the Executive Vice President and Chief Financial Officer for Wake Forest Baptist Medical Center. He replaces Bobbi Carbone and Mike Rutherford who have stepped down.

Morre Dean has been named the Chief Executive Officer for Centura Health’s Port Adventist Hospital.

Peconic Bay Medical Center has become a full component member of the North Shore-LIJ Health System. 

Industry Service Providers

Jon Denissen has been named the Vice President of Good Manufacturing Practices Laboratories for Pharmaceutical Product Development, LLC.

Medical Device Manufacturers

Analogic Corporation announced that Michael Levitz will resign as Senior Vice President, Chief Financial Officer and treasurer, effective April 24, 2015. He is succeeded by the company’s Vice President and Corporate Controller, Michael Bouque, who will fill the role in an interim capacity.

NuVasive, Inc. announced that Alex V. Lukianov has resigned as Chairman, Chief Executive Officer and member of the Board of Directors. He is succeeded by current Director Gregory T. Lucier, who has been appointed Chairman and interim Chief Executive Officer. 

Pharmaceutical Manufacturers

Noven Pharmaceuticals, Inc. appointed Scott Briggs Vice President of Marketing and Sales. He replaces Andrew Panagy, who has retired from the company.

RHIOs/HIEs

The Indiana Health Information Exchange appointed Charles E. Christian Vice President of Technology and Engagement, effective May 1, 2015.

 

 

March 26, 2015

Academic Health Center

Hal Mueller has been named the new Chief Supply Chain Officer for the Wexner Medical Center.

Biotech

Halozyme Therapeutics, Inc. appointed James S. Mazzola Vice President of Corporate Communications and Investor Relations.

Charities

The National Kidney Foundation announced that Bruce Skyer will step down as Chief Executive Officer on May 18, 2015. He will be succeeded by board member Kevin Longino, who will fill the role in an interim capacity.  

Companies

New York Life Insurance Company appointed Aaron Ball Vice President and leader of its Long-Term Care Insurance business, which is based in Austin, Texas. 

Alere Inc. appointed James F. Hinrichs Executive Vice President and Chief Financial Officer, effective April 2015.  He succeeds David Teitel, who is stepping down as Chief Financial Officer.

Select Medical Corporation announced on March 23, 2015, that it has entered into an agreement to acquire Concentra Inc. through a joint venture it has created with Welsh, Carson, Anderson & Stoew WII, L.P. The transaction is expected to close in the second quarter of 2015.

Teva Pharmaceutical Industries Ltd. appointed Timothy R. Wright Head of Business Development, Strategy and Innovation, effective April 13, 2015.

Biogen Idec, Inc. announced that it has dropped “Idec” and changed its corporate name to Biogen, Inc.

Tenet Healthcare Corporation and Welsh, Carson, Anderson & Stowe announced on March 23, 2015, that it has entered into a definitive agreement under which Tenet will combine its ambulatory surgery and imaging centers in a new joint venture with United Surgical Partners International. Tenet will own a majority stake in the joint venture and have full ownership within the next five years. USPI will continue to be led by Bill Wilcox and Kyle Burtnett will join USPI as President of Ambulatory Services and Chief Integration Officer. The transaction is expected to close by the third quarter of 2015.

Paladina Health, LLC appointed Jennifer Bajaj, MD, MPH, Chief Medical Officer. 

Health Systems

Stephen O’Mahony has been named the Chief Medical Information Officer for Saint Barnabas Corporation. 

Robert Sehring has been named the new Chief Executive Officer of OSF HealthCare’s Central Region. 

Hospitals

Alice Cheng has been named the new Chief Executive Officer for Beverly Hospital.

David Ploss has been named the new Chief Medical officer for Ukiah Valley Medical Center.

Insurance and Managed Care

The Permanente Federation, LLC, appointed Bill Marsh, MD, Associate Executive Director of Government Relations and Care Delivery Information Technology.  

Medical Device Manufacturers

Cantel Medical Corp. announced that it Laura Forese, MD, President of NewYork-Presbyterian Healthcare System, has been appointed to its Board of Directors.

Pharmaceutical Manufacturers

Sun Pharmaceutical Industries Ltd. completed its acquisition of Ranbaxy Laboratories Limited.

 

 

March 19, 2015

Companies

Becton, Dickinson and Company completed its acquisition of CareFusion Corporation on March 17, 2015. CareFusion now operates as a part of BD's Medical segment. 

Actavis plc completed its acquisition of Allergan, Inc. on March 17, 2015. The company intends to subsequently change its corporate name to Allergan, pending shareholder approval. 

Corporate Boards of Directors

Tenet Healthcare Corporation announced that Tammy Romo, Senior Vice President of Finance and Chief Financial Officer of Southwest Airlines Co., has been appointed to its Board of Directors. 

Health Net, Inc. announced that former U.S. Representative George Miller has been appointed to its Board of Directors. The company also announced that Patrick Foley will not stand for re-election at the 2015 Annual Meeting of Stockholders and will retire from the board on May 7, 2015. 

Magellan Health, Inc. announced on March 18, 2015, that it has entered into an agreement to acquire 4D Pharmacy Management Systems, Inc. for up to $85 million. The transaction is expected to close in the second quarter of 2015. 

Former Government Officials Joining Health World

The Lung Cancer Alliance appointed Marianne Adezio Myers Director of Health Policy. She previously served as Legislative Director for Representative Scott Perry.  

Health IT

Computer Task Group, Inc. appointed Cliff Bleustein, MD, President and Chief Executive Officer, effective April 6, 2015. He succeeds James R. Boldt who passed away in October 2014. 

Wipro, Ltd. appointed Abid Ali Neemuchwala Group President and Chief Operating Officer, effective April 1, 2015. 

Health Systems

Michael Edbauer has been selected to succeed Dennis Horrigan as Chief Executive Officer for Catholic Medical Partners, effective at the end of 2015.

Brian Gragnolati has been named the Chief Executive Officer for Atlantic Health System.

Michael Mandl has been named the Chief Executive Officer for Emory Healthcare.

Dennis Lund has been named the Chief Medical Officer for Stanford Children’s Health.

Todd Werner has been named the President of Banner Health’s Arizona East Region. 

Hospitals

Brian Gamble has been named the new Chief Financial Officer for Karmanos Cancer Institute. 

James Hobson has resigned from his position as Chief Executive Officer of CHI Memorial, effective July 2015.

Joyce Soule has been named the Chief Nursing Officer for Wesley Medical Center.

John Remillard has announced he will retire as Chief Executive Officer for A.O. Fox Memorial Hospital, effective December 31, 2015. 

Lee Johannsen has been chosen as the Chief Medical Officer for Central Texas Medical Center. 

Barr Chambers has been named the Chief Financial Officer for Boone Hospital Center, effective April 20, 2015.

Mary Jane Krebs has been appointed the President of Spring Harbor Hospital.  

Medical Device Manufacturers

Elekta AB announced that Asa Hedin will resign as Executive Vice President of Corporate Strategy on March 30, 2015, to pursue another opportunity outside of the company. 

Medical Supply Distributors

GN Store Nord A/S appointed Rene Svendesen-Tune Chief Executive Officer of GN Netcom, effective April 1, 2015. He replaces Niels Svenningsen, who is stepping down for family reasons. As a result of the appointment, Mr. Svendsen-Tune has stepped down from GN Store Nord’s Board of Directors.

Pharmaceutical Distributors/Wholesalers

H. D. Smith announced several executive appointments, effective immediately: Dale Smith has been appointed Chairman and Chief Executive Officer of H. D. Smith Holding Company, the umbrella company for H. D. Smith and its subsidiaries; Chris Smith has been appointed President and Chief Executive Officer of H. D. Smith Drug Wholesale Co.; Bob Appelby has been appointed President of H.D Smith Specialty Solutions; and Joe Conda has been appointed Executive Vice President of H. D Smith in the Office of the Chairman.

Pharmaceutical Manufacturers

Apotex, Inc. announced a new operating structure under which it will operate under the following three business lines: Global Generics, Global Specialty Pharma and Global Active Pharmaceutical Ingredients. In relation to this realignment, the company appointed Jeff Watson President of Global Generics and Steve Lydeamore President of Global Specialty International, effective April 1, 2015. Dr. Keshava Murthy will remain President of Global API. 

RHIOs/HIEs

The Indiana Health Information Exchange appointed John P. Kansky President and Chief Executive Officer. He has filled the role in an interim capacity since June 2014.

 

 

 

March 16, 2015

Biotech

Acceleron Pharma, Inc. promoted Steven Ertel to Executive Vice President and Chief Operating Officer and Matthew Sherman, MD to Executive Vice President and Chief Medical Officer.

PharmAthene, Inc. announced that it plans to reduce its staff by approximately two thirds. As a part of the plan, Eric Richman will step down as President and Chief Executive Officer, effective March 12, 2015, but will remain a Director. He will be succeeded by current Director John M. Gill. In addition, Linda Chang will step down as Chief Financial Officer, effective May 1, 2015. She will be succeeded by current Vice President and Controller Philip MacNeill. The company also announced that Directors Joel McCleary and Brian Markison will resign from the Board.

Bind Therapeutics, Inc. announced that Andrew Hirsch, the company’s Chief Operating Officer and Chief Financial Officer, has assumed the role of acting Chief Executive Officer. He replaces Scott Minick who has resigned from the company but will remain a member of the Board.

Charities

The Muscular Dystrophy Association appointed Amanda Haidet-Phillips, PhD and Laura Hagerty, PhD Scientific Program Officers.

Companies

Abbvie Inc. announced on March 4, 2015, that it has entered into a definitive agreement to acquire Pharmacyclics, Inc. for approximately $21 billion. The transaction is expected to close in mid-2015.

Kindred Healthcare, Inc. appointed Jon B. Rousseau Executive Vice President and President of RehabCare, effective April 1, 2015. He replaces Patricia M. Henry, who is retiring from Kindred. The company also announced that it has appointed Christopher Day Senior Vice President of Strategy and Care Management.

Alere Inc. announced that David Tietel will transition from the role of Chief Financial Officer once a successor is named.

Mutual of Omaha announced that Dan Neary’s previously announced retirement as Chief Executive Officer will be effective on April 1, 2015. He is succeeded by the company’s President, James T. Blackedge, who has been appointed to the Board of Directors.

Actavis plc ad Allergan, Inc. announced on March 10, 2015, that all proposals regarding Activis’ acquisition of Allergan were approved by both company’s shareholders and the transaction is expected to close late in the first quarter or early in the second quarter of 2015.

Ventas, Inc. promoted Randy Sohanaki to Vice President of IT Applications, Wilkingson Germain to Senior Investment Officer, and Shane Seitz to Senior Investment Officer. The company also announced that it has appointed Timothy Sanders Senior Investment Officer.

McKesson Canada appointed Richard Brennan Senior Vice President of Retail Banner Management Services, replacing Dale Weil, who has been filling the role in an interim capacity.

Corporate Boards of Directors

Hill-Rom Holdings, Inc. announced that Stacy Enxing Seng, former President of the Vascular Therapies Division at Covidien, has been elected to its Board of Directors. She replaces Joanne Smith, who chose to not stand for re-election at the company’s Annual Meeting of Shareholders.

AmerisourceBergen Corporation announced that Edward E. Hagenlocker retired from its Board of Directors at the company’s Annual Meeting of Stockholders.

CVS Health Corporation appointed Alecia A. DeCoudreaux, President of Mills College, to its Board of Directors.

Health Systems

Theodore Lawrence has been named the Director of the University of Michigan Comprehensive Cancer Center.

Cheryl Harmon has been named the Chief Financial Officer for St. Vincent Health.

Ira Jacobson has been named the new Chairman of Medicine for Mount Sinai Berth Israel.

Bill Leaver has announced his retirement as Chief Executive Officer for UnityPoint Health, effective January 2016.

Hospitals

Jeff Sperring has been named the Chief Executive Officer for Seattle Children’s Hospital, effective May 2015.

Imran Andrabi has been promoted to Chief Executive Officer of Mercy Health – Toledo.

Chad Aduddell has been named the Chief Executive Officer for CHI St. Vincent Healthcare on an interim basis.

Pharmacies

BioScrip, Inc. announced that Christopher Shackelton, Co-Founder and Managing Partner of Coliseum Capital, has been appointed to its Board of Directors.

Pharmaceutical Manufacturers

Mallinckrodt plc announced on March 5, 2015, that it has entered into a definitive agreement with Ikaria, Inc. under which a subsidiary of Mallinckrodt will acquire Ikaria for approximately $2.3 billion. The transaction is expected to close early in the second quarter of 2015.

 

 

March 5, 2015

Biotech

Oncothyreon, Inc. announced that Steven P. James, former President and Chief Executive Officer of Labrys Biologics, has been appointed to its Board of Directors. 

Companies

Carestream Health, Inc. appointed Ted Taccardi Vice President of Global Customer Care. 

Almost Family, Inc. announced on February 25, 2015, that it has entered into a definitive agreement to acquire the stock of WillCare HealthCare for approximately $46 million to $53 million. Almost Family expects to complete the transaction for WillCare's Ohio operations in early March 2015 and its New York operations in the second half of 2015.

Anthem, Inc. appointed Michael Malouf President of its Dental business.  

Mylan, Inc. acquired Abbott Laboratories' non-U.S. developed markets specialty and branded generics business on February 27, 2015. Mylan's existing operations have been combined with those acquired from Abbott. The combined company now operates as Mylan N.V. 

GlaxoSmithKline plc and Novartis AG completed on March 2, 2015, their 3-part transaction in which: GSK and Novartis created a new Consumer Healthcare business, of which GSK has majority control; GSK acquired the global Vaccines business of Novartis; and GSK divested its Oncology portfolio to Novartis. 

Cigna acquired QualCare Alliance Networks, Inc., the parent company of QualCare, Inc., on February 28, 2015. 

Brookdale Senior Living Inc. appointed Dr. Paul Nussbaum, PhD, National Director of Brain Health. 

Cardinal Health, Inc. announced on March 2, 2015, that it has entered into an agreement with Johnson & Johnson to acquire its Cordis business for $1.944 billion in cash. The transaction is expected to close towards the end of 2015. 

Boston Scientific Corporation announced on March 2, 2015, that it has entered into a definitive agreement with Endo International plc to acquire its American Medical Systems urology portfolio, including its Men's Health and Prostate Health businesses, for up to $1.65 billion. The transaction is expected to close in the third quarter of 2015. 

Health Net, Inc. appointed Peter O’Neill Vice President of Investor Relations and Corporate Communications. 

Consultants and Service Providers

ICON plc acquired MediMedia Pharma Solutions, a division of MediMedia USA, from Vestar Capital Partners on March 2, 2015.

Etienne Drouet has been named the Vice President of Strategic Development for SynteractHCR.  

Corporate Boards of Directors

Unum Group announced that Ronald P. O’Hanley, former president of Asset Management and Corporate Services for Fidelity Investments, has been appointed to its Board of Directors. 

Boston Scientific Corporation announced that Charles J. Dockendorff, former Executive Vice President and Chief Financial Officer of Covidien, and Stephen P. MacMillan, President and Chief Executive Officer of Hologic, have been appointed to its Board of Directors, effective April 1, 2015. The company also announced that directors Uwe E. Reinhardt and Bruce L. Byrnes will not stand for re-election at its 2015 Annual Meeting of Stockholders.  

Hospitals

Paul Wright has been promoted to the Chair of Neurology for North Shore University Hospital. 

John Raffoul has been named the Chief Executive Officer for White Memorial Medical Center.

Jonathan Weld has been named the Brooklyn Hospital Center on an interim basis.

Tad Hatton has been named the Vice President and Chief Operating Officer for Seton Medical Center Austin, Texas.

Insurance and Managed Care

Highmark Inc. announced that J. Robert Baum has stepped down as Chairman of the Board of Directors. He is succeeded by President and Chief Executive Officer David L Holmberg, who will assume the additional title of Chairman.

Health Care Service Corporation appointed Maurice Smith President of Blue Cross and Blue Shield of Illinois.

Affinity Health Plan promoted Sharon Deans, MD, to Chief Medical Officer. She has been serving as interim Chief Medical Officer since November 2014. 

Medical Device Manufacturers

Sorin Group announced on February 26, 2015, that it has entered into a definitive agreement to merge with Cyberonics Inc. in a transaction valued at approximately $2.7 billion. The new company will be led by André-Michel Ballester, who will serve as Chief Executive Officer, and Dan Moore, who will serve as non-executive Chairman, and will be domiciled in the UK. The transaction is expected to close by the end of the third quarter of 2015. 

BREG, Inc. promoted Brad Lee from President to President and Chief Executive Officer.

Sonova Holdings AG announced that Maarten Barmentlo has resigned as Group Vice President of Marketing.  

Pharmaceutical Manufacturers

Ipsen S.A. appointed Dominique Laymand Senior Vice President and Chief Ethics and Compliance Officer, effective March 16, 2015.

 

 

February 26, 2015

Biotech

Anika Therapeutics, Inc. announced that it has Glen R. Larsen, Chief Executive Officer of Aquinnah Pharmaceuticals, Inc., to its Board of Directors.

Compugen Ltd. appointed Felix Karim, PhD, Vice President of Corporate and Business Development, effective March 2, 2015. He will be based at the company’s South San Francisco facilities.

Dendreon Corporation completed the sale of substantially all of its assets to Valeant Pharmaceuticals International, Inc. on February 23, 2015. The company intends to wind down its operations and as a result Dennis M. Fenton and Bogdan Dziurzynsk have resigned from the Board of Directors. 

Lexicon Pharmaceuticals, Inc. announced that Brian P. Zambrowicz has resigned as Executive Vice President and Chief Scientific Officer. 

Companies

Kimberly-Clark Corporation announced that its Chief Financial Officer Mark Buthman plans to retire from the company at the end of the year. He will step down as Senior Vice President and Chief Financial Officer on April 27, 2015, and will continue to serve as Executive Vice President through the end of the year to assist with the transition. He is succeeded by Maria Henry, who will serve as Senior Vice President and Chief Financial Officer, effective April 27, 2015.

Laboratory Corporation of American Holdings, Inc. completed its acquisition of Covance, Inc. on February 19, 2015.

Sanofi SA appointed Olivier Brandicourt Chief Executive Officer, effective April 2, 2015. He replaces Serge Weinberg, who has been serving as Interim Chief Executive Officer since October 2014. In a separate announcement, Bayer AG announced that Werner Baumann will succeed Olivier Brandicourt as Chairman of the Board of Management of Bayer HealthCare AG. 

Valeant Pharmaceuticals International, Inc. announced on February 22, 2015, that it has entered into a definitive agreement with Salix Pharmaceuticals, Ltd. under which Valeant will acquire Salix for approximately $14.5 billion. The transaction is expected to close in the second quarter of 2015.

Shire plc completed its acquisition of NPS Pharmaceuticals, Inc. on February 21, 2015. 

DaVita HealthCare Partners Inc. appointed Mahesh Krishnan, MD, Group Vice President of Research and Development and International Chief Medical Officer of its DaVita Kidney Care division.

Asahi Kasei Corporation announced on February 23, 2015, that it has entered into a definitive merger agreement with Polypore International, Inc. under which Asahi Kasei will acquire Polypore for approximately $2.2 billion.

AmerisourceBergen Corporation completed its acquisition of MWI Veterinary Supply, Inc. on February 24, 2015.

Health Systems

David Feinberg has been announced the new President and Chief Executive Officer for Geisinger Health System, effective May 1, 2015. He replaces Glenn Steele Jr. who is stepping down. 

Joseph Kelly, former Aetna executive, has been named the new Senior Vice President and Chief Marketing Officer for Sisters of Mercy Health System.  

Hospitals

Deborah Proctor, the President and Chief Executive Officer for St. Joseph Health, has announced her retirement, effective December 31, 2015. 

Industry Service Providers

David Smith has been named the Corporate Executive Vice President and Chief Financial Officer for Charles River Laboratories, effective February 2016. He replaces Thomas Ackerman who is stepping down.

Pharmaceutical Manufacturers

Alkermes plc appointed Mark Namchuk, PhD, Senior Vice President of Research, Pharmaceutical and Nonclinical Development.

 

 

February 19, 2015

Charities

The National Parkinson Foundation appointed Ricardo Caporal, Founder & President of Mattoni Group, to its Board of Directors.  

Companies

Kindred Healthcare, Inc. promoted Marc Rothman, MD, to Senior Vice President and Senior Chief Medical Officer. He had previously served as Senior Vice President and Chief Medical Officer of the Nursing Center Division since 2011.

Team Health Holdings, Inc. appointed Matthew Tormey Chief Compliance Officer.

Kimberly-Clark Corporation appointed Sandra MacQuillan Senior Vice President of Global Supply Chain, effective in the second quarter of 2015.

McKesson Corporation announced that Bansi Nagji was appointed Executive Vice President of Corporate Strategy and Business Development. He succeeds Brian Tyler, who has fully transitioned to his new role as President of North American Pharmaceutical Distribution and Services. 

MedAssets, Inc. announced that John A. Bardis has retired as Chairman and Chief Executive Officer for personal reasons relating to family health issues. He will remain on the Board of Directors until the 2015 Annual Meeting of Stockholders, at which point he will assume the title of Non-Executive Chairman Emeritus. Mr. Bardis is succeeded as Chairman and Chief Executive Officer by R. Halsey Wise, who has been a board member since March 2014. 

Actavis plc announced on February 13, 2015, that it has entered into a definitive agreement to divest its Aptalis Pharmaceuticals Technologies (Pharmatech) business to TPG Capital. Upon completion of the divesture, Pharmatech will become a standalone company with John Fraher serving as Chief Executive Officer. The transaction is expected to close by mid-2015.  

Health IT

HealthStream, Inc. announced on February 13, 2015, that it has entered into a definitive agreement with HealthLine Systems, Inc. under which HealthStream will acquire HealthLine for approximately $88 million. HealthStream will combine HealthLine with its existing SyMed business to form a new rebranded business, which will be headed by Michael Sousa who will serve as its President. The transaction is expected to close in the first quarter of 2015.  

Health Systems

Jennifer Velez has been named the Senior Vice President of Strategy and Planning for Saint Barnabas Corporation, effective March 10, 2015. She comes from the New Jersey Department of Human Services. 

The University of Pittsburgh Medical Center has approved a definitive agreement to acquire Jameson Health System. 

William Hurford has been named the Chief Medical Officer for the University of Cincinnati Health. 

Michael Tengeres has been named the Chief Financial Officer, effective April 6, 2015, for the Bassett Healthcare Network.

Reginald Eadie has been named the Chief Executive Officer for Detroit Receiving Hospital. He succeeds Iris Taylor who has stepped down.

Prime Healthcare has completed their acquisition of Saint Joseph Medical Center and Saint Mary’s Medical Center.

Hospitals

Robert Erickson has been named the Chief Executive Officer for Saint Joseph Medical Center. 

Jesse Jantzen has been named the President and Chief Executive Officer for Ascension Health Senior Care, effective March 27, 2015. 

John Dubis, the President and Chief Executive Officer of St. Elizabeth Healthcare, has announced his intent to step down. Garren Volvin, current Chief Operating Officer of the institution, will serve in an interim capacity. 

Christine Bartel has been named the President and Chief Executive Officer of McLaren Homecare Group.

  

 

February 12, 2015

Companies

Pfizer Inc. announced on February 5, 2015, that it has entered into a definitive merger agreement with Hospira, Inc. under which Pfizer will acquire Hospira for approximately $17 billion. The transaction is expected to close in the second half of 2015.

Catalent, Inc. appointed Thomas Castellano Vice President of Finance and Investor Relations and Treasurer.

Rite Aid Corporation announced on February 11, 2015, that it has entered into a definitive agreement with Envision Pharmaceutical Services (“EnvisionRx”) under which Rite Aid will acquire EnvisionRX for approximately $2 billion. EnvisionRX will operate as a wholly owned subsidiary of Rite Aid led by its current management team. The transaction is expected to close by September 2015. 

Valeant Pharmaceuticals International, Inc. announced that it is the sole bidder to acquire substantially all the assets of Dendreon Corporation and expects the transaction to close by the end of February 2015. 

Aflac Incorporation announced that Thomas J. Kenny has been appointed to its Board of Directors.  

Corporate Boards of Directors

Hooper Holmes, Inc. announced that Mark J. Emkjer, former Chief Executive Officer of the Health Services Division of WebMD, has been appointed to its Board of Directors.

Kemper Corporation announced that George N. Cochran, former Chairman in the Global Financial Institutions Group at Macquarie Capital and Kathleen M. Cronin, Senior Managing Director, General Counsel and Corporate Secretary of CME Group Inc., have been appointed to its Board of Directors. 

Edwards Lifesciences Corporation announced that Kieran T. Gallahue, Chairman and Chief Executive Officer of CareFusion Corporation, has been appointed to its Board of Directors. The company also announced that Mike R. Bowlin will not stand for re-election at the company’s Annual Meeting of Shareholders on May 14, 2015.  

Health IT

Cumberland Consulting Group, LLC, appointed Brian Cahill Chief Executive Officer. He succeeds Jim Lewis, who will continue as Chairman. 

Hayes Management Consulting appointed Michael Kreitzer Vice President of Strategic Services. 

Health Systems

David Torchiana has been named the President and Chief Executive Officer for Partners HealthCare System, effective March 2015. 

Darryl Cardoza is stepping down March 31, 2015 as the President and Chief Executive Officer of Hill Physicians Medical Group. He will be replaced by David Joyner who has served as the organization’s Chief Operating Officer. 

John Porter has been named Chief Operating Officer for WellSpan Health.  

Syed Raza has been named the new Chief Medical Officer for CHI St. Luke’s Health – The Woodlands. 

Hospitals

Dignity Health promoted Darryl VandenBosch to President of St. Bernadine Medical Center. He succeeds Steven Barron, who will now focus full-time on his role as Dignity’s Senior Vice President of Operations for its Southern Californian East Service Area.

Louis Smith has been appointed the new President of Northeast Georgia Medical Center in Gainesville, GA, effective March 2, 2015.

Elizabeth Kromm has been appointed the Senior Director of Population Health and Community Relations for Howard County General Hospital.

Insurance and Managed Care

Kaiser Permanente appointed Richard “Dick” Daniels Executive Vice President and Chief Information Officer. He had been serving as interim Chief Information Officer since September 2014.

Pharmacies

BioScrip, Inc. announced that Hai V. Tran will retire as Chief Financial Officer and Treasurer, effective March 27, 2015. In a separate announcement, the company stated that it will nominate David Golding, Michael Goldstein and R. Carter Pate for election to the Board of Directors at its 2015 Annual Meeting of Shareholders. If elected, they will replace Samuel P. Frieder, David R. Hubers and Gordon H. Wooward, who will all not be standing for re-election.

 

 

February 5, 2015

Affiliated Organizations

Affymetrix, Inc. announced that Stephen Fodor has retired from its Board of Directors. Jami Nachtsheim has been appointed to succeed Mr. Fodor as Chair of the Board. 

Associations

The New Jersey Hospital Association installed Leslie D. Hirsch, President and Chief Executive Officer of Saint Clare’s Health System, as the association’s newest Chairman at its Annual Meeting.  

Biotech

Array Biopharma Inc. announced that R. Michael Carruthers will resign as Chief Financial Officer, effective February 6, 2015. David Horin, Managing Partner at Chord Advisers, will serve as interim Chief Financial Officer until a permanent replacement has been named. 

Ligand Pharmaceuticals, Inc. promoted Matthew W. Foehr to President and Chief Operating Officer. He had previously served as Executive Vice President and Chief Operating Officer.  

Charities

Richard J. Geswell announced that he will retire as President and Chief Executive Officer of the Crohn’s and Colitis Foundation of America at the end of 2015.  

Companies

Alexion Pharmaceuticals, Inc. promoted David L. Hallal to Chief Executive Officer, effective April 1, 2015. He has been serving as Chief Operating Officer since December 2014. He succeeds Leonard Bell, who will continue to serve as Chairman of the Board of Directors.

Endo International plc completed its acquisition of Auxilium Pharmaceuticals, Inc. on January 29, 2015. 

HCA Holdings, Inc. promoted Sam Hazen to Chief Operating Officer. He had been serving as President of Operations since 2011. 

Bayer MaterialScience LLC appointed Kenneth Schwartz Business Development Manager for Makrolon polycarbonate sheet products. 

Hooper Holmes, Inc. appointed Neil Gordon, MD, PhD, MOPH, FACC, Corporate Medical Director. 

Genesis HealthCare, LLC completed its merger with Skilled Healthcare Group, Inc. on February 2, 2015, and now operates under the name Genesis Healthcare, Inc. as a publicly-traded company. 

Cerner Corporation completed its acquisition of the assets of Siemens Health Services from Siemens AG on February 2, 2015. John Glasser, former Chief Executive Officer of Siemens Health Services, has joined Cerner as Senior Vice President. 

Walgreens Boots Alliance, Inc. appointed Marco Pagni Executive Vice President and Global Chief Legal and Administrative Officer. The company also appointed Jan Stern Reed Senior Vice President, General Counsel and Corporate Secretary. 

AmerisourceBergen Corporation promoted Robert P. Mauch to Executive Vice President and President of AmerisourceBergen Drug Corporation. He had previously served as Senior Vice President of Operations for AmerisourceBergen Drug Corporation. The division’s former president, David W. Neu, has assumed a new role as Executive Vice President of Retail Strategy and President of Good Neighbor Pharmacy. 

Unum Group announced that Thomas R. Watjen will step down as President on April 1, 2015 and Chief Executive Officer at the company’s Annual Meeting of Shareholders on May 21, 2015. He will remain on the Board of Directors as Non-Executive Chairman until his retirement at the 2017 Annual Meeting. The company’s current Chairman, William J. Ryan, will assume the role of Lead Independent Director on May 21, 2015. Mr. Watjen is succeeded by Richard P. McKenney, who will assume the role of President and a member of the Board of Directors on April 1, 2015, and Chief Executive officer on May 21, 2015. John F. McGarry will assume Mr. McKenney’s current position of Chief Financial Officer on April 1, 2015.

IASIS Healthcare LLC announced on February 2, 2015, that its parent company, IASIS Healthcare Corporation, has filed a registration statement for a proposed initial public offering.

Corporate Boards of Directors

Zoetis Inc. announced that William F. Doyle, a member of Pershing Square Capital Management’s Investment Team, has been appointed to its Board of Directors.

Group Purchasing Organizations

VHA Inc. announced on February 3, 2015, that it has entered into an agreement with University HealthSystem Consortium (UHC) to merge and combine into a single organization. Curt Nonomaque will serve as President and Chief Executive Officer, Marna Borgstrom as Chair of the Board and Ann Madden Rice as Vice Chair of the Board. The new company will be headquartered in Irving, TX. The merger is expected to be close by the end of March 2015.  

Health IT

Silverlink Communications appointed Jim Wolf Senior Vice President of Sales.  

Health Systems

Jane Motes has been named the Vice President of Revenue Cycle Operations for Capella Healthcare.

Peter Bernard has announced his retirement as the Chief Executive Officer of Bon Secours Virginia, effective August 2015.

Chris Truax has been named the new Chief Operating Officer of OhioHealth Marion General Hospital, effective March 1, 2015. 

C.J. Miller has been named the President and Chief Executive Officer for Morrow County Hospital, effective March 1, 2015. 

David Smith has been promoted to Senior Vice President and Chief Financial Officer for the Memorial Healthcare System.

Hospitals

Peter Thoreen has announced his retirement from his post as the Chief Executive Officer for UnityPoint Health – St. Luke’s by the end of 2015. 

Beth Hughes has resigned as the Chief Executive Officer of Saint Joseph Medical Center. 

Heath Rushing has been named the Chief Executive Officer for Memorial Hermann Northeast Hospital, on an interim basis. 

Candace Johnson has been named the President and Chief Executive Officer of Roswell Park Cancer Institute. 

Industry Service Providers

ICON plc has agreed to acquire MediMedia Pharma Solutions for a cash consideration of $120 million. MediMedia Pharma Solutions is division of MediMedia USA and is owned by Vestar Capital Partners. The transaction is currently pending. 

Insurance and Managed Care

Blue Cross and Blue Shield of Kansas appointed Danette K. Wilson President and Chief Executive Officer. She had been serving as Interim President and Chief Executive Officer since August 2014. 

Pharmaceutical Manufacturers

Biocon Limited announced that Dr. Vijay K. Kuchroo, Samuel L. Wasserstrom Professor of Neurology and Director of Evergrande Center for Immunologic Diseases at Harvard Medical School, and Dr. Jeremy Levin, former Chief Executive Officer of Teva Pharmaceuticals, have been appointed to its Board of Directors.

Myriad Genetics, Inc. announced that Peter D. Meldrum will retire as President, Chief Executive Officer and member of its Board of Directors, effective June 30, 2015. He will be succeeded by Mark C. Capone on July 1, 2015. 

Research Organizations

Health Sciences South Carolina appointed Helga Rippen, MD, PhD, MPH, FACPM, President and Chief Executive Officer.

 

 

January 29, 2015

Charities

Muscular Dystrophy Association Inc. appointed Kristin Stephenson Vice President of Policy and Advocacy.

Companies

Invacare Corporation appointed Matthew E. Monaghan President and Chief Executive Officer, effective April 1, 2015. He succeeds Robert K. Gudbranson, who has been serving as Interim President and Chief Executive Officer since August 2014 and will continue to serve as Senior Vice President and Chief Financial Officer.

Rite Aid Corporation promoted Ray Payne to Group Vice President of Real Estate. He previously served as Vice President of Real Estate West Coast.

Cook Medical Incorporation promoted Cynthia Kretz to Vice President and General Counsel. She had been serving as General Counsel since 2008. 

AmerisourceBergen Corporation announced on January 26, 2015, that it has entered the next step of its previously announced acquisition of MWI Veterinary Supply, Inc., and has commenced a tender offer to purchase MWI’s outstanding shares. 

Community Health Systems, Inc. announced on January 23, 2015, that it has entered into a definitive agreement with Metro Health Corporation under which CHS will purchase an 80% interest in the health system. 

Walgreens Boots Alliance, Inc. appointed George Fairweather Executive Vice President and Global Chief Financial Officer, effective February 20, 2015. He succeeds Timothy McLevish, who will continue to serve as Senior Advisor to the Chief Executive Officer for Finance, Integration and Business Development through August 20, 2015. 

Kindred Healthcare, Inc. appointed Kent H. Wallace Executive Vice President and Chief Operating Officer, effective February 2, 2015. 

Health Systems

James Bleicher has been named the new President and Physicians Organization for SSM Health.

Prime Healthcare Services completed the acquisition of North Vista Hospital. 

Marco Costa has been named the Chief Innovation Officer for the University Hospitals Health System Inc. 

Hospitals

Monica Hilt has been named the President of St. Elizabeth Hospital and the Vice President of the Eastern Region for Ministry Health Care. 

Pamela Paulk has been named the President of International for Johns Hopkins Medicine.  

Pharmaceutical Manufacturers

Ferring Pharmaceuticals appointed Pascal Danglas, MD, Executive Vice President and Chief Medical Officer and Per Falk, MD, PhD, Executive Vice President and Chief Financial Officer.

  

 

January 22, 2015

Biotech

Medivir AG appointed Christine Lind Head of Business Development and Ola Burmark Chief Financial officer, both effective March 1, 2015. In addition, Christina Kassberg, Rein Piir, Paul Wallace and Håkan Wallin will resign from the company by the end of February 2015.

Halozyme Therapeutics, Inc. announced that Jean-Pierre Bizzari, MD, Head of Clinical Oncology Development at Celgene Corporation, has been appointed to its Board of Directors.

Companies

Astellas Pharma Inc. appointed Eric Terhaerdt Senior Vice President of Global Development Operations. He will be based at Astellas’ United States headquarters in Northbrook, IL.

Bristol-Myers Squibb Company announced several leadership changes that will take effect at the close of the company’s annual meeting of shareholders on May 5: Giovanni Caforio will become Chief Executive Officer; Lamberto Andreotti will become Executive Chairman of the Board of Directors, and will continue to serve as Chairman after his retirement on August 3; James M. Cornelius will step down as Non-Executive Chairman and not seek re-election to the Board; and Togo D. West, Jr. will become Lead Independent Director of the Board.

HCA Holdings, Inc. appointed Stephen W. Nesbit, DO, Chief Medical Officer of its Gulf Coast Division.

CareMore Health Group, Inc., a subsidiary of Anthem, Inc., appointed Sachin H. Jain, MD, MBA, Chief Medical Officer of CareMore Health System.

Walgreen Co. announced on January 20, 2015, that it has entered into a definitive agreement with Madison Dearborn Partners under which MDP will acquire a majority interest in Walgreens Infusion Services. The division will become a new independent company headed by Paul Mastrapa, who will serve as Chief Executive Officer. MDP will own a majority interest in the company and Walgreens Boots Alliance will own a minority interest and have representatives on its Board of Directors. The transaction is expected to close in the second quarter of 2015.

Hologic, Inc. appointed John Griffin General Counsel and Allison (Ali) Bebo Senior Vice President of Human Resources, both effective February 2, 2015.

Corporate Boards of Directors

AmerisourceBergen Corporation announced that Ornella Barra, Executive Vice President of Walgreens Boost Alliance, has been appointed to its Board of Directors. She replaces Gregory D. Wasson, who has resigned from the board.

Group Purchasing Organizations

Corporate United, Inc. appointed Doug Blossey President and Chief Operating Officer.

Health IT

Hayes Management Consulting appointed Gay Fright Vice President of Strategic Services.

Wipro, Ltd. announced that Suresh Senapaty will retire as Chief Financial Officer on March 31, 2015. He will be succeeded by Jatin Dalal, who will assume the position on April 1, 2015.

Hospitals

Richard Becker is stepping down from his post as the Chief Executive Officer for Brooklyn Hospital Center.

Omar Lateef has been name the new Chief Medical Officer for Rush University Medical Center.

Carla Parker Hollis has been named the President and Chief Executive Officer at Columbus Regional Healthcare System, effective February 16, 2015.

Pharmacies

Diplomat Pharmacy, Inc. appointed Susan O. Faust Vice President of Specialty Infusion and Market Development.

 

 

January 15, 2015

Affiliated Organizations

Affymetrix, Inc. announced that Merilee Raines, former Chief Financial Officer of IDESS Laboratories, has been appointed to its Board of Directors.

Biotech

Vermillion, Inc. appointed Laura Miller Senior Vice President of Sales and Customer Experience. Holly Bauzon, who has been serving as Vice President of Sales and Managed Markets, will now be responsible exclusively for managed markets. In a separate announcement, the company also appointed Patrick Carpenter General Manager of ASPiRA LABS, the company’s clinical laboratory. 

CTI BioPharma Corp. appointed Alan K. Nurnett, MD, Therapeutic Area Lead for Myeloid Diseases.  

Companies

Endo International announced several upcoming changes to its management structure. Effective March 1, 2015, Don DeGolyer will resign but remain Special Advisor to the Chief Executive Officer until August 1, 2015. Also effective March 1, Robert Rush will serve as interim General Manager of Qualitest Pharmaceuticals. Effective following the completion of the company’s acquisition of Auxilium Pharmaceuticals, which is expected to occur this month: Blaine Davis will serve as Senior Vice President and General Manager of a newly created specialty pharmaceuticals business unit; Robert Cobuzzi will serve as President of Endo Ventures Limited; and Keri Mattox will join Endo from Ausilium as Senior Vice President of Investor Relations and Corporate Affairs. 

Quest Diagnostics Incorporated appointed Michael Cole Vice President of Health Plans. 

AmerisourceBergen Corporation announced on January 12, 2015, that it has entered into a definitive merger agreement with MWI Veterinary Supply, Inc., under which AmerisourceBergen will acquire MWI for $2.5 billion. The transaction is expected to close in March 2015. 

Shire plc announced on January 11, 2015, that it has entered into a merger agreement with NPS Pharmaceuticals, Inc., under which Shire will acquire NPS Pharma for approximately $5.2 billion. The transaction is anticipated to close in the first quarter of 2015.

Alere, Inc. completed its sale of Alere Health, LLC and its subsidiaries to Optum, Inc. for $600 million in cash. 

HCA Holdings, Inc. appointed Lyn Ketelsen, RN, MBA, Chief Patient Experience Officer, effective February 23, 2015. 

Health Systems

Michael Marshall has been named the President and Chief Medical Officer for Franciscan Medical Group

Eugene Washington has been appointed the new President and Chief Executive Officer for Duke University Health System, effective April 1, 2015. 

Jeffrey Thompson has announced his intention to retire as the Chief Executive Officer for Gundersen Health System in 2015, effective upon the appointment of a successor.  

Hospitals

Marc Hurowitz has been appointed the new Chief Executive Officer for Jeanes Hospital, effective March 7, 2015. He replaces Linda Benfield Grass who is stepping down.

Marilyn Margolis and Daniel Owens have been named the new Chief Executive officers for Emory Johns Creek Hospital and Emory University Hospital Midtown, respectively. They have both been serving in an interim capacity since 2014. 

Insurance and Managed Care

The Blue Cross and Blue Shield of Minnesota Foundation announced that Nancy Vyskocil, President and Chief Executive Officer of Northwest Minnesota Foundation, and Bukata Hayes, Executive Director of the Greater Mankato Diversity Council, have been appointed to its Board of Directors. 

Pharmaceutical Manufacturers

BioMarin Pharmaceuticals Inc. announced that Pierre Lapalme will step down as Chairman of the Board of Directors at the company’s annual meeting of stockholders, which is anticipated to take place this June. He will continue to serve as a Director of the Board, pending his re-election. The company also announced that it has appointed Chief Executive Officer Jean-Jacques to the additional position of Chairman and Richard Meier to Lead Independent Director, both effective upon Mr. Lapalme’s resignation as Chairman.

 

 

January 8, 2015

Biotech

Halozyme Therapeutics appointed Athena Countouriotis, MD, Chief Medical Officer. 

Companies

Walgreens Co. completed its acquisition of Alliance Boots plc on December 31, 2014. The two companies merged to create the new, publically-traded company Walgreens Boots Alliance, Inc. Walgreens is now a part of the new company's Retail Pharmacy USA division and Alliance Boots is a part of its Retail Pharmacy International division.

Eli Lilly and Company completed its acquisition of Novartis Animal Health on January 1, 2015. Its portfolio of products is now a part of Lilly’s Elanco Animal Health division.

Eli Lilly and Company promoted Darren J. Carroll to Senior Vice President of Corporate Business Development. 

Isis Pharmaceuticals, Inc. appointed Sarah Boyce Chief Business Officer. The company also appointed Paula Soteropoulos President and Chief Executive Officer of Akcea Therapeutics, it’s newly formed Cambridge, MA based subsidiary.  

Rite Aid Corporation promoted Jocelyn Zazyczny Konrad to Group Vic President of Pharmacy Initiatives and Clinical Services. She succeeds Karen Staniforth, who was recently promoted to Chief Operating Officer of Rite Aid’s Health Dialog subsidiary.

Endo International plc announced that Caroline B. Manogue intends to retire as Executive Vice President and Chief Legal Officer on July 1, 2015. 

Medtronic announced that its shareholders have approved all proposals related to its acquisition of Covidien plc. The transaction is now expected to be completed in the last week of January or early February.  

Corporate Boards of Directors

Brookdale Senior Living, Inc. announced on December 30, 2014, that it has appointed William G. Petty, Jr., a founding partner of Beecken Petty O'Keefe & Company, to its Board of Directors. 

KYTHERA Biopharmaceuticals announced that it has appointed Hollings C. Renton, former Chairman, President and Chief Executive Officer of Onyx Pharmaceuticals, to its Board of Directors. It also announced that David Schnell and Robert T. Nelson have resigned from the Board. 

Boston Scientific Corporation announced that its founder and current Chairman Peter M. Nicholas plans to retire from the Board of Directors at the annual meeting of stockholders in 2017, where he will not stand for re-election.  

Former Government Officials Joining Health World

Bayer Corporation appointed Steven Immergut Vice President and Head of Pharmaceutical Communications. He will be based in Washington, DC. Mr. Immergut most recently served as Acting Associate Commissioner for External Affairs at the U.S. Food and Drug Administration.  

Group Purchasing Organizations

HealthTrust Purchasing Group, L.P. appointed Michael J. Schlosser, MD, FAANS, Chief Medical Officer, effective February 2, 2015.

Health Systems

John T. Fox has been appointed the new President and Chief Executive Officer for Beaumont Health, effective March 2015. 

Hospitals

Sharmila Makhija has been named the new Chair of Obstetrics and Gynecology for Albert Einstein College of Medicine and Montefiore Health System. 

Industry Service Providers

Eric Mendelsohn has been named the new Executive Vice President of Corporate Finance for National Health Investors, Inc.  

Insurance and Managed Care 

Affinity Health Plan announced that it plans to move its headquarters to a new office space in March 2015. The company plans to remain in the Bronx, NY.

 

 

December 30, 2014

Biotech

ImmunoGen, Inc. appointed Richard J. Gregory, PhD, Executive Vice President of Research and Chief Scientific Officer, effective January 5, 2015. He succeeds John Lambert, PhD, who will continue as Executive Vice President and Distinguished Research Fellow.

Companies

Walgreens Co. shareholders approved all proposals regarding its acquisition of Alliance Boots GmbH. The transaction is now expected to close on December 31, 2014.

Actavis plc appointed Jonathon Kellerman Executive Vice President and Global Chief Compliance Officer.

Corporate Boards of Directors

Tenet Healthcare Corporation announced that John Ellis “Jeb” Bush, former Governor of Florida, has resigned from its Board of Directors, effective December 31, 2014. 

Invacare Corporation appointed C. Martin Harris, a director since 2003, interim Chairman of the Board of Directors. He replaces A. Malachi Mixon, III, who retired as Executive Chairman earlier this month but remains a director.

 

 

December 18, 2014

Biotech

Vermillion, Inc. promoted Valerie Palmieri to President and Chief Executive Officer, effective January 1, 2015. She succeeds James LaFrance, who has stepped down as Chief Executive Officer but will remain Chairman of the Board. 

Companies

Merck & Co., Inc. appointed Julie Gerberding, MD, MPH, Executive Vice President of Strategic Communications, Global Public Policy and Population Health, effective December 15, 2014. She will be succeeded as President of Merck Vaccines by Jacques Cholat, who will serve as interim President of the division. 

Takeda Pharmaceutical Company Limited announced that its global oncology business unit, Millennium: The Takeda Pharmaceutical Company, is retiring the “Millennium” brand and will now be known as Takeda Oncology. 

Cigna Corporation appointed Mark Butler President and General Manager of its New England Market. He will be based on Boston, MA. 

New York Life Insurance Company appointed Kathleen Navarro Vice President and Chief Diversity Officer. She succeeds Joanne Rodgers, who will assume a new role in human resources. 

Gilead Sciences, Inc. appointed Philippe C. Bishop, MD, Senior Vice President of Hematology and Oncology Therapeutics. 

Human Inc. appointed Cynthia H. Zipperle Vice President, Chief Accounting Officer and Controller. She succeeds Steven E. McCulley, who will continue to serve as Senior Vice President of Medicare Operations. 

Vertex Pharmaceuticals Incorporated appointed David Altshuler Executive Vice President of Global Research and Chief Scientific Officer. He has resigned as a director of the company and will assume his new role in early 2015. 

DaVita HealthCare Partners Inc. announced on December 15, 2014, that it plans to merge its DaVita Clinical Research and HealthCare Partners Clinical Research business units.

WellCare Health Plans, Inc. appointed Kenneth A. Burdick Chief Executive Officer, effective January 1, 2015, and a member of the Board of Directors, effective immediately. He succeeds David Gallitano, who has been serving as interim Chief Executive Officer since November 2013. Mr. Gallitano will remain as the company’s chairman of the board. 

Express Scripts Holding Company appointed James H. Havel Executive Vice President and Interim Chief Financial Officer, effective January 2, 2015. He succeeds Cathy R. Smith, who has stepped down as Chief Financial Officer but will remain an employee of the company into the first quarter of 2015. 

IMS Health Services, Inc. appointed Mason Tenaglia Vice President of Payer and Managed Care Insights at the IMS Institute for Healthcare Informatics. 

The Allstate Corporation announced a number of upcoming leadership transitions, each effective January 4, 2015: Matthew E. Winter was promoted to President of Allstate and Chief Executive Officer of Allstate Life Insurance Company, with Thomas J. Wilson continuing as Chairman and Chief Executive Officer; James A. Haskins was promoted to Executive Vice President of Allstate Brand Distribution; James D. DeVries was appointed Executive Vice President of Allstate Brand Operations; Dogan “Don” Civgin was appointed President of Emerging Businesses; Suren Gupta was appointed Executive Vice President of Enterprise Technology and Strategic Ventures; and Harriet Harty was promoted to Executive Vice President of Human Resources. 

United Therapeutics Corporation promoted Roger Jeffs, PhD, to President and Co-Chief Executive Officer and David Zaccardelli, PharmD, to Executive Vice President and Chief Operating Officer, both effective January 1, 2015. Martine Rothblat will continue as Chairman and Co-Chief Executive Officer.  

Health IT

Extreme Networks, Inc. appointed Bob Gault Vice President of Global Channels and Partners. He replaces Theresa Caragol, who has assumed a new role as Vice President of Strategic Sales Initiatives. 

Quality Systems, Inc. appointed Zachary J. Sherburn Senior Vice President and Global Chief Information Officer.

Health Systems

John Bonamo has been named the new Chief Medical Officer for Barnabas Health, effective January 1, 2015. 

Bill Hardimon has been named the President and Chief Executive Officer of McLaren Medical Group. 

Kristin Bertell has been named the Chief Philanthropy Officer for City of Hope. 

Philip Loftus has been named the new Senior Vice President and Chief Information Officer for SSM Health Care, effective January 19, 2015. 

Bradley Solberg has been appointed the new President and Chief Executive Officer for OSF Saint James, effective January 5, 2015. He replaces David Ochs who has stepped down. 

Health – Hospitals

Chad Grant has been named the President and Chief Executive Officer for McLaren Oakland.

 

 

December 11, 2014

Biotech

Synta Pharmaceuticals Corp. appointed Chen Schor Executive Vice President and Chief Financial Officer and Marc Scheenbaum Senior Vice President and Chief Financial Officer. Mr. Scheenbaum succeeds Keith S. Ehrlich, who has stepped down as Chief Financial Officer. 

Companies

New York Life Insurance Company announced on December 4, 2014, that New York Life Investment Management has entered into a definitive agreement with IndexIQ Inc. under which NYLIM will acquire IndexIQ. Upon completion of the acquisition, IndexIQ will be integrated into NYLIM. The transaction is expected to close in the first half of 2015. 

Walgreen Co. appointed Linda Filler President of Retail Products and Chief Merchandising Officer. 

NBTY, Inc. appointed Brian Wynne President of NBTY Americas and Chief Executive Officer of its United States Nutrition, Inc. subsidiary, effective January 1, 2015. 

Walgreen Co. announced that its Greg Wasson, the company’s President and Chief Executive Officer, will retire upon the completion of its merger with Alliance Boots, which is expected to occur in the first quarter of 2015. Stefano Pessina will be appointed acting Chief Executive Officer of Walgreens Boots Alliance until a successor has been named. James Skinner will serve as Executive Chairman and William Foote will serve as lead independent director of the board of directors. 

Consultants and Service Providers

Bioclinica, Inc. appointed John Hubbard, PhD, Chief Executive Officer and a member of the Board of Directors, effective January 5, 2015. He succeeds Mark Weinstein, who is leaving the company. 

Corporate Boards of Directors

Tenet Healthcare Corporation appointed Freda C. Lewis-Hall, MD, Executive Vice President and Chief Medical Officer of Pfizer Inc., to its Board of Directors.  

Health Systems

David Currow has been named the Director of Palliative Medicine and Hospice Care at Dartmouth-Hitchcock. 

Weldon Gage has been selected the new Chief Financial Officer for M.D. Anderson Cancer Center.

Sheldon Retchin has been appointed the new Chief Executive Officer for Wexner Medical Center, effective March 2, 2015.

Boris Kuvshinoff has been named the Chief Medical Quality Officer and Interim Chief Medical Officer for Roswell Park. 

Georgetown Hospital System has announced that it will officially change its name to Tidelands Health, effective April 2015. 

Hospitals

Bob Moore has been appointed the new Chief Executive Officer for the Munroe Regional Medical Center. 

Karen Fordham has been named the new Chief Executive Officer for DMC Huron Valley-Sinai Hospital, effective January 1, 2015.  

Insurance and Managed Care

Kaiser Permanente appointed Claire Tamo Chief Financial Officer of The Permanente Federation.

Group Health Cooperative appointed John Harris Vice President of Line of Business and Product Management within its Health Plan Division.

Pharmaceutical Manufacturers

Lannett Company, Inc. appointed Michael Bogda President of the company. Arthur Bedrosian remains Chief Executive Officer. 

 

 

 

December 4, 2014 

Affiliated Organizations

Ontario Teachers’ Pension Plan appointed Jo Taylor Managing Director for Europe, Middle East and Africa and head of the London office. 

Biotech

Affymax, Inc. appointed Jonathan M. Couchman President and Chief Executive Officer and Director of the board as it continues to review strategic alternatives to dissolution. The remaining board members have resigned from their positions. 

Osiris Therapeutics, Inc. appointed Adrian Mollo General Counsel, Jon Hooper, MD, Chief Medical Officer, and Gregory Law Vice President of Finance and Principle Accounting Officer. 

Companies

Assurant Solutions, a division of Assurant, Inc., appointed Gilles Giacosa Senior Vice President of Strategy and Strategic Initiatives for its Connected Living division. 

Mutual of Omaha Insurance Company announced that Daniel P. Neary will retire as Chief Executive Officer in 2015. He will continue to serve as Chairman of the Board of Directors following his retirement. James T. Blackledge has been appointed President, effective immediately, and will succeed Mr. Neary after his retirement. 

Alere, Inc. appointed Juliet Cunningham Vice President of Investor Relations. 

HMS Holdings Corp. appointed Spencer Young President of its HealthDataInsights, Inc. subsidiary. He succeeds Andrea Benko who has retired as Executive Vice President and HMS and President of HDI, but will continue to serve as its President Emeritus until her resignation on February 27, 2015. 

Zoetis Inc. appointed Roman Trawicki President of Global Manufacturing and Supply, effective January 1, 2015. He succeeds Carolyn Hawver, who is retiring from the company. 

H. Lundbeck A/S announced that Ulf Wiinberg has resigned as President and Chief Executive Officer, effective immediately, as the result of a breaching the company’s Code of Conduct. Chairman of the Board Håkan Björklund will serve as Chairman with extended operational responsibilities and act as the day-to-day leader of the company until a replacement Chief Executive Officer is named. 

ValueOptions, Inc. appointed Jason Bearden Chief Executive Officer of the Georgia Collaborate ASO. 

WebMD Health Corp. appointed Lisa Ryan Howard Executive Vice President and Chief of Commercial Strategy. 

Teva Pharmaceutical Industries Ltd. appointed Yitzhak Peterburg Chairman, effective January 1, 2015. He succeeds Phillip Frost, who is stepping down from the position at the end of the year and plans to retire from the Board of Directors at the 2015 Annual General Meeting of Shareholders. The company also announced that Sol J. Barer, Managing Partner at SJ Barer Consulting, will join the Board of Directors on January 1, 2015. 

Avanir Pharmaceuticals, Inc. announced on December 2, 2014, that it has entered into a definitive agreement with Otsuka Pharmaceutical Co., Ltd. under which Otsuka will acquire Avanir for approximately $3.5 billion. Avanir will continue to operate as an independent subsidiary of Otsuka America, Inc. The transaction is expected to close in the first quarter of 2015.

Aetna Inc. appointed Karen S. Rohan President of the company, effective January 1, 2015. Mark Bertolini will remain Chairman and Chief Executive Officer. Ms. Rohan will assume responsibility for the National, Government and Specialty businesses in addition to Local and Regional businesses. Joseph M. Zubretsky will remain Senior Executive Vice President leading the Healthagen organization. 

On December 2, 2014, McKesson Corporation announced that a German court has approved a registration of domination and profit and loss transfer agreement, which will allow McKesson to operate as a combined company with Celesio Corporation, of which it is the majority shareholder. Celesio will become part of McKesson’s Distribution Solutions segment and continue to be led by its existing management board. The agreement is expected to be formally registered soon. 

CompuGroup Medical AG appointed Navid Asgari Vice President of Service and Support for its U.S. subsidiary’s Ambulatory Information Services Division. 

Wellpoint, Inc. officially changed its corporate name to Anthem, Inc.

Corporate Boards of Directors

Henry Schein, Inc. appointed Lawrence Bacow, PhD, former President of Tufts University, to its Board of Directors. 

Health IT

Nightingale Informatix Corporation appointed David Toews, CPA, CA, Chief Financial Officer. 

Anthelio Healthcare Solutions Inc. appointed Gary Trickett Senior Vice President of Information Technology Services. 

Extreme Networks, Inc. appointed Frank Yoshino Vice President of Treasurer and Investor Relations.

Health Systems

Bruce Hagen has been named the new President of OhioHealth Marion General Hospital, effective January 12, 2015. 

Steve Bunyard has been named the President of Dublin Methodist and Grady Memorial Hospital, effective January 12, 2015. 

Ketul Patel has been named the new Chief Executive Officer for CHI Franciscan Health, effective February 23, 2015.

Hospitals

Coleen Santa Ana has been named the new President for Sentara Albemarle Medical Center, effective December 8, 2014. She replaces Kenneth Wood who has been serving in an interim capacity. 

David Kirshner has been named the University of Rochester Medical Center, effective January 1, 2015.

Brian Skrainka has been named the Director of Pediatric Emergency for St. David’s North Austin Medical Center 

Karen Davis has been named the new Vice President of Nursing and Chief Nursing Officer for Howard County General Hospital, Inc. 

Deborah Miller has been named the new Director of Cultural Transformation for Howard County General Hospital, Inc. 

 

 

 

November 20, 2014

Biotech

Bioniche Life Sciences Inc. announced on November 13, 2014, that it plans to change its name to Telesta Therapeutics Inc. within the next few weeks.

Seattle Genetics, Inc. appointed Jean I. Liu Executive Vice President of Legal Affairs, General Counsel and Corporate Secretary. She succeeds Kirk Schumacher, who is retiring from the company.

Vermillion, Inc. announced that it has formed a new Strategic and medical Advisory Board to be co-led by the Donald Munroe, the company’s Chief Scientific Officer, and Judith Wolf, Chief Medical Officer. Other members include: Daniel Chan of the Johns Hopkins University School of Medicine; Robert E. Bristow of the University of California, Irvine; and Calaneet Balas, Chief Executive Officer of the Ovarian Cancer National Alliance.

Charities

The ALS Association announced that Nancy Frates, Christi Kolarcik and Ted Harada have been appointed to its Board of Directors.

Companies

Fresenius Medical Care AG & Co. KGaA announced on November 13, 2014, that it has entered into an agreement to acquire Cogent Healthcare, Inc. through Sound Physicians Inc., of which Fresenius is the majority shareholder. The transaction is expected to close this quarter. 

Rite Aid Corporation appointed Web Golinkin Chief Executive Officer and Karen Staniforth Chief Operating Officer of its Health Dialog Services Corporation subsidiary.  

Lumera Health Inc. completed the sale of its Women's Healthcare business to Perrigo Company plc and was acquired by AMAG Pharmaceuticals, Inc. on November 12, 2014. It now operates as AMAG's Maternal Health division.

InvaCare Corporation announced that A. Malachi Mixon, III, will retire and resign as Executive Chairman of the company, effective December 21, 2014. He will continue to serve until he reaches his mandatory retirement age at the 2016 annual meeting of shareholders. The company also announced that Joseph B. Richey, II, will step down as Senior Vic3e President of Electronic and Design Engineering and President of the Invacare Technologies Division, effective November 30, 2014. 

Actavis plc announced on November 17, 2014, that it has entered into a definitive agreement with Allergan, Inc. under which Actavis will acquire Allergan for approximately $66 billion. Following the completion of the transaction, two members of the Allergan Board of Directors will join the Actavis board. The transaction is expected to close in the first quarter of 2015. 

Sanofi SA appointed Chief Scientific Officer Gary Nabel as its Ebola Response Coordinator. 

Shire Plc appointed Jeff Poulton interim Chief Financial Officer, effective January 1, 2015. He replaces James Bowling, who is leaving the company effective February 28, 2015. The company also announced that it plans to start transitioning its US headquarters to 300 Shite Way, Lexington, MA 02421 starting in the first quarter of 2015. It anticipates the move to be completed by the first quarter of 2015. 

Endo International plc announced that the HSR Act Waiting Period has been terminated early and it expects to complete its acquisition of Auxilium Pharmaceuticals, Inc. by the first quarter of 2015. 

Cerner Corporation announced that John Glaser, Chief Executive Officer of Siemens Health Services, will serve as a Senior Vice President, effective upon the completion of Siemens Health Services, which is expected to close in the first quarter of 2015. 

Corporate Boards of Directors

United Therapeutics Corporation announced that Katherine J. Klein, PhD, Vice Dean of the Wharton Social Impact Initiative and Edward H. Bowman Professor of Management, has been appointed to its Board of Directors.  

Edwards Lifesciences Corporation announced that Nicholas J. Valeriani, Chief Executive of the West Health Institute, has been appointed to its Board of Directors. 

Health IT

Computer Task Group, Inc. promoted Ted Reynolds to Senior Vice President, where he will continue to head the company’s Healthcare IT Division.

Wipro, Ltd. appointed Hervé Sortais General Manager and Country Head for France. He will be based in Wipro’s Paris office.

Hospitals

Tin Nee has been named the new President and Chief Executive Officer for McLaren-Greater Lansing. He replaces Rick Wright who has resigned.

Chris Christie has been named the new Senior Executive Vice President and Chief Administrative Officer for Cooper Hospital. 

John Moore has been named the new Executive Vice President and Chief Financial Officer for Parkland Health and Hospital System, effective January 5, 2015. He replaces Mark Erath who has been serving in an interim basis.

Insurance and Managed Care

Highmark, Inc. (Highmark Health) announced that James Eisen, who has been serving as Co-Chief Executive Officer of HVHC, Inc., is assuming full Chief Executive Officer responsibilities for the division.

Medical Device Manufacturers

Cantel Medical Corp. announced that it has promoted several executives: Jorgen Hansen has been promoted to President and Chief Operating Officer; Eric Nodiff to Executive Vice President, General Counsel and Secretary; Craig Sheldon to Executive Vice President, Chief Financial Officer and Treasurer; and Steven Anaya to Senior Vice President and Chief Accounting Officer.

RHIOs/HIEs

Southern Tier Healthlink announced on November 17, 2014, that it plans to merge with Taconic Health Information Network and Community to form a new organization called HealthlinkNY. It will be governed by a combined 20-person Board.

 

  

November 13, 2014

Biotech

Dendreon Corporation announced on November 10, 2014, that it has filed for relief under Chapter 11 of the Bankruptcy Code. The company will continue to operate normally during the restructuring process.

Companies

HCA Holdings, Inc. appointed Hugh Tappan President of its South Atlantic Division, effective January 1, 2015. He succeeds Jamie Thomas, who is retiring from the company.

Perrigo Company plc announced on November 6, 2014, that it has entered into a definitive agreement with Omega Pharma NV under which Perrigo will acquire Omega for $4.5 billion. The transaction is expected to close in the first quarter of 2015.

Kindred Healthcare, Inc. announced that David Causby will serve as President of its Kindred at Home business, effective upon the completion of Kindred's acquisition of Gentiva Health Services, which is expected in the first quarter of 2015.

McKesson Medical Surgical announced that it plans to relocate its headquarters to 9954 Mayland Drive in summer 2015.

Alexion Pharmaceuticals, Inc. announced that Stephen Squinto, PhD, will retire from the company, effective January 1, 2015. He will continue to serve the company as Chair of its newly formed Scientific Advisory Board. He will be succeeded by Julie O’Neill, who has been promoted to Executive Vice President of Global Operations, effective on the same date.

UCB S.A. announced on November 7, 2014, that it has signed an agreement to sell Kremers Urban Pharmaceuticals to Advent International and Avista Capital Partners for $1.525 billion. Brian Markison will serve as President and Chief Executive Officer of KU following the completion of the sale. The transaction is expected to close by the first quarter of 2015.

Actavis plc appointed Maria Teresa Hilado Chief Financial Officer, effective December 8, 2014. She succeeds R. Todd Joyce, who will remain with the company through early 2015 to assist with the transition.

UnitedHealth Group Incorporated announced that it has made several executive changes and formed an Office of the Chief Executive comprised of the following members: Stephen J. Hemley, Chief Executive Officer; Larry C. Renfro, who has been named Vice Chairman of the company in addition to his role as Chief Executive Officer of Optum; David S. Wichmann, who has been promoted to President and will transition out of his role as Chief Financial Officer in the next 12 to 18 months; Marianne Short, Executive Vice President and Chief Legal Officer; Ellen Wilson, Executive Vice President of Human Capital; and Dirk McMahon, who has been appointed Executive Vice President of Enterprise Operations. In addition, Gail K. Bourdreaux has stepped down as Executive Vice President and Chief Executive Officer of UntiedHealthcare. All changes are effective immediately.

Centene Corporation appointed Cynthia J. Brinkley Executive Vice President of International Operations and Business Integration.

Aflac Incorporated promoted Michael J. Tomlinson to Senior Vice President and Director of Aflac U.S. Sales. He succeeds Thomas R. Giddens, who will step down from the role at the end of 2014.

Health Systems

Jeffrey Wilks has been named the President of Advertising at InVentive Health.

Penny Wheeler has been named the new Chief Executive Officer for Allina Health at the end of the year. She replaces Kenneth Paulus who is stepping down.

Hospitals

Paulette Evans has named the President and Chief Executive Officer for St. Joseph Hospital in Breese.

Ryan Brown has been appointed the new Vice President of Operations for Howard County General Hospital. He has been serving in an interim capacity since July of 2014.

Kathy Connerton has been named the new President and Chief Executive Officer for Lourdes Hospital, effective December 15, 2014.

Industry Service Providers

David Kobrinetz has been named the new National Director of Telemedicine for U.S. HealthWorks.

Kathryn Bohannon has been named the Vice President of Business Development in Europe and Asia for Theorem Clinical Research.

Insurance and Managed Care

Neighborhood Health Plan, Inc. announced that Deborah Enos will retire as Chief Executive Officer, effective February 1, 2015. She will remain in an advisory role through the end of March 2015. She will be succeeded by Chief Operating Officer David Segal, also effective February 1, 2015.

Affinity Health Plan, Inc. announced that Bert Scott will resign as President and Chief Executive Officer on December 31, 2014. He will be succeeded by current Chief Financial Officer Glenn MacFarlane, who will assume the role on January 1, 2015. Effective on the same date, Chaunte Tucker, the company’s controller, will assume the role of interim Chief Financial Officer.

Pharmacies

Diplomat Pharmacy, Inc. appointed Martino Luu Vice President of Innovation and Process Improvement.

Pharmaceutical Manufacturers

CONMED Corporation appointed Curt Hartman President and Chief Executive Officer. He had been serving as interim Chief Executive Officer since July 2014.

 

 

November 6, 2014

Behavioral Health Centers

Acadia Healthcare Company, Inc. announced on October 29, 2014, that it has entered into a definitive agreement with CRC Health Group, Inc. under which Acadia will acquire CRC Health. The transaction is expected to close in the first quarter of 2015.

Biotech

GenVec, Inc. announced that Quinterol J. Mallette, MD, a Senior Analyst at SWK Holdings, Inc., was appointed to its Board of Directors.

BIND Therapeutics, Inc. appointed Hagop Youssoufian, MD, Chief Medical Officer. He replaces Edward Schnipper, MD, who has been serving as interim Chief Medical Officer since January 2014. The company also announced that Jeff Hrkach is stepping down as Chief Technology Officer at the end of November, but will continue to serve the company as a member of its Scientific Advisory Board.

Lexicon Pharmaceuticals, Inc. appointed Kenneth B. Kassler-Taub, MD, Vice President of Clinical Operations and Kiernan A. Seth, PhD, MBA, Executive Director of Marketing.

NPS Pharmaceuticals, Inc. appointed Pierre Legault, Chief Executive officer of NephroGenex, Inc., to its Board of Directors.

Companies

Zimmer Holdings, Inc. announced that, following the completion of its merger with Biomet, Inc., the combined company will be known as Zimmer Biomet.

New York Life Insurance Company appointed Gary Bennett Chief Executive Officer of Seguros Monterrey New York Life, its insurance company based in Mexico, effective in November 2014.

Kindred Healthcare, Inc. appointed Benjamin A. Breier Chief Executive Officer and a member of the Board of Directors, effective March 31, 2015. He succeeds Paul J. Diaz, who will continue to serve the company as Executive Vice Chairman.

Laboratory Corporation of American Holdings announced on November 3, 2014, that it has entered into a definitive merger agreement with Covance Inc. under which LabCorp will acquire Covance for approximately $5.6 billion. Covance's Chairman and Chief Executive Officer, will head LabCorp's new Covance division. The transaction isexpected to close in the first quarter of 2015. 

Parallon Business Solutions, LLC appointed David Osborn, PhD, Senior Vice President of Parallon Consulting Services, effective November 10, 2014.

The Allstate Corporation appointed Stephanie D. Neely Vice President of Treasury, effective December 1, 2014.

NBTY, Inc. appointed Andrew Archambault Chief Customer Officer. He succeeds Rich Scoza, who has stepped down as President of US Nutrition.

Reckitt Benckiser Pharmaceuticals, Inc. appointed Cary J. Claiborne Chief Financial Officer.

New York Life Insurance Company appointed Kelli Parsons Chief Corporate Communications and Marketing Officer, effective November 17, 2014.

Actavis plc announced that its Chief Financial Officer R. Todd Joyce will retire from the company in early 2015.

Cubist Pharmaceuticals, Inc. promoted Patrick Vink, MD, MBA, currently Senior Vice President and General Manager of International Operations, to Executive Vice President and Chief Operating Officer, effective January 1, 2015.

Team Health Holdings, Inc. appointed Kevin Klauer, DO, Chief Medical Officer of Emergency Medicine, effective January 1, 2015.

Health IT

HealthPort announced on October 31, 2014, that it has entered into a definitely agreement to be acquired by a fund managed by New Mountain Capital, LLC in an all-cash transaction. The transaction is expected to close in the fourth quarter of 2014.

Computer Task Group, Inc. (CTG) appointed Filip J.L. Gyde, the company’s Senior Vice President and General Manager of CTG Europe, to the position of Interim Executive Vice President of Operations. It also named John M. Laubacker, the company’s Treasurer, as Interim Chief Financial Officer.

Nightingale announced on October 31, 2014, that its Chief Financial Officer, Peter Cauley, has left the company.  It retained a new Chief Financial Officer, whose name has yet to be announced. He will join the company in the next few weeks.

Extreme Networks, Inc. appointed David Hume Chief Information Officer. In a separate announcement, the company also appointed Stephen Patak Vice President of Sales for the United States and Canada region.

Hayes Management Consulting appointed Jim Gibson Vice President of Strategic Services.

Pharmaceutical Manufacturers

Ipsen Biopharmaceuticals, Inc. appointed Donald Pearl Vice President of Neurology.

Pharmavite, LLC appointed Nitin Deshpande Chief Financial Officer.

 

 

October 30, 2014

Biotech

Vermillion Inc. appointed Valerie Palmieri Chief Operating Officer.

Alnylam Pharmaceuticals, Inc. appointed Pushkal Gard, MD, Senior Vice President of Clinical Development.

Companies

Aflac Incorporated promoted Hiroshi Yamauchi to President of Aflac Japan, effective January 1, 2015. He succeeds Tohru Tonoike, who will assume the role of Vice Chairman, effective at the same time.

Hill-Rom Holdings, Inc. appointed Steven J. Strobel Senior Vice President and Chief Financial Officer. He will join the company as Senior Vice President on November 3, 2014, and assume the position of Chief Financial Officer on December 1, 2014.

Alere Inc. appointed Namal Nawana President, Chief Executive Officer and member of the Board of Directors. He had previously been serving as interim President and Chief Executive Officer since July 2014.

Optum Inc. announced on October 28, 2014, that it has entered into a definitive agreement with Alere Inc. under which Optum will acquire Alere Health, LLC and its subsidiaries for $600 million.

Sanofi SA announced that its Board of Directors has voted to remove Christopher A. Viehbacher as Chief Executive Officer. As a consequence, Mr. Viehbacher has also resigned from the company’s Board. Sanofi Chairman Serge Weinberg has been named interim Chief Executive Officer of the company.

Corporate Boards of Directors

HCA Holdings, Inc. appointed its President and Chief Executive Officer R. Milton Johnson to the additional position of Chairman of the Board of Directors, effective December 31, 2014. He succeeds Richard M. Bracken, who is retiring from the company effective on the same date.

Health Systems

Partners HealthCare announced that Gary Gottlieb will resign as President and Chief Executive Officer, effective July 1, 2015. He is leaving the company to become Chief Executive Officer of Partners In Health.

Mercy Health System and Rockford Health System announced on October 28, 2014, that they have entered into an agreement to combine as a new, as-yet-unnamed health system. The two organizations will continue to maintain their names. The transaction is expected to close in early 2015.

Hospitals

McClaren Bay Region appointed Clarence Sevillian President and Chief Executive Officer, effective December 20, 2014. He succeeds Alice Gerard, who is retiring from the hospital.

Insurance and Managed Care

CareSource Management Group appointed Kim Roherty Vice President of Quality and Performance Outcomes.

Medical Device Manufacturers

Wright Medical Group, Inc. announced on October 27, 2014, that it has entered into a definitive agreement with Tornier N.V. under which the two companies will combine in a transaction valued at approximately $3.3 billion. The combined company will operate as Wright Medical Group N.V and be headquartered in the Netherlands with its U.S. headquarters in Memphis, TN. Robert Palmisano will serve as President and Chief Executive Officer and David Mowry will serve as Executive Vice President and Chief Operating Officer. The company's board will be comprised of five representatives from Wright and Tornier's existing boards. The transaction is expected to close in the first half of 2015.

Integra LifeSciences Holdings Corporation completed its acquisition of the MicroFrance and Xomed manual ENT and laparoscopy instrumentation lines from Medtronic Inc. on October 27, 2014.

Pharmaceutical Manufacturers

CSL Limited announced on October 27, 2014, that it has entered into an agreement with Novartis AG under which CSL will acquire Novartis' global influenza vaccine business for $275 million. The business will be integrated into CSL's subsidiary, bioCSL. The transaction is expected to be completed in the second half of 2015.

ZOLL Medical Corporation announced on October 28, 2014, that it has entered into an agreement with Impact Instrumentation, Inc. under which ZOLL will acquire substantially all of Impact Instrumentation's assets.

 

 

October 23, 2014

Biotech

GenVec, Inc. announced that Zola P. Horovitz is retiring from its Board of Directors, effective October 24, 2014.

Charities

Hospital Foundation of America appointed Michael Abrams, a partner with Ballard Partners and former Florida State representative, to its Board of Directors, effective November 1, 2014.

Companies

Regeneron Pharmaceuticals, Inc. appointed Alan Shuldiner, MD, Vice President of Translational Genetics. It also announced that Richard Lifton, MD, PhD, has been appointed Chairman of the Scientific Advisory Board of its Regeneron Genetics Center subsidiary.

Shire Plc announced that James Bowling, interim Chief Financial Officer, will leave the company at the end of the first quarter of 2015.

Cubist Pharmaceuticals, Inc. appointed Robert J. Perez Chief Executive Officer, effective January 1, 2015. He succeeds Michael W. Bonney, who will continue to serve the company as Non-Executive Chairman of the Board. Current Chairman Kenneth M. Bath will assume the role of Lead Independent Director.

Reckitt Benckiser Group plc announced that it expects to complete the demerger of Reckitt Benckiser Pharmaceuticals Inc. by December 31, 2014. Upon completion of the demerger, the pharmaceutical division will operate independently under a new holding company Indivior Plc, which will be listed on the London Stock Exchange.

Abbvie Inc. and Shire plc announced on October 20, 2014, that they have agreed to terminate their proposed merger following the choice of the Abbvie’s Board of Directors to withdraw support for the transaction and the subsequent likelihood that its shareholders would vote against the proposal.

Davita Healthcare Partners Inc. appointed John Wigneswaran, MD, Vice President of Clinical Affairs for Hospital Services of its Davita Kidney Care Division.

Davita HealthCare Partners Inc. announced on October 22, 2014, that its HealthCare Partners subsidiary has entered into an agreement with Colorado Springs Health Partners under which HealthCare Partners will acquire CSHP. The transaction is expected to close in the fourth quarter of 2014.

Corporate Boards of Directors

Amgen, Inc. announced that R. Sanders Williams, President of Gladstone Institutes, has been appointed to its Board of Directors.

Quest Diagnostics, Inc. announced that Jeffrey M. Leiden, MD, PhD, Chairman, President and Chief Executive Officer of Vertex Pharmaceuticals, has been appointed to its Board of Directors, effective December 1, 2014.

Health Systems

David Joos has been named the new Vice President of Access Management and Transitions of Care for KentuckyOne Health.

Michael Williams has been named the new Chief Medical Information Officer for University of Virginia Health System.

Eric Deaton has been named the new Executive Vice President and Chief Operating Officer for Wellmont Health System, effective November 10, 2014.

Hospitals

David Schultz has been appointed the new President of Harrison Medical Center, effective December 15, 2014.

Insurance and Managed Care

San Francisco Health Plan appointed James Glauber, MD, MPH, Chief Medical Officer.

Horizon Healthcare Services, Inc. (d/b/a Horizon Blue Cross Blue Shield of New Jersey) appointed Minal Patel, MD, Senior Vice President and Chief Strategy Officer.

Pharmaceutical Manufacturers

Grünenthal GmbH appointed Sascha Becker Group Chief Financial Officer, effective in the first quarter of 2015. She succeeds Stefan Genten, whose contract ends at the end of the year.

RHIOs/HIEs

The North Carolina Healthcare Information and Communications Alliance appointed Jennifer Anderson its new Executive Director, effective November 3, 2014. She succeeds Holt Anderson who is retiring on October 31.

 

 

October 16, 2014

Companies

Endo International plc announced on October 9, 2014, that it has entered into a definitive agreement with Auxilium Pharmaceuticals, Inc. under which Endo will acquire Auxilium for $2.6 billion in a cash and stock transaction. The transaction is expected to close in the first half of 2015.

Kindred Healthcare, Inc. announced on October 9, 2014, that it has entered into a definite merger agreement with Gentiva Health Services, Inc. under which Kindred will acquire Gentiva for $1.8 billion. The combined home health and hospice businesses will operate within the Kindred at Home division. The transaction is expected to close in the first quarter of 2015.

Hill-Rom Holdings, Inc. appointed Carlyn D. Solomon Chief Operating Officer. She will join the company next month, no later than November 30, 2014.

Medtronic Inc. announced the executive team that will lead the new company, Medtronic plc, following Medtronic’s merger with Covidien plc. The new company will remain headed by Omar Ishrak, who will continue to serve as Chairman and Chief Executive Officer, and be divided into four major business groups: Mike Coyle will serve as Executive Vice President and President of the Cardiac and Vascular Group; Hooman Hakami will serve as Executive Vice President and President of the Diabetes Group; Chris O’Connell will serve as Executive Vice President and President of the Restorative Therapies Group; and Bryan Hanson will serve as Executive Vice President and President of the newly formed Covidien Group. Covidien’s existing Peripheral Vascular business will be integrated into the Cardiac and Vascular Group and its Neurovascular business will be integrated into the Restorative Therapies Group.

The executive team will also assume a new regional structure divided into four major regions: Bob White will serve as Senior Vice President and President of Medtronic Asia Pacific; Mike Genau will serve as Senior Vice President and President of Medtronic’s Americas Region; Rob ten Hoedt will serve as Executive Vice President and President, of the Europe, Middle East, and Africa Region; and Chris Lee will Senior Vice President and President of the Greater China Region. Medtronic’s current functional leaders represented on its Executive Committee will continue in their roles.

STERIS Corporation announced on October 13, 2014, that it has commenced a recommended offer to acquire Synergy Health, plc for approximately $1.9 billion. Upon completion of the merger, STERIS will expand its board to thirteen members, adding three current Synergy board members, including Chief Executive Officer Richard Steeves. The transaction is expected to close by March 31, 2015.

DaVita HealthCare Partners, Inc. appointed Lorne L. Holland, MD, MBA, Chief Laboratory Officer of its Davita Labs division.

Esurance Inc. appointed Eric Brandt Managing Director and Chief Claims Officer.

The Allstate Corporation appointed Russell K. Mayerfield Senior Managing Director of Allstate Investments. The company also announced that it has promoted Peter Keehn to Managing Director of Private Equity Investing.

AbbVie Inc. announced on October 15, 2014, that its Board of Directors has withdrawn its recommendation to stockholders to adopt the company’s merger agreement with Shire plc.

Novo Nordisk A/S appointed Jackie Scanlan Corporate Vice President of Human Resources for Novo Nordisk Inc., its North American affiliate.

Corporate Boards of Directors

Alexion Pharmaceuticals, Inc. appointed Leonard Bell, MD, Chairman of the Board of Directors. He will continue to serve as the company’s Chief Executive Officer. The company also announced that it has appointed R. Douglas Norby Lead Independent Director. The appointments come following the death of Max Link, PhD, who had served as Chairman of the Board of Directors.

Health IT

Silverlink Communications, Inc. appointed David Veroff Senior Vice president of Analytics.

Computer Task Group, Inc. announced that James R. Boldt, the company’s Chairman and Chief Executive Officer, died on October 13, 2014. Brendan M. Harrington, the company’s Chief Financial Officer, was appointed interim Chief Executive Officer and Daniel J. Sullivan was appointed Non-Executive Chairman of the Board of Directors.

Hospitals

Margaret Van Bree has been named the new President and Chief Executive Officer for Lifespan Corporation’s Rhode Island Hospital, effective January 5, 2015. She replaces Timothy Babineau who will remain President and Chief Executive Officer for Lifespan Corporation.

Robert Bonar Jr. has been named the new Chief Executive Officer for the Children’s Hospitals and Clinics of Minnesota, effective December 8, 2014.

Thomas Balcezak has been named the Chief Medical Officer for Yale-New Haven Hospital.

Insurance and Managed Care

Premera Blue Cross appointed John Espinola, MD, MPH, MBA, Executive Vice President of Health Care Services.

Kaiser Permanente appointed Julie Miller-Phipps President of Kaiser Foundation Health Plan of Georgia. She succeeds Kerry W. Kohnen who is retiring from the company.

Pharmaceutical Manufacturers

Ipsen S.A. appointed Aymeric Le Chatelier Executive Vice President and Chief Financial Officer, effective November 3, 2014. He succeeds Susheel Surpal who is leaving the company at the end of October.

Merz North America appointed Patrick Urban Head of the Ulthera Business Unit, which was acquired by Merz in July 2014.